 STOCK PURCHASE AGREEMENT     

Exhibit 2.1

  

  

 

  

  

  

  

  

STOCK PURCHASE AGREEMENT 
  
  
 Dated as of April 14, 2017 
  
  
  by and among

  


 

  

ASHLAND LLC, 
  
  PHARMACHEM LABORATORIES, INC., 
 

  


 

  

the holders of Common Stock identified on Exhibit A hereto, 
 

  


 

  

DR. DAVID PEELE 
  
 and 
  
  PHOTON SH REPRESENTATIVE LLC, as the Shareholders' Representative

  

    

  

     

TABLE OF CONTENTS

   
--- 
     |  |  |   
     |  |  |  

 _Page_

   
     |  |  |   
    

ARTICLE 1. DEFINED TERMS

  |  

2

   
     |  

1.1

  |  

Certain Definitions

  |  

2

   
     |  

1.2

  |  

Additional Definitions

  |  

9

   
     |  

1.3

  |  

Interpretation

  |  

11

   
     |  

1.4

  |  

Calculation of Time Period

  |  

12

   
     |  |  |   
    

ARTICLE 2. PURCHASE AND SALE

  |  

12

   
     |  

2.1

  |  

Purchase and Sale of Common Stock and Atom Minority Shares

  |  

12

   
     |  

2.2

  |  

Closing

  |  

12

   
     |  |  |   
    

ARTICLE 3. CLOSING MATTERS; REPRESENTATIONS AND WARRANTIES OF THE SHAREHOLDERS

  |  

13

   
     |  

3.1

  |  

Pre-Closing Statement

  |  

13

   
     |  

3.2

  |  

Closing Payments

  |  

13

   
     |  

3.3

  |  

Withholding

  |  

13

   
     |  

3.4

  |  

Post-Closing Adjustment

  |  

14

   
     |  

3.5

  |  

Purchase Price Escrow Amount; Tax Return Escrow Amount; and Tax Escrow Amount

  |  

17

   
     |  

3.6

  |  

Representations and Warranties of the Shareholders

  |  

19

   
     |  |  |   
    

ARTICLE 4. REPRESENTATIONS AND WARRANTIES OF THE COMPANY

  |  

21

   
     |  

4.1

  |  

Corporate Organization

  |  

21

   
     |  

4.2

  |  

Subsidiaries and Minority Interests

  |  

21

   
     |  

4.3

  |  

Capitalization; Ownership

  |  

22

   
     |  

4.4

  |  

Authority

  |  

22

   
     |  

4.5

  |  

Consents and Approvals; No Violations

  |  

22

   
     |  

4.6

  |  

[Intentionally Omitted]

  |  

23

   
     |  

4.7

  |  

[Intentionally Omitted]

  |  

23

   
     |  

4.8

  |  

Financial Statements

  |  

23

   
     |  

4.9

  |  

No Undisclosed Liabilities

  |  

24

   
     |  

4.10

  |  

Absence of Certain Changes

  |  

24

   
     |  

4.11

  |  

Personal Property

  |  

24

   
     |  

4.12

  |  

Real Property

  |  

25

   
     |  

4.13

  |  

Intellectual Property

  |  

26

   
     |  

4.14

  |  

Contracts

  |  

28

   
     |  

4.15

  |  

Related Party Agreements

  |  

30

   
     |  

4.16

  |  

Compliance with Applicable Law; Permits

  |  

30

   
     |  

4.17

  |  

Litigation

  |  

31

   
     |  

4.18

  |  

Labor

  |  

31

   
     |  

4.19

  |  

Employee Matters

  |  

32

   
     |  

4.20

  |  

Environmental Matters

  |  

34

   
     |  

4.21

  |  

Tax Returns and Tax Payments

  |  

36

   
     |  

4.22

  |  

Insurance

  |  

37

   
     |  

4.23

  |  

Broker's Fees

  |  

37

   
   


 

  

 

i  

 

  

  

    

TABLE OF CONTENTS

  

(continued)

   
--- 
     |  |  |   
     |  |  |  

 _Page_

   
     |  |  |   
     |  

4.24

  |  

Significant Customers and Suppliers

  |  

37

   
     |  

4.25

  |  

Fairness Opinion

  |  

38

   
     |  

4.26

  |  

No Other Representations

  |  

38

   
     |  |  |   
    

ARTICLE 5. REPRESENTATIONS AND WARRANTIES OF PARENT

  |  

38

   
     |  

5.1

  |  

Organization

  |  

39

   
     |  

5.2

  |  

Authority

  |  

39

   
     |  

5.3

  |  

Consents and Approvals; No Violation

  |  

39

   
     |  

5.4

  |  

Vote Required

  |  

40

   
     |  

5.5

  |  

Litigation

  |  

40

   
     |  

5.6

  |  

Financing

  |  

40

   
     |  

5.7

  |  

Acquisition for Investment

  |  

40

   
     |  

5.8

  |  

Solvency

  |  

40

   
     |  

5.9

  |  

Broker's Fees

  |  

41

   
     |  

5.10

  |  

No Other Representations

  |  

41

   
     |  |  |   
    

ARTICLE 6. COVENANTS

  |  

42

   
     |  

6.1

  |  

Conduct of Business Prior to the Closing

  |  

42

   
     |  

6.2

  |  

Payoff Letters

  |  

45

   
     |  

6.3

  |  

Company Transaction Expense Direction Notice

  |  

45

   
     |  |  |   
    

ARTICLE 7. ADDITIONAL AGREEMENTS

  |  

45

   
     |  

7.1

  |  

Expenses

  |  

45

   
     |  

7.2

  |  

Certain Tax Matters

  |  

45

   
     |  

7.3

  |  

Publication/Distribution of Agreement

  |  

48

   
     |  

7.4

  |  

Access to Information; Confidentiality

  |  

49

   
     |  

7.5

  |  

Consents; Further Assurances

  |  

51

   
     |  

7.6

  |  

Directors' and Officers' Insurance; Company Release

  |  

53

   
     |  

7.7

  |  

Shareholder Release

  |  

54

   
     |  

7.8

  |  

RandW Insurance

  |  

55

   
     |  

7.9

  |  

280G Vote

  |  

56

   
     |  

7.10

  |  

Exclusive Dealing

  |  

56

   
     |  

7.11

  |  

Restrictive Covenant

  |  

57

   
     |  

7.12

  |  

Continued Existence

  |  

57

   
     |  

7.13

  |  

ESOP Matters

  |  

58

   
     |  

7.14

  |  

Resignations

  |  

58

   
     |  |  |   
    

ARTICLE 8. CONDITIONS PRECEDENT

  |  

58

   
     |  

8.1

  |  

Conditions to Each Party's Obligation To Effect the Transactions

  |  

58

   
     |  

8.2

  |  

Conditions to Obligations of Parent

  |  

59

   
     |  

8.3

  |  

Conditions to Obligation of the Company and the Shareholders

  |  

60

   
     |  

8.4

  |  

Frustration of Closing Conditions

  |  

60

   
     |  |  |   
    

ARTICLE 9. TERMINATION, AMENDMENT AND WAIVER

  |  

60

   
     |  

9.1

  |  

Termination

  |  

60

   
     |  

9.2

  |  

Effect of Termination

  |  

61

   
  

  

  

 

ii  

  

  

    

TABLE OF CONTENTS

  

(continued)

   
--- 
     |  |  |   
    

 _Page_

   
     |   
    

ARTICLE 10. INDEMNIFICATION

  |  

62

   
     |  

10.1

  |  

Indemnification of Parent Indemnitees

  |  

62

   
     |  

10.2

  |  

Indemnification by Parent

  |  

63

   
     |  

10.3

  |  

Calculation of Losses

  |  

63

   
     |  

10.4

  |  

Termination of Indemnification

  |  

64

   
     |  

10.5

  |  

Procedures.

  |  

64

   
     |  

10.6

  |  

Release from Indemnity Escrow Account

  |  

66

   
     |  

10.7

  |  

Release from Tax Return Escrow Account

  |  

66

   
     |  

10.8

  |  

Release from Tax Escrow Account

  |  

66

   
     |  

10.9

  |  

Damages

  |  

66

   
     |  

10.10

  |  

Tax Treatment

  |  

67

   
     |  |  |   
    

ARTICLE 11. GENERAL PROVISIONS

  |  

67

   
     |  

11.1

  |  

Survival of Representations, Warranties and Agreement

  |  

67

   
     |  

11.2

  |  

Exclusive Remedy

  |  

67

   
     |  

11.3

  |  

Notices

  |  

68

   
     |  

11.4

  |  

Counterparts

  |  

70

   
     |  

11.5

  |  

Entire Agreement; No Third-Party Beneficiaries

  |  

70

   
     |  

11.6

  |  

Amendment

  |  

70

   
     |  

11.7

  |  

Extension; Waiver

  |  

70

   
     |  

11.8

  |  

Governing Law

  |  

70

   
     |  

11.9

  |  

Assignment; Binding Effect

  |  

70

   
     |  

11.10

  |  

Shareholders' Representative

  |  

71

   
     |  

11.11

  |  

Specific Performance; Enforcement

  |  

72

   
     |  

11.12

  |  

Jurisdiction

  |  

72

   
     |  

11.13

  |  

WAIVER OF TRIAL BY JURY

  |  

73

   
     |  

11.14

  |  

Severability

  |  

73

   
     |  

11.15

  |  

Company Disclosure Schedule

  |  

74

   
     |  

11.16

  |  

Legal Representation

  |  

74

   
     |  

11.17

  |  

No Obligation or Liability of Nonparties

  |  

75

   
  

  

  

 

iii  

  

  

    EXHIBITS AND SCHEDULES  
--- 
     |   
    _Exhibits_  |   
     |   
   Exhibit A  |  

Company Shareholders

   
   Exhibit B  |  

Escrow Agreement

   
   Exhibit C  |  

Certification of Non-U.S. Real Property Interest (Pharmachem Laboratories,
Inc.)

   
   Exhibit D  |  

Certification of Non-U.S. Real Property Interest (Avoca Inc.)

   
   Exhibit E  | Fairness Opinion   
     |   
    

 _Shareholders ' Disclosure Schedule_

   
     |   
    

Section 3.6(b)(i)

  |  

Title to Shares

   
     |   
    

 _Company Disclosure Schedule_

   
     |   
    

Section 1.1

  |  

Permitted Liens

   
    

Section 4.2

  |  

Subsidiaries

   
    

Section 4.3(b)

  |  

Ownership of Common Stock

   
    

Section 4.5(b)(iv)

  |  

Consents and Approvals

   
    

Section 4.8(a)

  |  

Financial Statements

   
    

Section 4.8(b)

  |  

Internal Accounting Controls

   
    

Section 4.8(c)

  |  

Accounts Receivable

   
    

Section 4.8(e)

  |  

Indebtedness

   
    

Section 4.9

  |  

No Undisclosed Liabilities

   
    

Section 4.10

  |  

Absence of Certain Changes

   
    

Section 4.11

  |  

Title to Personal Property

   
    

Section 4.12(a)

  |  

Leased Real Property

   
    

Section 4.12 (b)

  |  

Owned Real Property

   
    

Section 4.13(a)

  |  

Registered Intellectual Property

   
    

Section 4.14(a)

  |  

Material Contracts

   
    

Section 4.15

  |  

Related Party Agreements

   
    

Section 4.16

  |  

Compliance with Applicable Law; Permits

   
    

Section 4.17

  |  

Litigation

   
    

Section 4.18(a)

  |  

Labor Complaints or Charges

   
    

Section 4.18(c)

  |  

Compliance with Labor Laws

   
    

Section 4.19(a)

  |  

Company Benefit Plans

   
    

Section 4.19(f)

  |  

Employee Matters

   
    

Section 4.20

  |  

Environmental Matters

   
    

Section 4.21

  |  

Tax Returns and Tax Payments

   
    

Section 4.22

  |  

Insurance

   
    

Section 4.24

  |  

Material Customers, Suppliers and Distributors

   
    

Section 6.1

  |  

Conduct of Business Prior to Closing

   
    

Section 6.1(e)

  |  

Contracts for Disposition of Properties or Assets

   
    

Section 6.1(l)

  |  

Settlements

   
  

  

  

 

iv  

  

  

    

 _EXHIBITS AND SCHEDULES_

  

(continued)

   
--- 
     |   
    _Annexes_  |   
     |   
    

Annex 1.1(a)

  |  

Allocation Annex

   
    

Annex 1.1(b)

  |  

Net Working Capital

   
  

  

  

 

v  

  

  

 

STOCK PURCHASE AGREEMENT

  


 

  

THIS STOCK PURCHASE AGREEMENT, dated as of April 14, 2017 (this " _Agreement_
"), is made by and among: (i) Ashland LLC, a Kentucky limited liability
company (" _Parent_ "); (ii) Pharmachem Laboratories, Inc., a New Jersey
corporation (the " _Company_ "); (iii) the holders of Common Stock identified
on _Exhibit A_ hereto (the " _Company Shareholders_ "); (iv) Dr. David Peele
(the " _Atom Minority Shareholder_ "); and (v) Photon SH Representative LLC,
solely in its capacity as the shareholder representative hereunder (the "
_Shareholders ' Representative_"). Capitalized terms used herein without
definition shall have the meanings specified in _ARTICLE 1_.

  


 

  

RECITALS

  


 

  

WHEREAS, the Company Shareholders own all of the issued and outstanding shares
of Common Stock;

  


 

  

WHEREAS, on the terms and subject to the conditions set forth in this
Agreement, the Company Shareholders desire to sell to Parent, and Parent
desires to purchase from the Company Shareholders, all of the issued and
outstanding shares of Common Stock;

  


 

  

WHEREAS, the Atom Minority Shareholder holds 16 shares of Atom Common Stock
(the " _Atom Minority Shares_ ") and the Company owns 84 shares of Atom Common
Stock, together constituting all of the issued and outstanding shares of Atom
Common Stock;

  


 

  

WHEREAS, on the terms and subject to the conditions set forth in this
Agreement, the Atom Minority Shareholder desires to sell to the Company, and
the Company desires to purchase from the Atom Minority Shareholder, all of the
Atom Minority Shares;

  


 

  

WHEREAS, at the Closing following the purchase of the Common Stock, Parent
desires to contribute cash to the capital of the Company for the purpose of
funding the Company's purchase of the Atom Minority Shares, and the Company
desires that Parent pay such cash directly to the Atom Minority Shareholder on
the Company's behalf on the terms and subject to the conditions set forth in
this Agreement;

  


 

  

WHEREAS, the ESOP Trustee has received an opinion from the Qualified
Independent Appraiser (the " _Fairness Opinion_ ") that (i) the price to be
received by the ESOP for its shares of Common Stock is not less than fair
market value (as such term is used in determining "adequate consideration"
under section 3(18) of the Employee Retirement Income Security Act of 1974, as
amended " _ERISA_ ") of such shares and (ii) the terms and conditions of the
transactions contemplated herein are fair and reasonable to the ESOP from a
financial point of view;

  


 

  

NOW, THEREFORE, in consideration of the foregoing, and the respective
representations, warranties, covenants and agreements set forth in this
Agreement, and intending to be legally bound hereby, the parties hereto hereby
agree as follows:

  

  

 

1  

  

  

ARTICLE 1. 
  DEFINED TERMS

  


 

  

1.1 _Certain Definitions_. For purposes of this Agreement:

  


 

  

" _Adjusted Base Consideration_ " means $660,000,000 plus (i) the Estimated
Closing Cash, plus (ii) the Estimated Net Working Capital Adjustment Amount
and minus (iii) Estimated Closing Indebtedness and minus (iv) Estimated
Company Transaction Expenses.

  


 

  

" _Adjustment Amount_ " equals the sum (which may be positive or negative) of:

  


 

  

(a) Closing Net Working Capital (as finally determined in accordance with the
procedures set forth in _Section 3.4_ ) minus Estimated Closing Net Working
Capital, plus

  


 

  

(b) Closing Cash minus Estimated Closing Cash, plus

  


 

  

(c) Estimated Closing Indebtedness minus Closing Indebtedness (as finally
determined in accordance with the procedures set forth in _Section 3.4_ ),
plus

  


 

  

(d) Estimated Company Transaction Expenses minus Company Transaction Expenses
(as finally determined in accordance with the procedures set forth in _Section
3.4_ ).

  


 

  

An " _affiliate_ " of any Person means another Person that directly or
indirectly, through one or more intermediaries, controls, is controlled by, or
is under common control with, such first person; _provided_ that such Person
shall be deemed an affiliate for only so long as such control exists and, for
purposes of this definition, " _control_ " means the possession, directly or
indirectly, of the power to direct, or cause the direction of, the management
and policies of such person, whether through the ownership of voting
securities, by Contract, or otherwise.

  


 

  

" _Allocation Annex_ " means _Annex 1.1(a)_ hereto.

  


 

  

" _Antitrust Laws_ " means the HSR Act, the Sherman Antitrust Act of 1890, as
amended, the Clayton Act of 1914, as amended, the Federal Trade Commission Act
of 1914, as amended, and any other Laws that are designed or intended to
prohibit, restrict or regulate (a) foreign investment or (b) actions having
the purpose or effect of monopolization or restraint of trade or lessening of
competition.

  


 

  

" _Atom_ " means Avoca Inc., a North Carolina corporation.

  


 

  

" _Atom Common Stock_ " means the common stock of Atom.

  


 

  

" _Base Working Capital_ " means $78,000,000.

  


 

  

" _Business Day_ " means a day, other than Saturday or Sunday, on which banks
generally are open for the transaction of business in New York, New York.

  


 

  

" _Cash_ " means all cash and cash equivalents (including certificates of
deposit and restricted cash) of the Company and its Subsidiaries. For the
avoidance of doubt, Cash shall be

  

  

 

2  

  

  

 

calculated net of issued but uncleared checks and drafts and shall include
checks and wire transfers and drafts deposited or available for deposit for
the account of the Company and its Subsidiaries.

  

 

  

" _Closing Date Cash Consideration_ " means an amount equal to (i) the
Adjusted Base Consideration minus (ii) the Reserve Amount minus (iii) the
Purchase Price Escrow Amount.

  


 

  

" _Code_ " means the Internal Revenue Code of 1986, as amended.

  


 

  

" _Common Stock_ " means the common stock of the Company.

  


 

  

" _Company Fundamental Representations_ " means the representations and
warranties set forth in the first sentence of _Section 4.1_ (Corporate
Organization), _Section 4.2_ (Subsidiaries and Minority Interests), _Section
4.3_ (Capitalization; Ownership), _Section 4.4_ (Authority) and _Section 4.23_
(Broker's Fees).

  


 

  

" _Company Material Adverse Effect_ " means any change, effect, event, state
of facts, development or occurrence that, individually or in the aggregate,
has had or would reasonably be expected to have a material adverse effect on
the condition (financial or otherwise), business, assets, properties or
results of operations of the Company and its Subsidiaries, taken as a whole;
_provided_ that in no event shall any of the following, alone or in
combination, be deemed to constitute, nor shall any of the following
constitute, or be taken into account in determining whether there has been or
may be a "Company Material Adverse Effect": (a) changes generally affecting
the United States or international economy or political, regulatory, business,
economic, financial, credit or capital market conditions, including interest
rates or exchange rates, or any changes therein; (b) changes generally in any
industry or segments therein currently engaged in by the Company or its
Subsidiaries; (c) the negotiation, execution, delivery, performance, pendency
or announcement of this Agreement and the transactions contemplated hereby,
including any litigation, customer cancellations of services or delays in the
start of services, any reduction in sales and adverse change in customer,
supplier, licensor, distributor, consultant, employee, independent contractor,
financing source, shareholder, partner or similar relationships (it being
understood that this clause (c) shall not apply with respect to any
representation or warranty contained in this Agreement (including for purposes
of _Section 8.2_ ) to the extent that the purpose of such representation or
warranty is to address the consequences resulting from the negotiation,
execution or delivery of this Agreement, the performance of obligations under
this Agreement or the consummation of the transactions contemplated by this
Agreement); (d) acts of war or military actions (whether or not declared), the
commencement, continuation or escalation of a war, acts of armed hostility,
sabotage or terrorism or other international or national calamity or any
material worsening of such conditions threatened or existing as of the date of
this Agreement; (e) any hurricane, tornado, volcano, earthquake, flood, or
other natural disaster or act of God; (f) changes in applicable Laws,
accounting requirements or principles, including GAAP, after the date hereof,
or any interpretations thereof by any Governmental Entity (or other
authoritative interpretation or enforcement thereof); or (g) any failure, in
and of itself, by the Company or its Subsidiaries to meet any estimates of
revenues, earnings, projections or other economic performance, whether
published, internally prepared or provided to Parent or any of its
Representatives (it being

  

  

 

3  

  

  

understood that this clause (g) shall not prevent a determination that any
change or effect underlying such failure to meet estimates has resulted in a
Company Material Adverse Effect (to the extent such change or effect is not
otherwise excluded from this definition of Company Material Adverse Effect));
_provided_ , _however_ , that the foregoing clauses (a), (b), (d), (e) and (f)
of this definition shall not apply to the extent such changes, effects,
events, state of facts, developments or occurrences have a disproportionate
adverse effect on the Company and its Subsidiaries, taken as a whole, relative
to the adverse effect that such changes, effects, events, state of facts,
developments or occurrences have on other companies in the industry in which
the Company and its Subsidiaries primarily operate.

  


 

  

" _Company Transaction Expenses_ " means (a) all out-of-pocket fees and
expenses of third-party advisors incurred or payable by the Company or any of
its Subsidiaries in connection with the transactions contemplated by this
Agreement, including the fees and expenses of investment bankers, legal
counsel and accountants, (b) 100% of the aggregate premium and costs relating
to the procurement by the Company of the DandO Insurance, (c) all payments under
the Pharmachem Laboratories, Inc. Sale Bonus Plan and all other change in
control, bonus, retention, incentive and other similar payments incurred or
payable by the Company or any of its Subsidiaries solely as a result of or in
connection with the transactions contemplated by this Agreement (including as
a result of an acceleration of any such payment), together with the employer-
paid portion of any employment or payroll taxes related thereto, and (d) all
other miscellaneous expenses or costs, in each case, incurred or payable by
the Company or any of its Subsidiaries in connection with the transactions
contemplated by this Agreement, but excluding ISRA Costs and Expenses. Company
Transaction Expenses shall not include any Company Transaction Expenses to the
extent paid prior to 12:01 a.m. on the Closing Date and shall include, without
duplication, any amounts paid at Closing pursuant to _Section 3.2(c)_.

  


 

  

" _Confidentiality Agreement_ " means that certain letter agreement, dated
November 9, 2016, between the Company and Parent.

  


 

  

" _Contract_ " means any written or oral contract, commitment, agreement,
arrangement, note, bond, mortgage, lease, sublease, license or other agreement
legally binding on any party, including all amendments thereto.

  


 

  

" _Default_ " means, with respect to any Person, a default (or an event which,
with notice or lapse of time or both would constitute a default) under, an
event or circumstance which gives rise to any right of termination,
acceleration, modification or cancelation of any right or obligation of such
Person under, entitle any person to increased, additional or guaranteed rights
or which result in the creation of any Lien on any of such Person's assets
pursuant to, or results in a loss of any benefit to which such Person is
entitled under, any Contract to which such Person is a party, or by which any
it or its properties or assets is bound.

  


 

  

" _Escrow Agent_ " means JPMorgan Chase Bank, N.A., or its successor, in its
capacity as such pursuant to the Escrow Agreement.

  


 

  

" _Escrow Agreement_ " means an escrow agreement in substantially the form
attached hereto as _Exhibit B_ among Parent, the Shareholders' Representative
and the Escrow Agent.

  

  

 

4  

  

  

" _ESOP_ " means the Pharmachem Laboratories, Inc. Employee Stock Ownership
Plan.

  


 

  

" _ESOP Trustee_ " means Wilmington Trust, N.A. and successors.

  


 

  

" _Estimated Net Working Capital Adjustment Amount_ " means the amount, which
may be positive or negative, equal to (a) Estimated Closing Net Working
Capital, minus (b) Base Working Capital.

  


 

  

" _Financial Statements_ " means (i) the audited consolidated balance sheet as
of September 30, 2016 (the " _Latest Balance Sheet_ ") and September 30, 2015
and the related statements of income and cash flows for the fiscal years then
ended, together with the related notes thereto and reports thereon and (ii)
the unaudited consolidated balance sheet as of December 31, 2016.

  


 

  

" _Fraud_ " means, with respect to any Person, an actual and intentional
fraud, _provided_ , _however_ , that such actual and intentional fraud of such
Person shall only be deemed to exist if such Person had actual knowledge (as
opposed to imputed or constructive knowledge) of the applicable misstatement
or omission (whether oral or written) and such misstatement or omission was
made with the specific intention to mislead the other party and for such other
party to rely thereon to its detriment and such party did in fact rely thereon
to such party's detriment. _Section 11.2(c)_ sets forth the liability of, or
other remedy with respect to, any Person (including any Shareholder) for any
Losses for claims of, or causes of action arising from, Fraud.

  


 

  

" _Fully Diluted Pro Rata Portion_ " has the meaning set forth in the
Allocation Annex.

  


 

  

" _Funded Debt_ " means, without duplication, (but, in each case, excluding
obligations of the Company or any of its Subsidiaries to the Company or any of
its Subsidiaries), the sum of (in each case, including any accrued interest,
prepayment penalties, make-whole payments and premiums, breakage costs, fees
and other amounts due on payment), (a) all obligations of the Company and its
Subsidiaries for borrowed money; and (b) other indebtedness of the Company and
its Subsidiaries evidenced by notes, bonds, debentures or other debt
securities.

  


 

  

" _GAAP_ " means United States generally accepted accounting principles.

  


 

  

" _Governmental Entity_ " means any federal, state or local court,
administrative or regulatory agency or commission or other governmental
authority or instrumentality, domestic or foreign (including, without
limitation, multi-national).

  


 

  

" _Indebtedness_ " means, without duplication (but, in each case, excluding
obligations of the Company or any of its Subsidiaries to the Company or any of
its Subsidiaries), the sum of (in each case, including any accrued interest,
prepayment penalties, make-whole payments and premiums, breakage costs, fees
and other amounts due on payment), (a) all Funded Debt; (b) any obligations of
the Company or any of its Subsidiaries to pay the deferred purchase price of
property, goods or services already received, except trade accounts payable
and other current liabilities arising in the ordinary course of business; (c)
capitalized lease obligations of

  

  

 

5  

  

  

the Company and its Subsidiaries; (d) all obligations by which the Company or
any of its Subsidiaries assures a creditor against loss, including
reimbursement obligations with respect to letters of credit, (e) all
indebtedness secured by a Lien on the assets or properties of the Company or
any of its Subsidiaries, whether or not the indebtedness secured thereby has
been assumed by the Company or its applicable Subsidiary, (f) all obligations
of the Company or any of its Subsidiaries in respect of interest rate
protection agreements, foreign currency exchange agreements or other interest
or exchange rate hedging arrangements and (g) indebtedness of the types
described in clauses (a) through (f) that is guaranteed, directly or
indirectly, in any manner by the Company or any of its Subsidiaries;
_provided_ , _however_ , that, notwithstanding the foregoing, for purposes of
calculating Estimated Closing Indebtedness and Closing Indebtedness,
Indebtedness of the type described in clause (d) or clause (g) shall be
included only to the extent there is a demand for payment of such
Indebtedness.

  


 

  

" _Intellectual Property_ " means all intellectual property rights arising
from or in respect of the following, whether protected, created or arising
under the Laws of the United States or any other jurisdiction or under any
international convention, including all (a) patents and patent applications
(including all utility and design patents), statutory invention registrations,
including all continuations, divisionals, continuations-in-part and
provisionals and patents issuing on any of the foregoing, and all reissues,
reexaminations, substitutions, renewals and extensions (including
supplementary protection certificates) of any of the foregoing (" _Patents_
"); (b) trademarks, service marks, trade dress, trade names, logos, corporate
names and other source or business identifiers, and all of the goodwill
associated with any of the foregoing, and all registrations, applications for
registration, renewals and extensions for any of the foregoing (collectively,
" _Marks_ "); (c) copyrights and copyrightable works, including Software,
documentation, databases and Internet website content and all registrations,
applications for registration, renewals, extensions and reversions of any of
the foregoing (collectively, " _Copyrights_ "); (d) Internet domain names, and
registrations and applications for registration therefor, and social media
identifiers, handles and tags; and (e) Trade Secrets.

  


 

  

" _ISRA Costs and Expenses_ " means any fees, expenses or costs incurred by
the Company or its Subsidiaries pursuant to _Section 7.5(c)_ or any other
fees, expenses or costs (including fees, expenses or costs of third party
advisors) arising from compliance with ISRA in connection with the
transactions contemplated by this Agreement.

  


 

  

" _Knowledge of the Company_ " and similar phrases mean the actual knowledge,
without investigation, of Colin MacIntyre, Joe Wesolowski, Paul Borrell, Paul
Halada, David Peele, Guus Gerritsen and Peter Hafermann.

  


 

  

" _Law_ " means any statute, code, law, ordinance, rule, regulation, directive
or Order of any Governmental Entity.

  


 

  

" _Liens_ " means all liens, mortgages, pledges, charges, encumbrances
(including restrictive covenants or deed restrictions in connection with
environmental or remedial obligations), options, leases, subleases, licenses,
adverse rights or claims and security interests whatsoever, including any
rights of refusal or offer, and any restriction on the right to vote, sell or
otherwise dispose of such capital stock or other ownership interests.

  

  

 

6  

  

  

" _Loss_ " or " _Losses_ " means any liability, obligations, fines, penalties,
losses, settlements, damages, claims, interest, awards and judgments, costs,
Taxes and expenses (including reasonable attorneys' fees and other reasonable
costs and expenses of investigating or contesting any of the foregoing).

  


 

  

" _Net Working Capital_ " means the sum of, without duplication, (a) a
positive amount equal to the consolidated current assets of the Company and
its Subsidiaries and (b) a negative amount equal to the consolidated current
liabilities of the Company and its Subsidiaries, each component as calculated
on a consolidated basis and determined in accordance with _Annex 1.1(b)_ , as
calculated as of 12:01 a.m. on the Closing Date, and for the avoidance of
doubt, not taking into account any of the transactions contemplated hereby.
Notwithstanding the foregoing, for purposes of calculating Net Working
Capital, current assets and current liabilities shall exclude (A) any
Indebtedness, (B) Cash (C) Company Transaction Expenses, (D) all current or
deferred income Tax assets and liabilities and (E) ISRA Costs and Expenses.

  


 

  

" _Order_ " means any writ, judgment, order, decree, injunction or ruling of
any Governmental Entity.

  


 

  

" _Parent Fundamental Representations_ " means the representations and
warranties set forth in the first two sentences of _Section 5.1_
(Organization), _Section 5.2_ (Authority), _Section 5.8_ (Solvency) and
_Section 5.9_ (Broker's Fees).

  


 

  

" _Parent Material Adverse Effect_ " means any material adverse effect on the
ability of Parent to consummate the Closing in a timely manner or to perform
any of its material obligations under this Agreement.

  


 

  

" _Payoff Letter_ " means the letters provided by any Person holding Funded
Debt setting forth the amount of such Funded Debt and the instructions for the
payment of such Funded Debt.

  


 

  

" _Permitted Liens_ " means all (a) mechanics', carriers' materialman's,
workmen's, warehousemen's, repairmen's and similar statutory Liens arising by
operation of Law in the ordinary course of business consistent with past
practice for amounts not yet due and payable and for which adequate accruals
or reserves have been established on the Financial Statements in accordance
with GAAP or which are being contested in good faith by appropriate
proceedings; (b) Liens for Taxes and assessments and other governmental
charges and levies that are not yet due and payable or that may thereafter be
paid without interest or penalty or which are being contested in good faith by
appropriate proceedings and for which adequate accruals and reserves have been
established on the Financial Statements in accordance with GAAP; (c) pledges
or deposits to secure obligations under workers' compensation or other similar
Laws or to secure public or statutory obligations; (d) easements, covenants,
rights of way, deed restrictions, restrictive covenants and other similar
restrictions and agreements, and options, rights of first refusal or offer and
other similar agreements, including any such covenants and restrictions in
connection with environmental or remedial obligations that do not adversely
affect in any material respect the current use of the property; (e) zoning and
building Laws and codes and other similar land use Laws; (f) Liens arising
under the Indebtedness; (g) with respect to Leased Real Property, Liens for
which any landlord or overlandlord is responsible, including mortgages,

  

  

 

7  

  

  

ground leases, mechanics' and similar Liens and unpaid Taxes, assessments and
other governmental charges and levies (other than Taxes, assessments, other
governmental charges and levies and other payments which the Company or any of
its Subsidiaries is obligated to pay pursuant to the terms of the applicable
Lease); and (h) Liens described on _Section 1.1 of the Company Disclosure
Schedule_.

  


 

  

" _Person_ " means an individual, corporation, partnership, limited liability
company, joint venture, association, trust, Governmental Entity,
unincorporated organization or other entity.

  


 

  

" _Qualified Independent Appraiser_ " means Adamy Valuation Advisors, Inc.

  


 

  

" _R andW Insurance_" means the insurance coverage provided pursuant to a buyer-
side representation and warranty insurance policy that is summarized in that
certain policy, effective as of the date hereof, by and between AIG Specialty
Insurance Company and Parent.

  


 

  

" _Representatives_ " means, as to any person, its officers, directors,
employees, legal counsel, accountants, financial advisors, financing sources,
consultants, insurers (including insurers and underwriters in respect of the
RandW Insurance) and other agents and advisors.

  


 

  

" _Reserve Amount_ " means $2,500,000.

  


 

  

" _Shareholder Fundamental Representations_ " means the representations and
warranties set forth in _Section 3.6(a)_ (Organization; Power and Authority),
_Section 3.6(b)_ (Title), _Section 3.6(c)_ ( _Authorization; Enforceability_ )
and _Section 3.6(f)_ ( _Brokers ' Fees_).

  


 

  

" _Shareholders_ " means the Company Shareholders and the Atom Minority
Shareholder.

  


 

  

" _Specified Person_ " means any person listed in the definition of "Knowledge
of the Company", Howard Tatz or Catherine Holmes.

  


 

  

" _Subsidiary_ " when used with respect to any Person means any corporation,
partnership, limited liability company or other organization, whether
incorporated or unincorporated, of which at least fifty percent of the
securities, or other interests having by their terms voting power to elect at
least half of the board of directors or others performing similar functions
with respect to such corporation or other organization, is directly or
indirectly owned by such Person or by any one or more of its subsidiaries.

  


 

  

" _Tax_ " or " _Taxes_ " means all taxes or similar duties, fees, charges or
assessments imposed by a Governmental Entity, in each case in the nature of a
tax, including all taxes measured by or referred to as income, gross receipts,
license, payroll, employment, excise, severance, stamp, occupation, premium,
windfall profits, environmental (including taxes under Section 59A of the
Code), customs duties, capital stock, franchise, profits, withholding, social
security (or similar), unemployment, disability, real property, personal
property, sales, use, transfer, registration, value added, alternative or add-
on minimum, estimated or other tax, together with any interest and any
penalties, additions to tax or additional amounts.

  

  

 

8  

  

  

" _Tax Return_ " means any return, report or statement required or permitted
to be filed with any Governmental Entity with respect to Taxes, including any
schedules, attachments or amendments thereto.

  


 

  

" _Trade Secrets_ " means trade secrets, know-how, confidential and
proprietary information, including financial, business or technical
information, inventions (whether patentable or not), invention disclosures,
improvements, designs, schematics, processes, formulas, methodologies,
techniques, plans and projections, customer, vendor and other business partner
information, clinical data, chemistry, manufacturing and controls data, other
data and all documentation (in whatever form or medium) embodying any of the
foregoing not generally known to the public and that are maintained under
secrecy.

  


 

  

" _Treasury Regulation_ " means the income tax regulations promulgated by the
Internal Revenue Service, Department of Treasury, pursuant to the Code.

  


 

  

1.2 _Additional Definitions_. In addition to those terms defined in _Section
1.1_ , the following terms have the meaning set forth in the Sections set
forth below:

  


 

     

Acceptance Period

  |  

3.4(c)

   
---|--- 
    

Agreement

  |  

Preamble

   
    

Antitrust Division

  |  

7.5(b)

   
    

Arbitrator

  |  

3.4(d)

   
    

Atom Minority Shareholder

  |  

Preamble

   
    

Atom Minority Shares

  |  

Recitals

   
    

Certificates

  |  

3.3(a)

   
    

Closing

  |  

2.2

   
    

Closing Cash

  |  

3.4(a)

   
    

Closing Date

  |  

2.2

   
    

Closing Indebtedness

  |  

3.4(a)

   
    

Closing Net Working Capital

  |  

3.4(a)

   
    

Company

  |  

Preamble

   
    

Company Benefit Plan

  |  

4.19(a)

   
    

Company Disclosure Schedule

  |  

Article 4

   
    

Company IP Agreements

  |  

4.14(a)(ix)

   
    

Company Personnel

  |  

4.19(a)

   
    

Company Shareholders

  |  

Preamble

   
    

Company Transaction Expense Direction Notice

  |  

6.3

   
    

Copyrights

  |  

1.1

   
    

DandO Insurance

  |  

7.6(e)

   
    

Disputed Items

  |  

3.4(d)

   
    

Disqualified Individual

  |  

7.9

   
    

Environment

  |  

4.20(f)

   
    

Environmental Laws

  |  

4.20(f)

   
    

Environmental Permit

  |  

4.20(f)

   
    

ERISA

  |  

Recitals

   
    

ERISA Affiliate

  |  

4.19(c)

   
    

Estimated Closing Cash

  |  

3.1

   
   

  

 

9  

  


 

     

Estimated Closing Indebtedness

  |  

3.1

   
---|--- 
    

Estimated Closing Net Working Capital

  |  

3.1

   
    

Estimated Company Transaction Expenses

  |  

3.1

   
    

Fairness Opinion

  |  

Recitals

   
    

Forward Looking Statements

  |  

5.10

   
    

FTC

  |  

7.5(b)

   
    

Hazardous Material

  |  

4.20(f)

   
    

HSR Act

  |  

4.5

   
    

indemnified party

  |  

10.5(a)

   
    

indemnifying party representative

  |  

10.5(a)

   
    

Indemnity Escrow Account

  |  

3.5(e)

   
    

Indemnity Escrow Amount

  |  

3.5(e)

   
    

Indemnity Escrow Release Date

  |  

3.5(f)

   
    

Interim Indemnity Escrow Release Date

  |  

3.5(f)

   
    

Interim Outstanding Claims

  |  

3.5(f)

   
    

ISRA

  |  

4.20(f)

   
    

IT System

  |  

4.13(g)

   
    

Leased Real Property

  |  

4.12(a)

   
    

Leases

  |  

4.12(a)

   
    

Legal Proceeding

  |  

4.17

   
    

Licensed Intellectual Property

  |  

4.13(b)

   
    

Marks

  |  

1.1

   
    

Material Contract

  |  

4.14(a)

   
    

Material Customers

  |  

4.24

   
    

Material Distributors

  |  

4.24

   
    

Material Suppliers

  |  

4.24

   
    

NJDEP

  |  

7.5(c)

   
    

Notice of Objection

  |  

3.4(c)

   
    

Outside Date

  |  

9.1(c)

   
    

Outstanding Claims

  |  

3.5(f)

   
    

Outstanding Tax Claims

  |  

3.5(d)

   
    

Outstanding Tax Return Claims

  |  

3.5(b)

   
    

Owned Intellectual Property

  |  

4.13(a)

   
    

Owned Real Property

  |  

4.12(b)

   
    

Parent

  |  

Preamble

   
    

Parent Indemnified Parties

  |  

7.2(b)

   
    

Parent Indemnitees

  |  

10.1(a)

   
    

Patents

  |  

1.1

   
    

Permits

  |  

4.16

   
    

Personal Data

  |  

4.13(g)

   
    

Post-Closing Statement

  |  

3.4(a)

   
    

Pre-Closing Statement

  |  

3.1

   
    

Pre-Closing Straddle Period

  |  

7.2(b)

   
    

Pre-Closing Tax Period

  |  

7.2(b)

   
    

Pre-Closing Tax Return

  |  

3.5(b)

   
    

Purchase Price Escrow Account

  |  

3.5(a)

   
   

 

10  

  

     

Purchase Price Escrow Amount

  |  

3.5(a)

   
---|--- 
    

Registered Intellectual Property

  |  

4.13(a)

   
    

Release

  |  

4.20(f)

   
    

Released Parties

  |  

7.6(b)

   
    

Releasing Parties

  |  

7.6(b)

   
    

Remedial Action

  |  

4.20(f)

   
    

Reserve

  |  

11.10(b)

   
    

Shareholder Group

  |  

11.16

   
    

Shareholder Indemnitees

  |  

10.2(a)

   
    

Shareholder Released Parties

  |  

7.7(a)

   
    

Shareholder Releasing Parties

  |  

7.7(a)

   
    

Shareholders' Representative

  |  

Preamble

   
    

Software

  |  

4.13(g)

   
    

Straddle Period

  |  

7.2(b)

   
    

Tax Escrow Account

  |  

3.5(c)

   
    

Tax Escrow Amount

  |  

3.5(c)

   
    

Tax Escrow Release Date

  |  

3.5(d)

   
    

Tax Return Escrow Account

  |  

3.5(b)

   
    

Tax Return Escrow Amount

  |  

3.5(b)

   
    

Tax Return Escrow Release Date

  |  

3.5(b)

   
    

Tax Return Excess

  |  

3.5(c)

   
    

Third Party Claim

  |  

10.5(a)

   
    

Transaction Tax Deductions

  |  

7.2(b)

   
    

Transfer Taxes

  |  

7.2(a)

   
   


 

  

1.3 _Interpretation_.

  


 

  

(a) When a reference is made in this Agreement to an Article or Section, such
reference shall be to an Article or Section of this Agreement unless otherwise
indicated.

  


 

  

(b) The table of contents, headings and index of defined terms contained in
this Agreement are for reference purposes only and shall not affect in any way
the meaning or interpretation of this Agreement.

  


 

  

(c) Whenever the words "include," "includes" or "including" are used in this
Agreement, they shall be deemed to be followed by the words "without
limitation." The word "will" shall be construed to have the same meaning and
effect of the word "shall". The words "hereof," "herein" and "hereunder" and
words of similar import when used in this Agreement shall refer to this
Agreement as a whole, including the Company Disclosure Schedule and all
exhibits and annexes hereto, and not to any particular provision of this
Agreement. The word "extent" in the phrase "to the extent" shall mean the
degree to which a subject or other thing extends, and such phrase shall not
mean simply "if." The word "or" shall be deemed to mean "and/or."

  


 

  

(d) All terms defined in this Agreement shall have the defined meanings when
used in any certificate or other document made or delivered pursuant thereto
unless otherwise defined therein. The definitions contained in this Agreement
are applicable to the singular as

  

  

 

11  

  

  

well as the plural forms of such terms and to the masculine as well as to the
feminine and neuter genders of such term.

  


 

  

(e) The phrase "made available," when used in reference to anything made
available to Parent or its Representatives, shall be deemed to mean uploaded
to and made available to Parent and its Representatives in the Intralinks on-
line data room hosted on behalf of the Company in the on-line workspace
captioned "Project Photon" or otherwise delivered to, or being in the
possession of, Parent or its Representatives.

  


 

  

(f) Each of the parties has participated in the drafting and negotiation of
this Agreement. If an ambiguity or question of intent or interpretation
arises, this Agreement must be construed as if it is drafted by all the
parties, and no presumption or burden of proof shall arise favoring or
disfavoring any party by virtue of authorship of any of the provisions of this
Agreement.

  


 

  

(g) Reference to any Person includes such Person's successors and assigns but,
if applicable, only if such successors and assigns are not prohibited by this
Agreement, and reference to a Person in a particular capacity excludes such
Person in any other capacity or individually.

  


 

  

1.4 _Calculation of Time Period_. When calculating the period of time before
which, within which, or following which, any act is to be done or step taken
pursuant to this Agreement, the date that is the reference date in calculating
such period shall be excluded. If the last day of such period is a non-
Business Day, then the period in question shall end on the next succeeding
Business Day.

  


 

  

ARTICLE 2. 
  PURCHASE AND SALE

  


 

  

2.1 _Purchase and Sale of Common Stock and Atom Minority Shares_.

  


 

  

(a) At the Closing, and upon the terms and subject to the conditions set forth
in this Agreement, Parent shall purchase from the Company Shareholders, and
the Company Shareholders shall sell, convey, assign, transfer and deliver to
Parent, all of the Common Stock, free and clear of all Liens.

  


 

  

(b) At the Closing, immediately after the purchase and sale of Common Stock
described in _Section 2.1(a)_ , and upon the terms and subject to the
conditions set forth in this Agreement, the Company shall purchase from the
Atom Minority Shareholder, and the Atom Minority Shareholder shall sell,
convey, assign, transfer and deliver to the Company, all of the Atom Minority
Shares, free and clear of all Liens.

  


 

  

2.2 _Closing_. Unless this Agreement shall have been terminated pursuant to
_Section 9.1_ , and subject to the satisfaction or waiver of the conditions
set forth in _ARTICLE 8_ , the closing of the transactions contemplated hereby
(the " _Closing_ ") shall take place at the offices of Arnold and Porter Kaye
Scholer LLP, 250 West 55th Street, New York, New York 10019-9710 at 10:00 a.m.
local time on the date which is three (3) Business Days following the date on
which all of the conditions set forth in _ARTICLE 8_ are satisfied or waived
(other than those conditions

  

  

 

12  

  

  

that by their terms cannot be satisfied until the Closing, but subject to the
satisfaction or waiver of such conditions) or such other date or time as may
be mutually agreed in writing by Parent and the Company (the date on which the
Closing actually occurs is the " _Closing Date_ ").

  


 

  


 

  

ARTICLE 3. 
  CLOSING MATTERS; REPRESENTATIONS AND WARRANTIES OF THE

  

SHAREHOLDERS

  


 

  

3.1 _Pre-Closing Statement_. On or prior to the third Business Day preceding
the Closing Date, the Company shall deliver to Parent a statement (the " _Pre-
Closing Statement_ ") setting forth its (a) reasonable estimate of Closing
Cash (" _Estimated Closing Cash_ "), Closing Net Working Capital (" _Estimated
Closing Net Working Capital_ "), Closing Indebtedness (" _Estimated Closing
Indebtedness_ "), and Company Transaction Expenses (" _Estimated Company
Transaction Expenses_ ") and (b) calculation of the Adjusted Base
Consideration. The Company shall provide Parent and its Representatives such
back-up or supporting data or materials relating to the preparation of the
Pre-Closing Statement as Parent may reasonably request.

  


 

  

3.2 _Closing Payments_. At or prior to the Closing, Parent shall make, or
cause to be made, the following payments by wire transfer of immediately
available funds:

  


 

  

(a) to (i) each Shareholder (other than the ESOP and, in the case of the Atom
Minority Shareholder, on behalf of the Company), its Fully Diluted Pro Rata
Portion of the Closing Date Cash Consideration and (ii) the ESOP an amount
equal to the difference of (A) its Fully Diluted Pro Rata Portion of the
Closing Date Cash Consideration _minus_ (B) the Tax Return Escrow Amount
_minus_ (C) the Tax Escrow Amount _minus_ (D) the Indemnity Escrow Amount; in
each case, by either wire transfer of immediately available funds;

  


 

  

(b) to the Shareholders' Representative an amount equal to the Reserve Amount;

  


 

  

(c) to the Person or Persons entitled thereto pursuant to the Company
Transaction Expense Direction Notice, in the amounts and to the account or
accounts designated therein, on behalf and for the account of the Company;

  


 

  

(d) to the Persons or Persons entitled thereto pursuant to the Payoff Letters,
to the account or accounts designated therein, the amounts specified therein;
and

  


 

  

(e) to the Escrow Agent the Purchase Price Escrow Amount, the Tax Return
Escrow Amount, the Tax Escrow Amount and the Indemnity Escrow Amount in
accordance with _Section 3.5_.

  


 

  

3.3 _Withholding_.

  


 

  

(a) _Certificates._ At the Closing, each of the Shareholders shall surrender
to Parent (or, in the case of the Atom Minority Shareholder, to the Company)
original certificate(s) evidencing the shares of Common Stock or Atom Common
Stock, as applicable, held by such Shareholder, duly endorsed or accompanied
by duly executed stock transfer powers (collectively,

  

  

 

13  

  

  

" _Certificates_ ") or, in the case of book-entry shares, an "agent's message"
(or such other evidence, if any, of transfer to Parent as Parent may
reasonably request).

  


 

  

(b) _Lost Certificates_. If any Certificate shall have been lost, stolen or
destroyed, the Person claiming such Certificate to be lost shall deliver a
customary affidavit of that fact to the Company (prior to the Closing) or
Parent (at the Closing) and, if requested by Parent, shall provide a customary
indemnity against any claim that may be made against the Company with respect
to such Certificate.

  


 

  

(c) _Withholding Taxes_. Parent, the Company, its Subsidiaries or the
Shareholders' Representative shall be entitled to deduct or withhold from any
amounts payable pursuant to this Agreement to any Person such amounts as
Parent, the Company, its Subsidiaries or the Shareholders' Representative, as
the case may be, is required to deduct and withhold with respect to the making
of such payment under the Code or any provision of state, local, or non-U.S.
Tax law. To the extent that amounts are so withheld by Parent, the Company,
its Subsidiaries or the Shareholders' Representative, they shall be paid over
to the appropriate Governmental Entity, and such withheld amounts shall be
treated for all purposes of this Agreement as having been paid to the Person
in respect of which such deduction and withholding was made by Parent, the
Company, its Subsidiaries or the Shareholders' Representative, as the case may
be.

  


 

  

3.4 _Post-Closing Adjustment_.

  


 

  

(a) As soon as practicable but in no event later than the sixty (60th) day
following the Closing Date, Parent shall deliver to the Shareholders'
Representative a statement (the " _Post-Closing Statement_ ") setting forth
(i) an unaudited consolidated balance sheet of the Company and its
Subsidiaries as of 12:01 a.m. on the Closing Date and (ii) its good faith
calculation of (w) Cash as of 12:01 a.m. on the Closing Date (" _Closing Cash_
"), (x) Net Working Capital as of 12:01 a.m. on the Closing Date (" _Closing
Net Working Capital_ "), (y) the aggregate amount of all Indebtedness of the
Company and its Subsidiaries as of the Closing (" _Closing Indebtedness_ "),
and (z) Company Transaction Expenses. The Post-Closing Statement shall be
prepared in accordance with _Annex 1.1(b)_.

  


 

  

(b) Parent shall provide to the Shareholders' Representative such back-up or
supporting data or materials relating to the preparation of the Post-Closing
Statement as the Shareholders' Representative may reasonably request. Parent
shall provide, and cause the Company to provide, the Shareholders'
Representative and its Representatives with reasonable access to the Company's
auditors and accounting and other personnel and to the books and records of
the Company and its Subsidiaries, and any other document or information under
its control that is reasonably requested by the Shareholders' Representative
(including the workpapers of the Company's auditors) for all purposes of this
_Section 3.4_ , including in order to allow the Shareholders' Representative
and its Representatives to prepare the Notice of Objection and participate in
the resolution of any items set forth in a Notice of Objection, subject in
each case to reasonable confidentiality restrictions, and other agreements
customarily required in such circumstances, and, in each case upon reasonable
advance notice and during normal business hours and in a manner that does not
unreasonably interfere with the operations of Parent and its Subsidiaries. The
Shareholders' Representative shall furnish to Parent and its

  

  

 

14  

  

  

Representatives such workpapers (including the workpapers of any accountant or
auditor retained by the Shareholders' Representative in connection with this
_Section 3.4_ ) or other documents or information under its control that is
reasonably requested by Parent for purposes of reviewing any Notice of
Objection and participating in the resolution of any items set forth in any
Notice of Objection.

  


 

  

(c) If the Shareholders' Representative has any objections to the Post-Closing
Statement or any of the amounts set forth therein, it shall deliver to Parent
a written statement (a " _Notice of Objection_ ") describing its objections in
detail and providing reasonable supporting detail with respect to any
objections set forth therein not later than forty-five (45) days after its
receipt of the Post-Closing Statement (such forty-five (45) day period, the "
_Acceptance Period_ "). If the Shareholders' Representative fails to deliver a
Notice of Objection within the Acceptance Period, the Post-Closing Statement
and the amounts set forth therein shall be deemed to have been accepted by the
Shareholders' Representative and shall be binding upon all of the parties to
this Agreement for all purposes hereof. Any items set forth in the Post-
Closing Statement that are not objected to by the Shareholders' Representative
in a Notice of Objection during the Acceptance Period shall be deemed to have
been accepted and shall be binding upon all of the parties to the Agreement
for purposes hereof. If the Shareholders' Representative delivers a Notice of
Objection to Parent within the Acceptance Period, the Shareholders'
Representative and Parent shall endeavor in good faith to resolve the
Shareholders' Representative's objections within the thirty (30) day period
following the delivery of the Notice of Objection. Within fourteen (14) days
of delivery by the Shareholders' Representative of the Notice of Objection
(or, if there is no timely Notice of Objection, after the expiration of the
Acceptance Period), if the balance of the Purchase Price Escrow Account
exceeds the aggregate amount disputed in the Notice of Objection, Parent and
Shareholders' Representative shall provide joint written instructions to the
Escrow Agent to deliver promptly from the Purchase Price Escrow Account an
amount equal to such excess to each Shareholder of its Fully Diluted Pro Rata
Portion of such amount, in accordance with the Allocation Annex.

  


 

  

(d) In the event that a written agreement resolving all of the Shareholders'
Representative's objections has not been reached within the thirty (30) day
period (or such longer period as may be agreed by Parent and the Shareholders'
Representative) after the delivery of a Notice of Objection, the resolution of
all unresolved items (" _Disputed Items_ ") shall be submitted to KPMG LLP
(the " _Arbitrator_ ") and the following procedures will apply:

  


 

  

(i) The Shareholders' Representative and Parent shall use their commercially
reasonable efforts to cause the Arbitrator to render a decision in accordance
with this _Section 3.4(d)_ along with a statement of reasons therefor within
thirty (30) days of the submission of the Disputed Items, or a reasonable time
thereafter, to the Arbitrator. The decision of the Arbitrator shall be final
and binding upon each party hereto and the decision of the Arbitrator shall
constitute an arbitral award that is final, binding and non-appealable and
upon which a judgment may be entered by a court having jurisdiction thereover.

  


 

  

(ii) In the event the Shareholders' Representative and Parent submit any
Disputed Items to the Arbitrator for resolution, the Shareholders'
Representative and Parent shall each pay their own costs and expenses incurred
under this _Section 3.4(d)_. The Shareholders' Representative shall be
responsible for that fraction of the fees and costs of the

  

  

 

15  

  

  

Arbitrator equal to (1) the absolute value of the difference between the
Shareholders' Representative's aggregate position with respect to the Disputed
Items and the Arbitrator's final determination with respect to the Disputed
Items over (2) the absolute value of the difference between the Shareholders'
Representative's aggregate position with respect to the Disputed Items and
Parent's aggregate position with respect to the Disputed Items, and Parent
shall be responsible for the remainder of such fees and costs.

  


 

  

(iii) The Arbitrator shall act as an arbitrator to determine, based upon the
provisions of this _Section 3.4(d)_ , only (x) whether the Post-Closing
Statement was prepared in accordance with this Agreement with respect to any
Disputed Items and (y) whether there were mathematical errors in the Post-
Closing Statement with respect to any Disputed Items. Any disputes regarding
the scope of disputes to be resolved by the Arbitrator pursuant to this
_Section 3.4(d)_ shall not be resolved by the Arbitrator but rather shall be
resolved in accordance with _Section 11.12_. The arbitration shall have its
seat in New York, shall take place in New York City and shall be governed by
the rules of the American Arbitration Association to the extent not
inconsistent with this _Section 3.4_. The determination of each amount of the
Disputed Items shall be made in accordance with the procedures set forth in
_Section 3.4(d)_ and, in any event, shall be no less than the lesser of the
amount claimed by either Parent or the Shareholders' Representative, and shall
be no greater than the greater of the amount claimed by either Parent or the
Shareholders' Representative.

  


 

  

(e) If, following the final determination procedures set forth in _Sections
3.4(c)_ and _(d)_ :

  


 

  

(i) the Adjustment Amount is a positive number:

  


 

  

(A) Parent and the Shareholders' Representative shall provide joint written
instructions to the Escrow Agent to deliver promptly all of the funds
contained in the Purchase Price Escrow Account allocated as follows:

  


 

  

    | i. |  

to the Shareholders' Representative, any amount thereof specified by the
Shareholders' Representative to be added to the Reserve; and

   
---|---|--- 
  

  


 

  

    | ii. |  

the remaining amount to each Shareholder of its Fully Diluted Pro Rata Portion
of such amount, in accordance with the Allocation Annex; and

   
---|---|--- 
  

  


 

  

(B) Parent shall pay an amount equal to the Adjustment Amount to each
Shareholder of its Fully Diluted Pro Rata Portion of such amount, in
accordance with the Allocation Annex.

  


 

  

(ii) the Adjustment Amount is a negative number, then Parent and the
Shareholders' Representative shall provide joint written instructions to the
Escrow Agent to deliver promptly from the Purchase Price Escrow Account all of
the funds contained therein as follows:

  

  

 

16  

  

  

(A) to Parent, an amount equal to the lesser of: (x) the balance of the
Purchase Price Escrow Account, or (y) the absolute value of the Adjustment
Amount; and

  


 

  

(B) if the absolute value of the Adjustment Amount is less than the balance of
the Purchase Price Escrow Account;

  


 

  

    | i. |  

to the Shareholders' Representative, any amount thereof specified by the
Shareholders' Representative to be added to the Reserve; and

   
---|---|--- 
  

  


 

  

    | ii. |  

the remaining amount to each Shareholder of its Fully Diluted Pro Rata Portion
of such amount, in accordance with the Allocation Annex;

   
---|---|--- 
  

  


 

  

(iii) the absolute value of the Adjustment Amount exceeds the balance of the
Purchase Price Escrow Account, Parent shall be entitled to indemnification
from the Shareholders pursuant to _Section 10.1(a)(iii)_ for the amount of
such excess.

  


 

  

(iv) the Adjustment Amount is zero, no payment shall be required by Parent and
Parent and the Shareholders' Representative shall provide joint written
instructions to the Escrow Agent to deliver promptly all of the funds
contained in the Purchase Price Escrow Account allocated as follows:

  


 

  

(A) to the Shareholders' Representative, any amount thereof specified by the
Shareholders' Representative to be added to the Reserve; and

  


 

  

(B) the remaining amount to each Shareholder of its Fully Diluted Pro Rata
Portion of such amount, in accordance with the Allocation Annex.

  


 

  

(f) Any amounts payable pursuant to this _Section 3.4_ shall be paid (or joint
instruction to the Escrow Agent shall be provided) within ten (10) Business
Days after final determination pursuant to _Section 3.4_ of the Post-Closing
Statement, by wire transfer of immediately available funds to an account
designated by the party receiving such payment.

  


 

  

3.5 _Purchase Price Escrow Amount; Tax Return Escrow Amount; and Tax Escrow
Amount_.

  


 

  

(a) For the purpose of securing the obligations of the Shareholders'
Representative under _Section 3.4_, at the Closing, Parent shall deliver
$5,000,000 in cash (the " _Purchase Price Escrow Amount_ ") to the Escrow
Agent by wire transfer of immediately available funds to an account (the "
_Purchase Price Escrow Account_ ") that will be designated and administered by
the Escrow Agent pursuant to the Escrow Agreement.

  


 

  

(b) For the purpose of securing the indemnification obligations of the ESOP
under _Section 7.2(b)_ with respect to Taxes shown as due and payable on any
Tax Return of the Company or any of its Subsidiaries for any Pre-Closing Tax
Period or Pre-Closing Straddle Period that is filed after the Closing (a "
_Pre-Closing Tax Return_ "), at the Closing, Parent shall deliver $1,700,000
(the " _Tax Return Escrow Amount_ ") in cash to the Escrow Agent by wire

  

  

 

17  

  

  

transfer of immediately available funds to an account (the " _Tax Return
Escrow Account_ ") that will be designated and administered by the Escrow
Agent pursuant to the Escrow Agreement. Promptly following the date on which
all Pre-Closing Tax Returns have been filed (the " _Tax Return Escrow Release
Date_ "), Parent and the Shareholders' Representative shall provide joint
written instructions to the Escrow Agent to release the available funds in the
Tax Return Escrow Account, less the ESOP's Fully Diluted Pro Rata Portion of
any amounts claimed by any Parent Indemnified Party as indemnification claims
in accordance with _Section 7.2(b_) and _(c)_ for Taxes shown as due and
payable on any Pre-Closing Tax Return, properly claimed against the Tax Return
Escrow Account and not fully resolved prior to the Tax Return Escrow Release
Date (" _Outstanding Tax Return Claims_ "), to the ESOP. Releases from the Tax
Return Escrow Account in respect of indemnification claims in accordance with
_Section 7.2(b_) and _(c)_ for Taxes shown as due and payable on any Pre-
Closing Tax Return properly claimed against the Tax Return Escrow Account
shall be made in accordance with Section 10.7.

  


 

  

(c) For the purpose of securing the indemnification obligations of the ESOP
under _Section 7.2(b)_ with respect to (i) Taxes shown as due and payable on
any Pre-Closing Tax Return to the extent not indemnified from the Tax Return
Escrow Account (the " _Tax Return Excess_ ") and (ii) Taxes other than Taxes
shown as due and payable on any Pre-Closing Tax Return, at the Closing, Parent
shall deliver $4,200,000 in cash (the " _Tax Escrow Amount_ ") to the Escrow
Agent by wire transfer of immediately available funds to an account (the "
_Tax Escrow Account_ ") that will be designated and administered by the Escrow
Agent pursuant to the Escrow Agreement.

  


 

  

(d) Promptly following the later of: (i) the date that is three (3) years from
the due date, including any extensions, of the Company's U.S. federal income
Tax Returns for all taxable periods ended on or prior to the Closing Date and
(ii) the date on which all Tax controversies (including audits) relating to a
Pre-Closing Tax Period or Pre-Closing Straddle Period that are commenced prior
to the time period specified in clause (i) have been concluded (the " _Tax
Escrow Release Date_ "), Parent and the Shareholders' Representative shall
provide joint written instructions to the Escrow Agent to release the
available funds in the Tax Escrow Account, less the ESOP's Fully Diluted Pro
Rata Portion of any amounts claimed by any Parent Indemnified Party as
indemnification claims in accordance with _Section 7.2(b) and (c)_ for any Tax
Return Excess and Taxes other than Taxes shown as due and payable on any Pre-
Closing Tax Return, properly claimed against the Tax Escrow Account and not
fully resolved prior to the Tax Escrow Release Date (" _Outstanding Tax
Claims_ "), to the ESOP. Releases from the Tax Escrow Account in respect of
indemnification claims in accordance with _Section 7.2(b_) and _(c)_ for any
Tax Return Excess and Taxes other than Taxes shown as due and payable on any
Pre-Closing Tax Return properly claimed against the Tax Escrow Account shall
be made in accordance with Section 10.8.

  


 

  

(e) For the purpose of securing the indemnification obligations of the ESOP
under Article 10, at the Closing, Parent shall deliver $4,200,000 in cash (the
" _Indemnity Escrow Amount_ ") to the Escrow Agent by wire transfer of
immediately available funds to an account (the " _Indemnity Escrow Account_ ")
that will be designated and administered by the Escrow Agent pursuant to the
Escrow Agreement.

  

  

 

18  

  

  

(f) Promptly following the date that is 18 months after the Closing Date (the
" _Interim Indemnity Escrow Release Date_ "), Parent and the Shareholders'
Representative shall provide joint written instructions to the Escrow Agent to
release from the Indemnity Escrow Account to the ESOP an amount equal to (but
not less than zero) (i) $2,100,000 minus (ii) the ESOP's Fully Diluted Pro
Rata Portion of any amount claimed by any Parent Indemnitee as indemnification
claims pursuant to _Section 10.1(a)_ , properly claimed against the Indemnity
Escrow Account in accordance with Article 10 and not fully resolved prior to
the Interim Indemnity Escrow Release Date (such claims, the " _Interim
Outstanding Claims_ ") minus (iii) any amounts released to Parent from the
Indemnity Escrow Account prior to the Interim Indemnity Release Date. Promptly
following the date that is 60 days after the last date on which the right to
assert any claim under _Section 10.1(a)_ of this Agreement expires under the
relevant statute of limitations, including any extensions thereof (the "
_Indemnity Escrow Release Date_ "), Parent and the Shareholders'
Representative shall provide joint written instructions to the Escrow Agent to
release from the Indemnity Escrow Account to the ESOP any remaining funds in
the Indemnity Escrow Account, less the ESOP's Fully Diluted Pro Rata Portion
of the aggregate amount of any amount claimed by any Parent Indemnitee as
indemnification claims pursuant to _Section 10.1(a)_ , properly claimed
against the Indemnity Escrow Account in accordance with Article 10 and not
fully resolved prior to the Indemnity Escrow Release Date (such claims, the "
_Outstanding Claims_ "). Releases from the Indemnity Escrow Account in respect
of indemnification claims pursuant to _Section 10.1(a)_ properly claimed
against the Indemnity Escrow Account shall be made in accordance with Section
10.6.

  


 

  

3.6 _Representations and Warranties of the Shareholders_. Subject to _Section
11.15_ (Company Disclosure Schedule), as set forth in the Company Disclosure
Schedule, each Shareholder severally (and not jointly) represents and warrants
to Parent as follows, solely with respect to such Shareholder:

  


 

  

(a) _Organization; Power and Authority_. To the extent the Shareholder is an
entity and not a natural person, the Shareholder is duly organized, validly
existing and in good standing under the Laws of the jurisdiction of its
incorporation or organization, and the Shareholder has all requisite power and
authority to own, lease and operate all of its properties and assets and to
carry on its business as it is now being conducted.

  


 

  

(b) _Title_. Except as set forth in _Section 3.6(b) of the Company Disclosure
Schedule_ , (i) the Shareholder is the sole record and beneficial owner of,
and has good, valid and marketable title to, in the case of the Company
Shareholders, the Common Stock indicated as being owned by such Shareholder on
_Exhibit A_, and in the case of the Atom Minority Shareholder, the Atom
Minority Shares, in each case, free and clear of any Liens, and at the
Closing, the Shareholder shall deliver to Parent good, valid and marketable
title to such Common Stock or to the Company good, valid and marketable title
to such Atom Minority Shares, as the case may be, free and clear of all Liens
and, in the case of any Shareholder that is a trust, any claims under such
trust by any beneficiary thereunder or any other Persons and (ii) assuming
that Parent and the Company have the requisite power and authority to be the
lawful owner of the Common Stock or the Atom Minority Shares, as applicable,
upon the Closing and upon receipt by the Shareholders' Representative of the
Adjusted Base Consideration, good, valid and marketable title to the Common
Stock or the Atom Minority Shares, as applicable, will pass to

  

  

 

19  

  

  

Parent or the Company, as applicable, free and clear of any Liens, other than
those arising from the acts of Parent or its affiliates.

  


 

  

(c) _Authorization; Enforceability_.

  


 

  

(i) To the extent the Shareholder is an entity and not a natural person, the
Shareholder has requisite power and authority to execute and deliver this
Agreement, to perform its obligations hereunder and to consummate the
transactions contemplated hereby. To the extent the Shareholder is a natural
person and not an entity, the Shareholder is a natural person and has the
legal capacity to execute and deliver this Agreement, to perform his
obligations hereunder and to consummate the transactions contemplated hereby.

  


 

  

(ii) To the extent the Shareholder is an entity and not a natural person, the
execution, delivery and performance of this Agreement by the Shareholder and
the consummation by the Shareholder of the transactions contemplated hereby
have been duly and validly authorized and approved by all necessary action,
and no other action on the part of the Shareholder is necessary to authorize
the execution and delivery of this Agreement or to consummate the transactions
contemplated hereby.

  


 

  

(iii) This Agreement has been duly and validly executed and delivered by the
Shareholder (or, in the case of any Shareholder that is a trust, the Person
executing this Agreement on behalf of the applicable Shareholder is the
trustee of such Shareholder and is authorized to act on behalf of such
Shareholder) and, assuming the due and valid authorization, execution and
delivery by the other parties hereto, constitutes the valid and legally
binding obligation of the Shareholder, enforceable against the Shareholder in
accordance with its terms and conditions, subject to Laws of general
application relating to public policy, bankruptcy, insolvency and the relief
of debtors and rules of Law governing specific performance, injunctive relief
and other equitable remedies.

  


 

  

(d) _Non-contravention_.

  


 

  

(i) Neither the execution and delivery of this Agreement, nor the consummation
of the transactions contemplated hereby, nor compliance by the Shareholder
with the terms hereof, will (A) assuming that the authorizations, consents and
approvals referred to in _Section 4.5(a)_ are duly obtained in accordance with
applicable Law, violate any Law applicable to the Shareholder or any of its
properties or assets, (B) to the extent the Shareholder is an entity and not a
natural person, conflict with or violate any provision of the constituent
documents of the Shareholder, or , or (C) violate, conflict with, constitute a
Default with respect to the Shareholder, except in each case of clause (A) or
(C) where the violation, conflict, breach, default, acceleration, termination,
modification, cancellation, or failure to obtain consent would not prevent or
materially adversely affect the Shareholder's ability to consummate the
Closing in a timely manner or to perform any of its material obligations under
this Agreement.

  


 

  

(ii) Except for filings, permits, authorizations, consents and approvals as
may be required under the HSR Act and any other Antitrust Laws, no consents or
approvals of, or filings, declarations or registration with, any Governmental
Entity are necessary for the execution, delivery and performance by the
Shareholder of this Agreement or the consummation

  

  

 

20  

  

  

by such Shareholder of the transactions contemplated hereby, except in each
case where the failure to give such notice or obtain such approval would not
prevent or materially adversely affect the Shareholder's ability to consummate
the Closing in a timely manner or to perform any of its material obligations
under this Agreement.

  


 

  

(e) _Litigation_. (i) There are no Legal Proceedings pending and (ii) the
Shareholder is not subject to any Order, except in each case as would not
prevent or materially adversely affect the Shareholder's ability to consummate
the Closing in a timely manner or to perform any of its material obligations
under this Agreement.

  


 

  

(f) _Brokers ' Fees_. Other than Moelis and Company and Adamy Valuation
Advisors, Inc., the Shareholder has no liability or obligation to pay any fees
or commissions to any broker, finder, financial advisor or agent with respect
to the transactions contemplated by this Agreement.

  


 

  

ARTICLE 4. 
  REPRESENTATIONS AND WARRANTIES OF THE COMPANY

  


 

  

Subject to _Section 11.15_ (Company Disclosure Schedule), as set forth in the
disclosure schedules delivered to Parent concurrently with the execution of
this Agreement (the " _Company Disclosure Schedule_ "), the Company represents
and warrants to Parent as follows:

  


 

  

4.1 _Corporate Organization_. The Company and each of its Subsidiaries is duly
organized, validly existing and in good standing under the Laws of the
jurisdiction of its organization and has the requisite power and authority to
own, lease and operate all of its properties and assets and to carry on its
business as it is now being conducted, except where the failure to have such
power or authority would not, individually or in the aggregate, reasonably be
expected to have a Company Material Adverse Effect. The Company and each of
its Subsidiaries is duly licensed or qualified to do business and is in good
standing in each jurisdiction in which the nature of the business conducted by
it or the character or location of the properties and assets owned or leased
by it makes such licensing to do business or qualification necessary, except
where the failure to be so licensed or qualified, individually or in the
aggregate, would not reasonably be expected to have a Company Material Adverse
Effect. The copy of the certificate of incorporation and by-laws of the
Company, in the form made available to Parent, are true, complete and correct
copies of such documents as in effect as of the date of this Agreement.

  


 

  

4.2 _Subsidiaries and Minority Interests_. _Section 4.2 of the Company
Disclosure Schedule_ sets forth (a) the name of each Subsidiary of the
Company, (b) the jurisdiction of organization for each such Subsidiary, (c)
for any such Subsidiary which is not wholly owned, directly or indirectly, by
the Company, the percentage interest of the Company in each such Subsidiary
and (d) the record ownership of all equity interests in each such Subsidiary.
All of the outstanding shares of capital stock of, or other equity interests
in, each Subsidiary of the Company have been duly authorized, validly issued
and, as applicable, are fully paid and nonassessable. Except as set forth in
_Section 4.2 of the Company Disclosure Schedule_ , there are no shares of
capital stock or other equity interests of any Subsidiary of the Company
issued, reserved for issuance or outstanding, nor are there any outstanding
subscriptions, options,

  

  

 

21  

  

  

warrants, calls, rights (including preemptive rights), commitments or
agreements of any character calling for the purchase, redemption or other
acquisition or issuance, of any equity securities of any Subsidiary of the
Company or requiring any payments based on or related to the value of any
equity securities of any Subsidiary of the Company, including any equity
securities representing the right to purchase or otherwise receive any other
equity securities of any Subsidiaries of the Company. Except as set forth in
_Section 4.2 of the Company Disclosure Schedule,_ there are no voting trusts,
stockholder agreements, proxies or other similar agreements, including rights
of first refusal, in effect with respect to the voting or transfer of any
equity interest of any Subsidiary of the Company.

  


 

  

4.3 _Capitalization; Ownership_.

  


 

  

(a) The authorized capital stock of the Company consists of 1,200 shares, of
which 459.3846 shares of Common Stock are issued and outstanding.

  


 

  

(b) All of the issued and outstanding shares of Common Stock have been duly
authorized and validly issued and are fully paid and nonassessable. Except as
described in _Section 4.3(a)_, there are no shares of capital stock or other
equity interests of the Company issued, reserved for issuance or outstanding,
nor are there any subscriptions, options, warrants, calls, rights (including
preemptive rights), commitments or agreements of any character calling for the
purchase, redemption or other acquisition or issuance, of any securities of
the Company or requiring payments based on or related to the value of any
securities of the Company, including any securities representing the right to
purchase or otherwise receive any other securities of the Company. Except as
set forth in _Section 4.3(b) of the Company Disclosure Schedule_ , there are
no voting trusts, stockholder agreements, proxies or other similar agreements,
including rights of first refusal, in effect with respect to the voting or
transfer of any equity interests of the Company. There are no bonds,
debentures, notes or other Indebtedness of the Company or any of its
Subsidiaries having the right to vote (or convertible into, or exchangeable
for, securities having the right to vote) on any matters on which holders of
capital stock of the Company or any of its Subsidiaries may vote.

  


 

  

4.4 _Authority_. The Company has all necessary corporate power and authority
to execute and deliver this Agreement, to perform its obligations hereunder
and to consummate the transactions contemplated hereby. The execution,
delivery and performance by the Company of this Agreement, and the
consummation of the transactions contemplated hereby, have been duly and
validly authorized and approved by the board of directors of the Company, and
no other action on the part of the Company is necessary to authorize the
execution and delivery by the Company and of this Agreement and the
consummation by the Company of the transactions contemplated hereby. This
Agreement (a) has been duly and validly executed and delivered by the Company
and (b) assuming due and valid authorization, execution and delivery hereof by
the other parties hereto, constitutes a valid and binding obligation of the
Company enforceable against it in accordance with its terms, except that such
enforceability (i) may be limited by bankruptcy, insolvency, moratorium or
other similar Laws affecting or relating to the enforcement of creditors'
rights generally and (ii) is subject to general principles of equity.

  


 

  

4.5 _Consents and Approvals; No Violations_.

  

  

 

22  

  

  

(a) Except for (i) filings, permits, authorizations, consents and approvals as
may be required under the Hart-Scott-Rodino Antitrust Improvements Act of
1976, as amended (the " _HSR Act_ "), and any other Antitrust Laws, and (ii)
as disclosed in the Company Disclosure Schedule, no consents or approvals of,
or filings, declarations or registrations with, any Governmental Entity are
necessary for the execution, delivery and performance by the Company of this
Agreement or the consummation by the Company of the transactions contemplated
hereby, other than such other consents, approvals, filings, declarations or
registrations that, if not obtained, made or given, would not, individually or
in the aggregate, reasonably be expected to result in a Company Material
Adverse Effect.

  


 

  

(b) None of the execution and delivery of this Agreement by the Company, the
consummation by the Company of the transactions contemplated hereby or
compliance by the Company with any of the terms or provisions hereof, will (i)
conflict with or violate any provision of the certificate of incorporation or
by-laws of the Company (ii) conflict with or violate any provision of the
certificate or articles of incorporation, by-laws or other organizational or
governing documents of any of the Company's Subsidiaries or (iii) assuming
that the authorizations, consents and approvals referred to in _Section
4.5(a)_ are duly obtained in accordance with applicable Law, violate any Law
applicable to the Company or its Subsidiaries or any of their respective
properties or assets or (iv) except as set forth in _Section 4.5(b)_ of the
Company Disclosure Schedule, violate, conflict with, constitute a Default with
respect to the Company or any of its Subsidiaries, except, with respect to
each of clauses (iii) and (iv), for such violations, conflicts, breaches,
defaults, terminations which, individually or in the aggregate, would not
reasonably be expected to result in a Company Material Adverse Effect, and
would not prevent or impair the ability of the Company to perform its
obligations hereunder or consummate the transactions contemplated hereby.

  


 

  

4.6 _[Intentionally Omitted]_.

  


 

  

4.7 _[Intentionally Omitted]_.

  


 

  

4.8 _Financial Statements_.

  


 

  

(a) The Financial Statements are set forth in _Section 4.8 of the Company
Disclosure Schedule_. The Financial Statements (i) were derived from and
prepared in accordance with the underlying books and records of the Company
and its Subsidiaries, (ii) are complete and accurate in all material respects,
(iii) have been prepared in conformity with GAAP, applied on a consistent
basis throughout the periods covered thereby, and (iv) present fairly in all
material respects the financial condition and results of operations of the
Company and its Subsidiaries, taken as a whole, as of the times and for the
periods referred to therein, subject in the case of the unaudited financial
statements to (x) the absence of footnote disclosures and other presentation
items and (y) changes resulting from normal yearend adjustments none of which
are or will be material in amount.

  


 

  

(b) The Company and its Subsidiaries have established and maintain systems of
internal accounting controls that are designed to provide reasonable
assurances that all transactions are recorded as necessary to permit the
preparation of proper and accurate financial statements in accordance with
GAAP. Except as set forth in _Section 4.8(b) of the Company_

  

  

 

23  

  

  

 _Disclosure Schedule_ , none of the Company or its Subsidiaries, or to the
Knowledge of the Company, any auditor, accountant or representative thereof
has received any complaint, allegation or assertion of a problem or claim in
writing or otherwise, regarding the accounting or auditing practices,
procedures, methodologies or methods of any of the Company or its Subsidiaries
or their respective accounting controls, except for any such complaint,
allegation or assertion that has been finally resolved.

  


 

  

(c) Except as set forth in _Section 4.8(c) of the Company Disclosure Schedule_
, the accounts receivable of the Company and its Subsidiaries, as set forth on
the Financial Statements or arising since the date thereof, (i) are valid and
genuine, (ii) have arisen solely out of bona fide sales and deliveries of
materials, supplies, goods, services, equipment, assets and other business
transactions in the ordinary course of business, (iii) have been billed or
invoiced in the ordinary course of business in accordance with all applicable
Law and (iv) except as would not be material to the Company and its
Subsidiaries, are not subject to valid defenses, set-offs or counterclaims.

  


 

  

(d) Except as would not reasonably be expected to result in a Company Material
Adverse Effect, the inventories of the Company and its Subsidiaries, as set
forth on the Financial Statements or arising since the date thereof, consist
of items usable and of a quantity and quality salable in the ordinary course
of business (other than any obsolete or unusable inventories that are
adequately reserved against and reflected on the face of the Latest Balance
Sheet).

  


 

  

(e) _Section 4.8(e) of the Company Disclosure Schedule_ sets forth a list of
(i) all Funded Debt and (ii) all other material Indebtedness as of the date
hereof.

  


 

  

4.9 _No Undisclosed Liabilities_. Except as set forth in _Section 4.9 of the
Company Disclosure Schedule_ , neither the Company nor any of its Subsidiaries
has any liabilities or obligations of any nature (whether accrued, absolute,
contingent or otherwise) that are not reflected or reserved against on the
face of the Latest Balance Sheet of the Company, other than liabilities and
obligations (a) incurred in the ordinary course of business since the date of
the Latest Balance Sheet that do not result from any breach of Contract,
warranty, infringement, tort or violation of applicable Law, (b) incurred or
to be incurred pursuant to the terms of this Agreement or (c) that would not,
individually or in the aggregate, reasonably be expected to result in a
Company Material Adverse Effect.

  


 

  

4.10 _Absence of Certain Changes_. Since the date of the Latest Balance Sheet,
(a) except as expressly contemplated by this Agreement and as set forth in
_Section 4.10 of the Company Disclosure Schedule_ , the Company and its
Subsidiaries have conducted their businesses in all material respects in the
ordinary course and in a manner consistent with past practice and have not
taken any actions that, if taken after the date hereof, would constitute a
breach of _Section 6.1(d)_, _(h)_ , _(k)_ , _(r)_ or _(s)_ and (b) there has
not been any Company Material Adverse Effect.

  


 

  

4.11 _Personal Property_. The Company and its Subsidiaries own good and
marketable title to, or hold a valid leasehold interest in, all of the
material personal property used by them in the conduct of their business, free
and clear of all Liens, except for Permitted Liens and Liens

  

  

 

24  

  

  

that will be terminated at or prior to the Closing (each of which such Lien
that will be terminated at or prior to the Closing is set forth on _Section
4.11 of the Company Disclosure Schedule_) . Each such item of material
personal property is in all material respects in operable condition and
repair, subject to normal wear and tear, ongoing repairs or refurbishments in
the ordinary course and obsolescence in the ordinary course, and is suitable
for the purpose for which it is used by the Company and its Subsidiaries.

  


 

  

4.12 _Real Property_.

  


 

  

(a) _Section 4.12(a) of the Company Disclosure Schedule_ lists all real
property and interests in real property leased, subleased or licensed to the
Company and its Subsidiaries (the " _Leased Real Property_ ") (together with
all amendments or supplements thereto, collectively, the " _Leases_ "). True,
complete and correct copies of each Lease have been made available to Parent.
Other than such exceptions as would not reasonably be expected to result in a
Company Material Adverse Effect, the Company or one or more of its
Subsidiaries holds a good, valid and binding leasehold interest in, and enjoys
peaceful and undisturbed possession of, the Leased Real Property, in each
case, in accordance with the provisions of the applicable Leases, free and
clear of all Liens, except for Permitted Liens. Other than such exceptions as
would not reasonably be expected to result in a Company Material Adverse
Effect, all of the Leases to which the Company and/or any Subsidiary of the
Company is a party constitute valid and binding obligations of the Company
and/or its Subsidiaries, as applicable, and the other parties thereto, in full
force and effect, and grant the leasehold estates and rights of occupancy and
use they purport to grant. Neither the Company nor its Subsidiaries is in
material breach or default of the terms of each Lease. None of, as applicable,
the Company or any of its Subsidiaries, or any of the other parties to such
Lease, has received or given any notice of default thereunder which was not
cured within the applicable grace period or any notice of termination thereof.
No event has occurred which, with the giving of notice or the passage of time,
or both, would constitute a default under any Lease. Except as set forth in
_Section 4.12(a) of the Company Disclosure Schedule_ , the transactions
contemplated under this Agreement do not require the consent of any other
party to any material Lease.

  


 

  

(b) _Section 4.12(b) of the Company Disclosure Schedule_ lists all parcels of
real property and interests in real property that are owned in fee by the
Company or any of its Subsidiaries (the " _Owned Real Property_ "), including
the name of the record owner of each such Owned Real Property. Other than such
exceptions as would not reasonably be expected to result in a Company Material
Adverse Effect, the Company or one or more of its Subsidiaries holds good and
marketable fee simple title to the Owned Real Property, free and clear of all
Liens, except for Permitted Liens.

  


 

  

(c) With respect to the Leased Real Property, except in any such case as would
not, individually or in the aggregate, have a material, adverse impact on the
continued use thereof, (i) none of the Company or its Subsidiaries has
subleased, licensed or otherwise granted to anyone (other than to the Company
or another Subsidiary) the right to use or occupy any Leased Real Property or
any portion thereof or collaterally assigned or granted any other security
interest in any such leasehold estate or any interest therein, (ii) all
improvements upon the Leased Real Property are in good operating condition and
repair (ordinary wear and tear excepted) and sufficient in all material
respects for the conduct of the business as currently

  

 

25  

  

conducted therein, and (iii) there is no condemnation or other proceeding in
eminent domain, pending or threatened in writing, affecting any portion of a
Leased Real Property.

  


 

  

(d) With respect to the Owned Real Property, except in any such case as would
not, individually or in the aggregate, have a material, adverse impact on the
continued use thereof, (i) none of the Company or its Subsidiaries has leased
or otherwise granted to anyone (other than to the Company or another
Subsidiary, and other than Permitted Liens) the right to use or occupy any
Owned Real Property or any portion thereof, (ii) there are no outstanding
contracts, options, rights of first offer or rights of first refusal granted
by the Company or its Subsidiaries, in favor of any third parties to purchase
any of the Owned Real Property or any portion thereof or interest therein,
(iii) all improvements upon the Owned Real Property are in good operating
condition and repair (ordinary wear and tear excepted) and sufficient in all
material respects for the conduct of the business as currently conducted
therein, and (iv) there is no condemnation or other proceeding in eminent
domain, pending or threatened in writing, affecting any parcel Owned Real
Property or any portion thereof or interest therein.

  


 

  

(e) Except for the Leases, the Leased Real Property and the Owned Real
Property, none of the Company or any of its Subsidiaries occupy, are legally
obligated for, have an interest in, or otherwise use, any land, buildings,
locations or offices, and nor do they have any rights or obligations to
acquire such interests. The Leased Real Property and the Owned Real Property
comprise in all material respects all of the real property utilized by the
Company and its Subsidiaries in the conduct of their business in the ordinary
course.

  


 

  

4.13 _Intellectual Property_.

  


 

  

(a) _Section 4.13(a) of the Company Disclosure Schedule_ lists all registered
Patents, Marks and Copyrights and pending applications for registration of
Patents, Marks, Internet domain names and Copyrights owned, filed or applied
for by the Company or any of its Subsidiaries that are material to the conduct
of the Company's business (collectively, the " _Registered Intellectual
Property_ "). Except for matters that would not, individually or in the
aggregate, reasonably be expected to have a Company Material Adverse Effect:
(i) except as set forth in _Section 4.13(a) of the Company Disclosure
Schedule_ , all right, title or interest in each item of its Registered
Intellectual Property is solely owned by the Company or one of its
Subsidiaries (collectively, " _Owned Intellectual Property_ ") free and clear
of Liens, except for Permitted Liens; (ii) the issuances and registrations
included in the Registered Intellectual Property are subsisting and valid and
enforceable; (iii) except as set forth in _Section 4.13(a) of the Company
Disclosure Schedule_ , there are no Legal Proceedings pending, and since
September 30, 2014 no Legal Proceedings have been threatened in writing,
against the Company or any of its Subsidiaries by any Person challenging the
validity, ownership, patentability or enforceability of the Registered
Intellectual Property or the rights of the Company or any of its Subsidiaries
to continued use of the Owned Intellectual Property; and (iv) since September
30, 2014 the Company and its Subsidiaries have not initiated or threatened any
Legal Proceedings against a third party for, and no third party is,
infringing, misappropriating or improperly using any of the Owned Intellectual
Property. All necessary responses and maintenance filings for Registered
Intellectual Property that is material to the Company and its Subsidiaries,
taken as a whole, having final non-extendable deadlines due to be completed or
submitted, within forty-five (45)

  

  

 

26  

  

  

days after the date of this Agreement shall be completed or appropriate steps
shall be taken to complete by the date of this Agreement.

  


 

  

(b) Except for matters that would not, individually or in the aggregate,
reasonably be expected to result in a Company Material Adverse Effect, with
respect to proprietary rights that are licensed by the Company or one of its
Subsidiaries and material to the conduct of the Company's business (the "
_Licensed Intellectual Property_ "): (i) the Company or a Subsidiary of the
Company holds a good and valid leasehold interest in each item of its Licensed
Intellectual Property, free and clear of Liens, except for Permitted Liens;
and (ii) since September 30, 2014, no Person has challenged in a writing
received by the Company or any of its Subsidiaries, the Company's use of any
of the Licensed Intellectual Property or the rights of the Company or any
Subsidiary of the Company to continued use of the Licensed Intellectual
Property.

  


 

  

(c) No Legal Proceedings are pending, have been threatened in writing, against
the Company or any of its Subsidiaries by any Person alleging that the conduct
of the business by the Company and its Subsidiaries infringes, violates or
constitutes an unauthorized use or misappropriation of any material
proprietary or Intellectual Property rights of any such Person (including
pursuant to any non-disclosure agreements or obligations to which the Company
or any of its Subsidiaries or any of their present or former employees is a
party), except as would not, individually or in the aggregate, reasonably be
expected to result in a Company Material Adverse Effect.

  


 

  

(d) The Company and its Subsidiaries use, and have used, commercially
reasonable efforts to protect, preserve and maintain the secrecy and
confidentiality of its Trade Secrets from unauthorized access and unauthorized
use and there have been no intrusions or breaches resulting in the disclosure
or loss of any material Trade Secrets owned by the Company or its
Subsidiaries, except as would not, individually or in the aggregate,
reasonably be expected to result in a Company Material Adverse Effect.

  


 

  

(e) The Company and its Subsidiaries (i) have taken reasonable measures to
preserve and maintain the performance and security of the IT Systems in all
material respects, and (ii) maintain reasonable documentation regarding the IT
Systems and support and maintenance thereof. Since September 30, 2014, (A)
there has been no material failure with respect to the IT Systems, and (B)
there has been no unauthorized access to the IT Systems by a third party, in
each case that has had or would reasonably be expected to have a material
impact on the Company and its Subsidiaries, taken as a whole, except as would
not, individually or in the aggregate, reasonably be expected to result in a
Company Material Adverse Effect.

  


 

  

(f) The Company and its Subsidiaries operate and conduct their businesses in
material compliance with applicable legal requirements pertaining to data
protection or information privacy and security, including the collection or
use of such data or information. Personal Data collected, stored and processed
by the Company and its Subsidiaries in the operation and conduct of their
business can be used by Parent after the Closing in the manner currently used
by the Company and its Subsidiaries in the operation and conduct of their
business. The Company and its Subsidiaries have used commercially reasonable
efforts to protect the secrecy of Personal Data and non-public personal and
proprietary information that the

  

  

 

27  

  

  

Company and its Subsidiaries collect, store, use or maintain for the operation
and conduct of the business of the Company and its Subsidiaries and to prevent
unauthorized use, disclosure, loss, processing, transmission or destruction of
or access to such Personal Data or non-public information by any other Person
and no Person has made any illegal or unauthorized use of Personal Data that
was so collected by the Company and its Subsidiaries. With respect to the
operation and conduct of the business of the Company and its Subsidiaries (i)
the Company and its Subsidiaries have not been legally required to provide any
notices in connection with a disclosure of Personal Data or non-public
information, nor have the Company or its Subsidiaries provided any such
notice, and (ii) there are no claims pending or threatened against the Company
or its Subsidiaries alleging a violation of any Person's Personal Data,
privacy or data rights.

  


 

  

(g) For purposes of this Agreement, (i) the term " _IT System_ " shall mean
the communications networks, data centers, Software, hardware, databases,
computer equipment or other information technology owned or leased by the
Company and its Subsidiaries; (ii) the term " _Personal Data_ " shall mean
data relating to one or more individuals that is personally identifying (i.e.,
data that identifies an individual or, in combination with any other
information or data available to the Company or its Subsidiaries, is capable
of identifying an individual); and (iii) " _Software_ " shall mean all: (w)
computer programs, including software or firmware implementations of
algorithms, models, formulas and methodologies, whether in source code, object
code, human readable form or other form; (x) databases and compilations,
including all data and collections of data, whether machine readable or
otherwise; (y) flow charts used to design, plan, organize, build and develop
any of the foregoing, screens, user interfaces, templates, menus, buttons and
icons; and (z) all documentation including user manuals and other training
documentation relating to any of the foregoing.

  


 

  

4.14 _Contracts_.

  


 

  

(a) Except for this Agreement and for Contracts disclosed in _Section 4.14(a)
of the Company Disclosure Schedule_, neither the Company nor any of its
Subsidiaries is a party to or expressly bound by any:

  


 

  

(i) loan agreements, promissory notes, indentures, bonds, guarantees or
obligations for borrowed money or other instruments or Contracts involving
Indebtedness of, or held by, the Company or any of its Subsidiaries excluding
any inter-company arrangements among the Company and its Subsidiaries;

  


 

  

(ii) partnership, limited liability agreement, joint venture, strategic
alliance or other similar Contract with any entity other than the Company or
any of its Subsidiaries pursuant to which the Company has any ownership or
control interest in any other Person;

  


 

  

(iii) agreement or Contract containing any covenant or provision (A)
prohibiting the Company or any of its Subsidiaries or affiliates from engaging
in any line or type of business or in any geographic area or from competing
with any business or Person (except for such agreements which would not have a
material impact on the operations of the Company and its Subsidiaries or
affiliates after the Closing Date), (B) by which the Company or its
Subsidiaries grants any Person "most favored nation" status in respect of a
material term or

  

  

 

28  

  

  

(C) that provide for the Company or its Subsidiaries to exclusively purchase
from a third party or exclusively sell to a third party any product or
material in the case where the payments made for such product or material are
reasonably expected to exceed $100,000 for the year ended September 30, 2017
or are otherwise material to the Company and its Subsidiaries, taken as a
whole;

  


 

  

(iv) Contracts for the acquisition, sale or disposition, directly or
indirectly (by merger or otherwise), of assets or the securities of another
Person, other than in the ordinary course of business, that has any material
ongoing obligations thereunder; and

  


 

  

(v) Contracts for the employment or consulting services of any officer,
individual employee or other Person on a full-time, part-time, consulting or
other basis providing target annual compensation in excess of $250,000;

  


 

  

(vi) Contracts or groups of related Contracts, excluding purchase orders
entered into in the ordinary course of business consistent with past practice,
with the same party involving payments to or from the Company and its
Subsidiaries, taken as a whole, in excess of $5,000,000 per year;

  


 

  

(vii) any agreement, Contract, commitment or arrangement relating to capital
expenditures with respect to the Company or any of its Subsidiaries and
involving future payments which exceed $1,000,000 in any 12-month period;

  


 

  

(viii) any Contract pursuant to which the Company or any of its Subsidiaries
makes any loan or advance (other than routine expense advances to employees of
the Company or any of its Subsidiaries, trade credits consistent with past
practice or pre-payments made to suppliers in the ordinary course of business
consistent with past practice) to any Person;

  


 

  

(ix) Contracts under which the Company or its Subsidiaries (1) have a license,
option or other right to use or exploit any Intellectual Property rights of a
third party that are material to the Company and its Subsidiaries, taken as a
whole, or (2) other than non-exclusive out-licenses to customers to use
Intellectual Property in connection with the sale, marketing and
commercialization of products, have licensed third parties to use any
Intellectual Property material to the Company and its Subsidiaries, taken as a
whole, or (3) have granted any exclusive right or license to use any
Intellectual Property material to the Company and its Subsidiaries, taken as a
whole (or, in the case of any product that has not been approved for
commercial sale, any right) to a third party, including for the research,
clinical trial, development, distribution, sale, supply, license, marketing,
co-promotion or manufacturing of any product (such agreements described in
clauses (1) through (3) above, the " _Company IP Agreements_ "), other than
such agreements for any off-the-shelf, commercially available software and/or
"shrink-wrap" agreements;

  


 

  

(x) Contract entered into by the Company or any of its Subsidiaries since
September 30, 2014 relating to the settlement or other resolution of any
material Legal Proceeding;

  

  

 

29  

  

  

(xi) leases (other than the Leases) or subleases pursuant to which material
personal or real property is leased to or from the Company or any of its
Subsidiaries requiring payment in excess of $100,000 per year; and

  


 

  

(xii) any other Contract made outside the ordinary course of business that is
otherwise material to the business of the Company and its Subsidiaries, taken
as a whole, as presently conducted.

  


 

  

Each Contract of the type described in clauses (i) through (xii) above is
referred to herein as a " _Material Contract_ ".

  


 

  

(b) The Company has made available to Parent a copy of each Material Contract
(including all amendments thereto). Each Material Contract (i) constitutes a
valid and binding obligation of the Company and/or its Subsidiaries, as
applicable, and, to the Knowledge of the Company, constitutes a valid and
binding obligation of the other parties thereto, and (ii) is in full force and
effect. Neither the Company nor its Subsidiaries is in material breach or
default of any Material Contract and no event has occurred and is continuing
that would reasonably be expected to result in a material breach of or default
thereunder. No counterparty to any Material Contract is in breach or default
of any Material Contract and no event has occurred and is continuing that
would reasonably be expected to result in a breach thereof or default
thereunder by any counterparty, except as would not reasonably be expected to
result in a Company Material Adverse Effect.

  


 

  

4.15 _Related Party Agreements_. Except as set forth in _Section 4.15 of the
Company Disclosure Schedule_ and except for payment of salaries and benefits
to employees in the ordinary course of business, (a) neither the Company nor
any of its Subsidiaries is a party to any agreement, Contract, commitment,
transaction or arrangement with, or indebted, either directly or indirectly,
to any of its officers, directors, managers, members, Shareholders or any of
their respective Affiliates or family members, (b) no officers or directors of
the Company (other than the Persons listed in the definition of Knowledge of
the Company) or any of its Subsidiaries or any of their respective Affiliates
or family members is indebted to the Company or any of its Subsidiaries or has
any direct or indirect ownership interest in any material property used by or
any contractual business relationship with any Person with which the Company
or any of its Subsidiaries has a material business relationship and (c) no
Shareholders or any of the Persons listed in the definition of Knowledge of
the Company or any of their respective Affiliates or family members is
indebted to the Company or any of its Subsidiaries or has any direct or
indirect ownership interest in any property used by or any contractual
business relationship with any Person with which the Company or any of its
Subsidiaries has a material business relationship (excepting, in each case of
clauses (b) and (c), less than three percent stock holdings for investment
purposes in securities of publicly traded companies).

  


 

  

4.16 _Compliance with Applicable Law; Permits_. Except as set forth in
_Section 4.16 of the Company Disclosure Schedule_ , none of the Company or any
of its Subsidiaries is, and since September 30, 2014, has not been, in
violation of any applicable federal, state, local, foreign or territorial Law
or any other requirement of any Governmental Entity, including any Law
relating to the exposure to hazardous or toxic materials in, or the use or
registration of chemicals in the production or formulation of, any of the
Company's or any of its Subsidiary's products

  

  

 

30  

  

  

(including any Law required or implemented pursuant to Regulation (EC) No.
1907/2006 concerning the Regulation, Evaluation, Authentication and
Restriction of Chemicals) or otherwise relating to the sale, distribution,
marketing or labeling of any of the Company's or any of its Subsidiary's
products, except for: (i) violations relating to employee, labor and benefits
matters, which are subject to _Sections 4.18_ and _4.19_ , (ii) violations
relating to Environmental Laws, which are subject to _Section 4.20_ , (iii)
violations relating to Taxes, which are subject to _Section 4.21_ or (iv)
violations that would not, individually or in the aggregate, reasonably be
expected to result in a Company Material Adverse Effect. To the Knowledge of
the Company, no investigation or review by any Governmental Entity concerning
any such possible violation of Law or other requirement is pending or
threatened. The Company and each of its Subsidiaries holds all licenses,
permits, registrations and other authorizations (" _Permits_ ") required to
conduct its business, and all such licenses, Permits, registrations and other
authorizations are valid and in full force and effect, except for those the
absence of which would not, individually or in the aggregate, reasonably be
expected to constitute a Company Material Adverse Effect. The Company and each
of its Subsidiaries is in compliance with all such licenses, Permits,
registrations and other authorizations, except for possible failures to be so
in compliance that would not, individually or in the aggregate, reasonably be
expected to constitute a Company Material Adverse Effect. Except as set forth
in _Section 4.16 of the Company Disclosure Schedule_ , the consummation of the
transactions contemplated by this Agreement, in and of itself, will not cause
the revocation or cancellation of any material Permit or material
Environmental Permit.

  


 

  

4.17 _Litigation_. Except as set forth in _Section 4.17 of the Company
Disclosure Schedule,_ there are no claims, suits, actions, proceedings,
investigations or arbitrations (each, a " _Legal Proceeding_ ") pending or
threatened in writing against (a) the Company or its Subsidiaries or any of
their respective properties, assets or businesses or (b) any director, agent,
officer or employee of the Company or any of its Subsidiaries acting in his or
her capacity as such who has a right to seek indemnification from the Company
or such Subsidiary, in each case (i) the outcome of which, if adversely
decided, would reasonably be expected to result in liability to the Company
and its Subsidiaries, taken as a whole, in excess of $100,000 individually or
$1,000,000 in the aggregate or otherwise result in a Company Material Adverse
Effect, (ii) seeks injunctive relief against the Company or any of its
Subsidiaries or (iii) alleges any criminal action or inaction against the
Company or any of its Subsidiaries. There is no Order outstanding against the
Company or its Subsidiaries or their respective properties or assets that
would reasonably be expected to result in a Company Material Adverse Effect.

  


 

  

4.18 _Labor_.

  


 

  

(a) Except as set forth on _Section 4.18(a) of the Company Disclosure
Schedule_ , no written charge or complaint of employment discrimination or
other similar charge or complaint, or any charge or complaint with the
National Labor Relations Board, the Equal Employment Opportunity Commission or
any comparable governmental authority, has been filed against or with respect
to the Company or any of its Subsidiaries during the last year, or is pending
or has been threatened in writing.

  


 

  

(b) (i) Neither the Company nor any of its Subsidiaries is a party to or bound
by any collective bargaining agreement or similar labor contract or any
bargaining order or

  

  

 

31  

  

  

injunction relating to any Company Personnel, (ii) there is no current or
threatened strike, lockout, slowdown or work stoppage by or with respect to
any Company Personnel and (iii) there are no current or written threats to
engage in activities or proceedings of any Company Personnel or any labor
organization to organize or certify a collective bargaining unit or to gain
recognition or bargaining rights.

  


 

  

(c) Except as disclosed in _Section 4.18(c) of the Company Disclosure
Schedule_ or as would not reasonably be expected to result in a Company
Material Adverse Effect, the Company and its Subsidiaries are in compliance
with all applicable Laws relating to labor, labor relations or employment.

  


 

  

4.19 _Employee Matters_.

  


 

  

(a) _Section 4.19(a) of the Company Disclosure Schedule_ contains a list of
all material Company Benefit Plans. The Company has delivered or made
available to Parent true, complete and correct copies of each such Company
Benefit Plan (or a written description thereof) and any amendments thereto,
and each of the following items, to the extent applicable; (1) any related
trust agreement, group annuity contract or other funding mechanism, (2) the
most recent summary plan description, (3) the most recent IRS determination,
opinion or advisory letter for each Company Benefit Plan that is intended to
be "qualified" within the meaning of Section 401(a) of the Code, (4) the most
recently filed annual report on IRS form 5500 and all schedules thereto and
(5) the most recent financial statements and actuarial or other valuation
reports prepared with respect thereto. As of the date hereof, no announcement
has been made to establish or amend any material Company Benefit Plan. For
purposes of this Agreement, " _Company Benefit Plan_ " means (I) any "employee
benefit plan," as defined in Section 3(3) of ERISA, whether or not subject to
ERISA and whether or not maintained in the United States or another
jurisdiction, (II) any severance or other termination, bonus, retention or
other incentive compensation, change of control, profit sharing, equity-based
compensation, deferred compensation, pension, retirement, disability,
vacation, death benefit, medical, dental or other employee benefit plan, fund
or arrangement maintained or contributed to or required to be contributed to,
by or on behalf of the Company or any of its Subsidiaries for the benefit or
welfare of any current or former director, officer or employee of the Company
or any of its Subsidiaries (" _Company Personnel_ ") and (III) any employment,
severance, retention, change of control or termination agreement between the
Company or any of its Subsidiaries and any Company Personnel.

  


 

  

(b) Each of the Company Benefit Plans has been established, operated and
administered in accordance with its terms and in compliance with all
applicable Laws, including ERISA and the Code, and the Company and its
Subsidiaries and the trustee of any Company Benefit Plan are in compliance
with all applicable Laws relating to the establishment, operation and
administration of each Company Benefit Plan, except where noncompliance would
not, individually or in the aggregate, reasonably be expected to result in a
Company Material Adverse Effect. There are no pending claims or claims
threatened in writing (other than routine claims for benefits), proceedings,
disputes, complaints or investigations by, on behalf of or against any Company
Benefit Plan or any trust related thereto, except where such claims,
proceedings, disputes, complaints or investigations would not, individually or
in the aggregate, reasonably be expected to result in a Company Material
Adverse Effect. Each Company Benefit Plan that is

  

  

 

32  

  

  

intended to be "qualified" within the meaning of Section 401(a) of the Code
has received a favorable determination letter as to such qualification from
the IRS or is entitled to rely upon a favorable opinion issued by the IRS and,
to the Knowledge of the Company, there are no existing circumstances or any
events that have occurred that could reasonably be expected to cause the loss
of any such qualification status of any such Company Benefit Plan.

  


 

  

(c) Neither the Company nor any of its Subsidiaries or any of their respective
ERISA Affiliates maintains, sponsors or contributes to, or has in the last six
years contributed to or has been obligated to contribute to, or has any
liability with respect to any plan that is or was subject to Title IV of
ERISA, including any "multiemployer plan", as defined in Section 3(37) of
ERISA, or any "multiple employer plan", within the meaning of Section 4063 or
4064 of ERISA. " _ERISA Affiliate_ " means, with respect to any person, any
trade or business, whether or not incorporated, that together with such Person
would be deemed a "single employer" within the meaning of Section 4001(a)(15)
of ERISA.

  


 

  

(d) Except as would not reasonably be expected to result in a Company Material
Adverse Effect, none of the Company Benefit Plans provide for post-employment
retiree life or health insurance, benefits or coverage for any Company
Personnel or any beneficiary thereof, except as may be required under the
Consolidated Omnibus Budget Reconciliation Act of 1985, as amended or similar
state Laws.

  


 

  

(e) With respect to each Company Benefit Plan that is maintained outside the
United States, except as would not, individually or in the aggregate,
reasonably be expected to result in a Company Material Adverse Effect, (i) all
amounts required to be paid with respect to such Company Benefit Plan
(including employer and employee contributions, insurance premiums, levies,
debts, Taxes and expenses, whether required by Law or by the terms of such
Company Benefit Plan) have been made or, if applicable, accrued in accordance
with normal accounting practices, and (ii) each such Company Benefit Plan
required to be registered has been registered and has been maintained in good
standing with applicable regulatory authorities.

  


 

  

(f) Except with respect to payments contemplated pursuant to _ARTICLE 3_ of
this Agreement or as set forth on _Section 4.19(f) of the Company Disclosure
Schedule_, the consummation of the transactions contemplated hereby (alone or
in conjunction with any other event, including any termination of employment
on or following the Closing Date) shall not (i) result in any contractual or
legal obligation on the part of the Company or any of its Subsidiaries to pay,
or to fund the payment of, any material severance, sale award, change of
control or other compensation or benefits to any Company Personnel, or any
other persons, (ii) materially increase, or accelerate the time of vesting of,
any compensation or benefits under any Company Benefit Plan, (iii) give rise
to any payment of any amount by the Company or any of its Subsidiaries that
would be nondeductible by reason of Section 280G of the Code or (iv) result in
any breach or violation of or default under, or limit any right to materially
amend, modify or terminate, any Company Benefit Plan. Neither the Company nor
any of its Subsidiaries has any obligation to provide, and no Company Benefit
Plan provides any individual with the right to, a gross-up, indemnification,
reimbursement or other payment for any excise or additional Taxes, interest or
penalties incurred pursuant to Section 409A or Section 4999 of the Code or due
to the failure of any payment to be deductible under Section 280G of the Code.
The Company has made available to Parent true, correct and

  

  

 

33  

  

  

complete copies of the Section 280G calculations (whether or not final) with
respect to the Disqualified Individuals in connection with the transactions
contemplated by this Agreement.

  


 

  

(g) (i) The ESOP constitutes an "employee stock ownership plan" under Section
4975(e)(7) of the Code and the regulations promulgated thereunder and Section
407(d)(6) of ERISA and the regulations promulgated thereunder; (ii) the ESOP
is exempt from federal income Tax under Section 501(a) of the Code; and (iii)
the ESOP Trustee or the plan administrator of the ESOP (as such term is
defined in Section 3(16) of ERISA) has commissioned an appraisal of the shares
of Common Stock held by the ESOP by a qualified independent appraiser, as such
term is used in Section 401(a)(28) of the Code, for each of the last three
plan years (as defined in the ESOP) and has utilized that appraisal for all
administrative purposes required under the terms of the ESOP.

  


 

  

4.20 _Environmental Matters_.

  


 

  

(a) Except as set forth in _Section 4.20 of the Company Disclosure Schedule_
or as, individually or in the aggregate, has not resulted in, and would not
reasonably be expected to result in a Company Material Adverse Effect, the
Company and its Subsidiaries (i) are, and during the five (5) years prior to
the date hereof have been, in compliance with all Environmental Laws
applicable to them or their respective operations and properties, (ii)
possess, and are, and during the five (5) years prior to the date hereof have
been, in compliance with all Environmental Permits required for the operation
of the business of the Company or its Subsidiaries during such five (5)-year
period and no revocation, suspension, cancelation or other adverse
modification of any Environmental Permit is pending, or threatened in writing,
and (iii) all prior noncompliance with Environmental Laws or Environmental
Permits has been resolved without any outstanding costs or obligations.

  


 

  

(b) The Company has made available to Parent all material filings and reports
submitted pursuant to ISRA, all material Phase I and Phase II site assessments
and all other similar material environmental audits and reports of
investigations in each case in the possession or control of the Company or its
Subsidiaries and relating to the Company, its Subsidiaries, the Owned Real
Property or the Leased Real Property or, except as would not reasonably be
expected to result in a Company Material Adverse Effect, to the extent
prepared in the previous five (5) years or, to the Knowledge of the Company,
before that time, relating to any property or entity formerly owned or
operated by the Company or its Subsidiaries.

  


 

  

(c) Except as set forth in _Section 4.20 of the Company Disclosure Schedule_
or as, individually or in the aggregate, has not resulted in, and would not
reasonably be expected to result in a Company Material Adverse Effect, (i) no
Legal Proceeding arising under Environmental Laws or Environmental Permits is
pending or threatened in writing against the Company or any of its
Subsidiaries, and there are no outstanding costs or obligations under any
binding agreement with any Governmental Entity, except for any such costs and
obligations pursuant to compliance with ISRA as a result of the transactions
contemplated by this Agreement, or Order involving the Company or its
Subsidiaries under any Environmental Law or Environmental Permit, and (ii)
none of the Company or any of its Subsidiaries has received any written
information request or written notice of any violation of, or any liability
under, any

  

  

 

34  

  

  

Environmental Law or Environmental Permit that has not been resolved with no
outstanding costs or obligations.

  


 

  

(d) Except as set forth in _Section 4.20 of the Company Disclosure Schedule_
or as, individually or in the aggregate, has not resulted in, and would not
reasonably be expected to result in a Company Material Adverse Effect, and
excluding any Release investigated pursuant to compliance with ISRA as a
result of the transactions contemplated by this Agreement (i) neither the
Company nor any of its Subsidiaries is conducting any Remedial Action at any
currently or formerly owned or operated real property or any other location,
and (ii) neither the Company nor any of its Subsidiaries has caused or allowed
a Release of or human exposure to any Hazardous Materials, nor, to the
Knowledge of the Company, has any third party caused or allowed such a Release
or exposure, in each case, for which the Company or its Subsidiaries has
incurred or would be expected to incur any liability or obligation under any
Environmental Law or Environmental Permit (other than such matters covered or
barred by workers' compensation and related insurance).

  


 

  

(e) Except as set forth in _Section 4.20 of the Company Disclosure Schedule_
or as, individually or in the aggregate, has not resulted in, and would not
reasonably be expected to result in a Company Material Adverse Effect, neither
the Company nor any of its Subsidiaries has assumed or retained by contract or
by operation of Law any costs, liabilities or obligations arising under or
relating to any Environmental Law or Environmental Permit.

  


 

  

(f) For purposes of this Agreement, (i) the term " _Environmental Laws_ "
shall mean all Laws and binding agreements with any Governmental Entity
relating to pollution, protection of the Environment and natural resources, or
protection of human health from environmental exposure to Hazardous Materials,
including any use, storage, recycling, treatment, generation, transportation,
processing, handling, labeling, management, disposal, remediation, Release or
threatened Release of, or environmental exposure to, any toxic or hazardous
substance, material or waste, including the New Jersey Industrial Site
Recovery Act (" _ISRA_ ") (or its predecessor statutes, such as the
Environmental Cleanup Responsibility Act), but excluding any Law related to
product sales or exposure to Hazardous Materials from products except the
California Safe Drinking Water and Toxic Enforcement Act of 1986; (ii) the
term " _Environmental Permit_ " shall mean any permit, approval,
identification number, license, registration, waiver or other authorization
required under any applicable Environmental Law; (iii) the term "
_Environment_ " shall mean all environmental media, including indoor or
ambient air, surface water, groundwater, drinking water supplies, creek,
stream or river sediments, marsh or wetlands and land surface or subsurface
strata or soil; (iv) the term " _Hazardous Material_ " shall mean any waste,
chemical, material or other substance that is listed, defined, designated,
regulated or classified as hazardous, radioactive, carcinogenic or toxic or a
pollutant or a contaminant (or words of similar import) by any Governmental
Entity with jurisdiction over the Environment, or that otherwise is regulated
or can result in liability under Environmental Law, including lead, mercury
and other metals, dioxin, nicotine, volatile organic compounds, petroleum and
all by-products or derivatives thereof, friable asbestos or asbestos-
containing materials in any form or condition, and polychlorinated biphenyls;
(v) the term " _Release_ " shall mean the release, spill, emission, leaking,
pumping, pouring, emptying, escaping, dumping, injection, deposit, disposal,
discharge, dispersal, leaching or migrating into or through the Environment;
and (vi) " _Remedial Action_ " means any action to investigate, clean up,
remove,

  

  

 

35  

  

  

treat, remediate, or to conduct any response, monitoring, restoration or
corrective action with respect to, Hazardous Materials in the Environment
undertaken in connection with any order or demand of any Governmental Entity.

  


 

  

4.21 _Tax Returns and Tax Payments_.

  


 

  

(a) The Company and each of its Subsidiaries has timely (after giving effect
to any extensions) filed all United States federal income Tax Returns and all
other material Tax Returns that it was required to file and paid all material
Taxes that it was required to pay. All United States federal income Tax
Returns and all other material Tax Returns filed by the Company and each of
its Subsidiaries are true, correct and complete in all material respects.

  


 

  

(b) The Company and its Subsidiaries have withheld and paid over to the proper
taxing authorities or other Governmental Entities all material Taxes required
to be withheld and paid over.

  


 

  

(c) Except as set forth in _Section 4.21 of the Company Disclosure Schedule_ ,
there is no pending dispute or claim concerning any material Tax liability of
the Company or any of its Subsidiaries either claimed or raised by any
Governmental Entity in writing.

  


 

  

(d) Except as set forth in _Section 4.21 of the Company Disclosure Schedule_ ,
neither the Company nor any of its Subsidiaries has waived any statute of
limitation with respect to a material amount of Taxes or agreed to any
extension of time with respect to a material Tax assessment or deficiency
(other than (i) any waiver or extension that is no longer in effect and (ii)
extensions of time to file Tax Returns obtained in the ordinary course).

  


 

  

(e) Neither the Company nor any of its Subsidiaries will be required to
include any material item of income or exclude any material item of deduction
from taxable income for any taxable period (or portion thereof) ending after
the Closing Date as a result of any (i) closing or similar agreement with any
Governmental Entity executed on or prior to the Closing Date, (ii) change in,
or use of an improper, method of accounting for a Pre-Closing Tax Period,
(iii) prepaid amount (other than deferred amounts reflected in the Financial
Statements or accrued thereafter in the ordinary course of business consistent
with past practice) received on or prior to the Closing Date, (iv) installment
sale, intercompany transaction or open transaction disposition made on or
prior to the Closing Date or (v) election under Section 108(i) of the Code or
any analogous provision or state, local or foreign Law made with respect to a
Pre-Closing Tax Period.

  


 

  

(f) Neither the Company nor any of its Subsidiaries has constituted either a
"distributing corporation" or a "controlled corporation" (within the meaning
of Section 355(a)(1)(A) of the Code) in a distribution of stock intended to
qualify for tax-free treatment under Section 355 of the Code in a distribution
occurring during the two-year period ending on the date of this Agreement or
that otherwise could constitute part of a "plan" or "series of related
transactions" (within the meaning of Section 355(e) of the Code) with the
transactions contemplated by this Agreement.

  


 

  

(g) Neither the Company nor any of its Subsidiaries (i) has been a member of
an affiliated group for U.S. federal, state or local or foreign Tax Law
purposes (other than a

  

  

 

36  

  

  

group the common parent of which is the Company or any of its Subsidiaries) or
(ii) has any liability for Taxes of any Person (other than the Company or any
of its Subsidiaries) arising from the application of Treasury Regulation
Section 1.1502-6 or any analogous provision of state, local or foreign Law, as
a transferee or successor or by Contract (other than any Contract a primary
purpose of which is not the indemnification or sharing of Taxes).

  


 

  

(h) There are no material Liens as a result of any unpaid Taxes (other than
Permitted Liens) upon any of the assets of the Company or any of its
Subsidiaries.

  


 

  

(i) Neither the Company nor any of its Subsidiaries has participated in any
"listed transaction" within the meaning of Treasury Regulation Section
1.6011-4(b)(2).

  


 

  

(j) Neither the Company nor any of its Subsidiaries has received written
notice of any claim from a Governmental Entity in any jurisdiction in which
the Company or a Subsidiary does not file Tax Returns that the Company or a
Subsidiary is, or may be, required to file Tax Returns or subject to Tax in
such jurisdiction.

  


 

  

4.22 _Insurance_. _Section 4.22 of the Company Disclosure Schedule_ sets forth
a complete listing of all material surety bonds and insurance policies
relating to the assets, business, operations, employees, officers or directors
of the Company or its Subsidiaries that are currently in effect. True and
complete copies of such surety bonds and insurance policies have been made
available to Parent. The Company and its Subsidiaries are insured against such
risks and losses and in such amounts as required by applicable Law or
Contracts to which the Company or any of its Subsidiaries are a party and as
the Company has reasonably determined to be reasonable and customary for the
business of the Company and its Subsidiaries. No written notice of
cancellation or nonrenewal with respect to or material increase in any premium
of any such insurance policy has been received by the Company or any of its
Subsidiaries. Except as would not, individually or in the aggregate,
reasonably be expected to result in a Company Material Adverse Effect, all
insurance policies maintained by the Company and its Subsidiaries, or of which
the Company or any of its Subsidiaries is the beneficiary, are in full force
and effect and all premiums due and payable thereon have been paid. Neither
the Company nor any of its Subsidiaries is in default with respect to its
obligations under any such insurance policy or has been denied coverage. All
outstanding material claims under such insurance policies have been reported
to the appropriate insurer and there are no outstanding material claims by the
Company or any of its Subsidiaries pending under any such policy or in respect
of which such insurer has reserved its rights.

  


 

  

4.23 _Broker 's Fees_. None of the Company or any Subsidiary of the Company,
or any of their respective officers or directors, as applicable, has employed
any financial advisor, broker or finder, or incurred any liability for any
broker's fees, commissions or finder's fees, in connection with any of the
transactions contemplated hereby, except for Moelis and Company.

  


 

  

4.24 _Significant Customers and Suppliers_. _Section 4.24 of the Company
Disclosure Schedule_ sets forth a list of (i) the 10 most significant
customers of the Company and its Subsidiaries, taken as a whole (the "
_Material Customers_ "), based on dollar sales volumes during the 12-month
period ended September 30, 2016, (ii) the 10 most significant suppliers (the "
_Material Suppliers_ ") to the Company and its Subsidiaries, taken as a whole,
based on amounts

  

  

 

37  

  

  

paid by the Company and its Subsidiaries during the 12-month period ended
September 30, 2016 and (iii) the 10 most significant distributors (the "
_Material Distributors_ ") of products of the Company and its Subsidiaries,
taken as a whole, based on amounts paid to the Company and its Subsidiaries
during the 12-month period ended September 30, 2016. Except as set forth in
_Section 4.24 of the Company Disclosure Schedule_ , since the date of the
Latest Balance Sheet, no Material Customer, Material Supplier or Material
Distributor has cancelled, terminated, failed to renew, materially reduced or
provided written notice of or taken any material actions with the Company and
its Subsidiaries to cancel, terminate, fail to renew or materially reduce its
relationship with the Company or any of its Subsidiaries.

  


 

  

4.25 _Fairness Opinion_. Prior to the execution of this Agreement, the Company
has provided to Parent a copy of the Fairness Opinion delivered by the
Qualified Independent Appraiser to the ESOP Trustee that (i) the price to be
received by the ESOP for its shares of Common Stock is not less than fair
market value (as such term is used in determining "adequate consideration"
under section 3(18) of ERISA) of such shares and (ii) the terms and conditions
of the transactions contemplated in this Agreement are fair and reasonable to
the ESOP from a financial point of view.

  


 

  

4.26 _No Other Representations_. Except for the representations and warranties
contained in this Agreement (as modified by the Company Disclosure Schedule),
neither the Company, the Shareholders, nor any other Person makes any other
express or implied representation or warranty with respect to the Company, any
of its Subsidiaries or the transactions contemplated by this Agreement, and
the Company and the Shareholders disclaim any other representations or
warranties. Except for the representations and warranties contained in this
Agreement (as modified by the Company Disclosure Schedule) and except with
respect to claims of, or causes of action arising from, Fraud, the Company and
the Shareholders hereby disclaim all liability and responsibility for any
representation, warranty, projection, forecast, statement, or information
made, communicated or furnished (whether orally or in writing, in any data
room relating to the transactions contemplated by this Agreement, in
management presentations, functional "break-out" discussions, responses to
questions or requests submitted by or on behalf of Parent or in any other form
in consideration or investigation of the transactions contemplated by this
Agreement) to Parent or its affiliates or Representatives (including any
opinion, information, forecast, projection or advice that may have been or may
be provided to Parent or its affiliates or Representatives by any director,
officer, employee, agent, consultant or other Representative of the Company,
the Shareholders or any of their respective affiliates). The Company and the
Shareholders make no representations or warranties to Parent regarding (i)
merchantability or fitness for any particular purpose or (ii) the probable
success or profitability of the Company or any of its Subsidiaries. The
disclosure of any matter or item in any section of the Company Disclosure
Schedule shall not be deemed to constitute an acknowledgment that any such
matter is required to be disclosed.

  


 

  

ARTICLE 5. 
  REPRESENTATIONS AND WARRANTIES OF PARENT

  


 

  

Parent represents and warrants to the Company and the Shareholders as follows:

  

  

 

38  

  

  

5.1 _Organization_. Parent is a corporation duly organized, validly existing
and in good standing under the Laws of the jurisdiction of its organization
and has the requisite power and authority to own, lease and operate all of its
properties and assets and to carry on its business as it is now being
conducted except where the failure to have such power or authority would not
reasonably be expected to result in a Parent Material Adverse Effect. Parent
is duly licensed or qualified to do business and is in good standing in each
jurisdiction in which the nature of the business conducted by it or the
character or location of the properties and assets owned or leased by it makes
such licensing or qualification necessary, except where the failure to be so
licensed or qualified, individually or in the aggregate would not reasonably
be expected to result in a Parent Material Adverse Effect.

  


 

  

5.2 _Authority_. Parent has all necessary power and authority to execute and
deliver this Agreement, to perform its obligations hereunder and to consummate
the transactions contemplated hereby. The execution, delivery and performance
by Parent of this Agreement, and the consummation by Parent of the
transactions contemplated hereby, have been duly and validly authorized and
approved by the board of directors of Parent, and no other action on the part
of Parent is necessary to authorize the execution and delivery by Parent of
this Agreement, and the consummation by Parent of the transactions
contemplated hereby. This Agreement (a) has been duly and validly executed and
delivered by Parent, and (b) assuming due and valid authorization, execution
and delivery hereof by the other parties hereto, constitutes a valid and
binding obligation of Parent, enforceable against Parent in accordance with
its terms, except that such enforceability (i) may be limited by bankruptcy,
insolvency, moratorium or other similar Laws affecting or relating to the
enforcement of creditors' rights generally, and (ii) is subject to general
principles of equity.

  


 

  

5.3 _Consents and Approvals; No Violation_.

  


 

  

(a) Except for (i) filings, permits, authorizations, consents and approvals as
may be required under the HSR Act and any other Antitrust Laws and (ii) as
disclosed in the Company Disclosure Schedule, no consents or approvals of, or
filings, declarations or registrations with, any Governmental Entity are
necessary for the execution, delivery and performance by Parent of this
Agreement and the consummation by Parent of the transactions contemplated
hereby, other than such other consents, approvals, filings, declarations or
registrations that, if not obtained, made or given, would not reasonably be
expected to result, individually or in the aggregate, in a Parent Material
Adverse Effect.

  


 

  

(b) None of the execution and delivery of this Agreement by Parent, the
consummation by Parent of the transactions contemplated hereby or compliance
by Parent with any of the terms or provisions hereof will (i) conflict with or
violate any provision of the certificates of incorporation or other governing
documents of Parent, or (ii) assuming that the authorizations, consents and
approvals referred to in _Section 5.3(a)_ are duly obtained in accordance with
applicable Law, violate any Law applicable to Parent or any of its properties
or assets, or (iii) violate, conflict with, constitute a Default with respect
to Parent under any material Contract to which the Parent is a party, or by
which any of its property or assets is bound, except for such violations,
conflicts, breaches or Defaults which, individually or in the aggregate, would
not reasonably be expected to result in a Parent Material Adverse Effect.

  

  

 

39  

  

  

5.4 _Vote Required_. No vote of the holders of any class or series of capital
stock or other equity interests of Parent is necessary to adopt this Agreement
or to consummate the transactions contemplated hereby.

  


 

  

5.5 _Litigation_. (a) As of the date hereof, there are no claims, suits,
actions, proceedings or arbitrations pending or threatened in writing against
Parent, the outcome of which, if adversely decided, would reasonably be
expected to result in a Parent Material Adverse Effect, and (b) there is no
Order outstanding against Parent that would reasonably be expected to result
in a Parent Material Adverse Effect.

  


 

  

5.6 _Financing_. Parent has available to it funds sufficient to consummate the
transactions contemplated by this Agreement, including the payment of all fees
and expenses payable by Parent in connection with the transactions
contemplated by this Agreement. Parent expressly acknowledges and agrees that
its obligation to consummate the transactions contemplated by this Agreement
is not subject to any condition or contingency with respect to any financing
or funding by any third party.

  


 

  

5.7 _Acquisition for Investment_. Parent has such knowledge and experience in
financial and business matters that it is capable of evaluating the merits and
risks of its participation in the transactions contemplated by this Agreement.
Parent confirms that the Company has made available to Parent and Parent's
Representatives (a) the opportunity to ask questions of the officers and
management employees of the Company and its Subsidiaries and (b) access to the
documents, information and records of the Company and its Subsidiaries in the
dataroom as of 12:01 a.m. on date of this Agreement, and Parent confirms that
it has made an independent investigation, analysis and evaluation of the
Company and its Subsidiaries and their respective properties, assets,
business, financial condition, documents, information and records. Parent is
acquiring the Common Stock and the Company is acquiring the Atom Minority
Shares for investment and not with a view toward or for sale in connection
with any distribution thereof, or with any present intention of distributing
or selling the Common Stock or the Atom Minority Shares.

  


 

  

5.8 _Solvency_. Parent is not entering into this Agreement or the transactions
contemplated hereby with the actual intent to hinder, delay or defraud either
present or future creditors of Parent, the Company or any of their respective
Subsidiaries. Assuming (a) that the representations and warranties of the
Company and the Shareholders contained in _this Agreement_ are true and
correct in all material respects and the compliance by the Company and the
Shareholders of their respective obligations and covenants under this
Agreement and (b) any estimates, projections or forecasts of the Company and
its Subsidiaries that were prepared by the Company or any of its Subsidiaries
and made available to Parent have been prepared in good faith based upon
assumptions that were and continue to be reasonable, and after giving effect
to the consummation of the transactions contemplated hereby at the Closing:
(x) the fair saleable value (determined on a going concern basis) of the
assets of Parent, the Company and their respective Subsidiaries will be
greater than the total amount of their respective liabilities (including a
reasonable estimate of the amount of all contingent liabilities); (y) Parent,
the Company and their respective Subsidiaries will be able to pay their
respective debts and obligations in the ordinary course of business as they
mature and become due; and (z) Parent, the

  

  

 

40  

  

  

Company and their respective Subsidiaries will have adequate capital to carry
on their respective businesses.

  


 

  

5.9 _Broker 's Fees_. Neither Parent, or any of their respective
equityholders, directors or managers, as applicable, has employed any
financial advisor, broker or finder or incurred or will incur any liability
for any broker's fees, commissions or finder's fees in connection with any of
the transactions contemplated hereby, except for Merrill Lynch, Pierce, Fenner
and Smith Incorporated.

  


 

  

5.10 _No Other Representations_. Parent agrees and acknowledges that, except
for the representations and warranties set forth in this Agreement, as
modified by the Company Disclosure Schedule, and any certificate delivered by
or on behalf the Company hereunder, neither the Company nor any of its
Subsidiaries, or any of their respective shareholders, trustees, affiliates or
Representatives or any other person, has made or is making any other
representations or warranties of any nature, oral or written, including any
other representations or warranties, express or implied, with respect to the
accuracy or completeness of any other information, provided, or made available
by, the Company, the Shareholders or any of their respective Representatives,
with respect to, or in connection with, the negotiation, execution or delivery
of this Agreement or the transactions contemplated hereby, notwithstanding the
delivery or disclosure to Parent or its Representatives of any documentation
or other information with respect to any one or more of the foregoing,
including in certain "data rooms", management presentations or other
information provided or made available to Parent or its Representatives in
anticipation or contemplation of any of the transactions contemplated hereby
(all of which are hereby expressly disclaimed), provided that Parent expressly
reserves the right to assert claims of, or causes of action arising from,
Fraud by any Specified Person in respect of the delivery or disclosure of any
such documentation or information. Furthermore, in connection with the due
diligence investigation of the Company and its Subsidiaries and their business
and operations by and on behalf of Parent, Parent or its Representatives have
received and may continue to receive from the Company or its Subsidiaries or
their Representatives certain estimates, projections, forecasts and other
forward-looking information, as well as certain business plan information,
regarding the Company and its Subsidiaries and their business and operations
(together, " _Forward Looking Statements_ "). Parent hereby acknowledges that
(i) there are uncertainties inherent in attempting to make such Forward-
Looking Statements, with which Parent is familiar, (ii) Parent is taking full
responsibility for making its own evaluation of the adequacy and accuracy of
all Forward-Looking Statements so furnished to it (including the
reasonableness of the assumptions underlying such Forward-Looking Statements)
and (iii) that Parent has not relied upon and will have no claim against the
Company or any of its Subsidiaries, the Shareholders or any of their
respective shareholders, trustees, affiliates or Representatives with respect
to any Forward-Looking Statements. Accordingly, Parent hereby acknowledges
that none of the Company or any of its Subsidiaries, the Shareholders or any
of their respective shareholders, trustees, affiliates or Representatives, has
made or is making any representation or warranty with respect to any Forward-
Looking Statements. For purposes hereof, "Forward-Looking Statements" do not
include (i) the representations and warranties contained in Section 3.6 and
Article 4 hereof or (ii) any statement or other information (other than
estimates), or any omission to make any statement, regarding any change,
event, state of facts, development or occurrence occurring prior to the time
such statement or omission was made, or such other

  

  

 

41  

  

  

information was provided, that provides the basis for an assumption underlying
any Forward-Looking Statements.

  


 

  

ARTICLE 6. 
  COVENANTS

  


 

  

6.1 _Conduct of Business Prior to the Closing_. Except as set forth in
_Section 6.1 of the Company Disclosure Schedule_ , as expressly required or
permitted by this Agreement or as required by applicable Law, during the
period from the date of this Agreement through the Closing, unless Parent
otherwise consents in writing (which consent shall not be unreasonably
withheld, delayed or conditioned), the Company shall, and shall cause its
Subsidiaries to, (a) conduct its business in the ordinary course of business
consistent with past practice and (b) use commercially reasonable efforts to
preserve substantially intact its business organization, keep available the
services of its officers and key employees and preserve its present commercial
relationships. Without limiting the generality of the foregoing, and except as
set forth in _Section 6.1 of the Company Disclosure Schedule_ , as expressly
required or permitted by this Agreement or as required by applicable Law,
during the period from the date of this Agreement through the Closing, the
Company shall not, and shall cause its Subsidiaries not to, without the prior
written consent of Parent (which consent shall not be unreasonably withheld,
delayed or conditioned):

  


 

  

(a) issue, sell, transfer, grant, dispose of, pledge or otherwise encumber, or
authorize or propose the issuance, sale, transfer, grant, disposition or
pledge or other encumbrance of, (i) any additional shares of its capital stock
(or other voting securities) or any securities or rights convertible into,
exchangeable or exercisable for, or evidencing the right to subscribe for any
shares of its capital stock (or other voting securities), or any rights,
warrants, option, calls, commitments or any other agreements of any character
to purchase or acquire any shares of its capital stock (or other voting
securities) or any securities or rights convertible into, exchangeable or
exercisable for, or evidencing the right to subscribe for, any shares of its
capital stock (or other voting securities); or (ii) any other securities in
respect of, in lieu of or in substitution for any shares of its capital stock
(or other voting securities) outstanding on the date hereof;

  


 

  

(b) redeem, purchase or otherwise acquire, or propose to redeem, purchase or
otherwise acquire, any of its outstanding shares of capital stock;

  


 

  

(c) split, combine, subdivide or reclassify any of its shares of capital
stock;

  


 

  

(d) declare, set aside for payment or pay any dividend, or make any other
actual, constructive or deemed distribution, in respect of any shares of its
capital stock or otherwise make any contributions or other payments to its
shareholders in their capacity as such, other than dividends, distributions,
contributions or other payments payable in cash; _provided_ that nothing
contained in this _Section 6.1(d)_ shall apply with respect to any
transactions solely between or among direct or indirect wholly owned
Subsidiaries of the Company;

  


 

  

(e) sell, transfer, lease, mortgage, encumber or otherwise dispose of any of
its properties or assets to any Person other than a direct or indirect
Subsidiary of the Company, except in each case (i) pursuant to Contracts in
force at the date of this Agreement and set forth

  

  

 

42  

  

on _Section 6.1(e) of the Company Disclosure Schedule_ , or (ii) sales or
other dispositions of inventory and obsolete equipment in the ordinary course
of business consistent with past practice;

  


 

  

(f) (i) make any investment in or acquisition of a business whether by
purchase of assets, stock or securities or by merger or consolidation or other
similar transaction, or (ii) purchase, or enter into any agreement to
purchase, equipment, inventory, materials, supplies, capital expenditures or
services, other than (1) purchases of equipment, inventory, materials,
supplies and services in the ordinary course of business consistent with past
practice or (2) undertake emergency repairs or replacements of equipment,
inventory, materials or supplies, or (3) capital expenditures of individually
less than $500,000 and in the aggregate less than $2,000,000;

  


 

  

(g) except as required by applicable Law or "by the terms of any Company
Benefit Plan as in effect as of the date hereof, (i) grant any loan or any
increase in the compensation of any Company Personnel or independent
contractor, other than grants or increases in the ordinary course of business
consistent with past practice to Company Personnel or applicable independent
contractors other than directors or executive officers of the Company or any
of its Subsidiaries, (ii) enter into any collective bargaining agreement,
(iii) establish, adopt, enter into, or amend to increase materially the
benefits under, any material Company Benefit Plan (or any plan or arrangement
that would be a Company Benefit Plan if it were in existence on the date
hereof), other than in connection with renewals or replacements of health
insurance and other Company Benefit Plans customarily renewed or replaced on
an annual basis, in each case, in the ordinary course of business consistent
with past practice, (iv) enter into any change in control, retention, or other
similar agreement with any Company Personnel or independent contractor, (v)
enter into any severance, termination or other similar agreement with any
Company Personnel or independent contractor, other than any such agreement
entered into in the ordinary course of business consistent with past practice
and, in the context of severance, termination or other similar agreements with
Company Personnel or independent contractors associated with Atom, not in
excess of such payments under the Atom severance policy; or (vi) take any
action to fund or in any way secure the payment of any compensation or
benefits under any Company Benefit Plan;

  


 

  

(h) terminate the employment of any Company Personnel in a position of vice
president or above, other than due to such individual's death, disability or
for cause (each as determined by the Company or its applicable Subsidiary in
its reasonable discretion in the ordinary course of business consistent with
past practice) or (B) hire any individual into a position of vice president or
above;

  


 

  

(i) approve or effectuate a communications plan approved by senior management
regarding the compensation, benefits or other treatment employees will receive
following the Closing Date (other than any ordinary course communication
regarding any increase in compensation or benefits that, if effected, would be
permitted under Sections 6.1(g)(i) or 6.1(g)(iii)), unless Parent is provided
with a reasonable opportunity to review and comment on such communications or
such communications are consistent with those previously agreed by Parent and
the Company;

  

  

 

43  

  

  

(j) amend its certificate of incorporation, by-laws or similar governing
documents;

  


 

  

(k) change any of the Company's accounting policies or practices, except as
may otherwise be required under GAAP;

  


 

  

(l) pay, discharge, settle, forgive or satisfy any litigation, arbitration,
proceedings, claims, liabilities or obligations (whether absolute, accrued,
asserted or unasserted, contingent or otherwise) other than any settlement,
payment, discharge or satisfaction (i) reflected or reserved against on the
face of the Latest Balance Sheet, (ii) as set forth in _Section 6.1(l) of the
Company Disclosure Schedule_ , (iii) if the loss resulting from which is
reasonably expected to be reimbursed to the Company or any of its Subsidiaries
under an insurance policy, (iv) concessions granted to customers, suppliers or
distributors arising in the ordinary course of business consistent with past
practice, or (v) in an amount individually less than $100,000 or in the
aggregate less than $1,000,000;

  


 

  

(m) except in the ordinary course of business and consistent with past
practice, file any amended material Tax Return, make or change any material
Tax election or settle or compromise any material income Tax liability;

  


 

  

(n) amend, modify, terminate or let lapse any material Permit or material
Environmental Permit required to conduct the business of the Company or any of
its Subsidiaries;

  


 

  

(o) (i) redeem or otherwise acquire any shares of Common Stock held by the
ESOP or permit the ESOP to make distributions in respect of shares of Common
Stock to ESOP participants, or (ii) take any action or fail to take any action
that would, or that could reasonably be expected to, adversely affect the tax-
qualified status of the ESOP under Section 501(a) of the Code or which would
constitute a breach of fiduciary duty under Section 409 of ERISA;

  


 

  

(p) merge or consolidate with or into any other Person or dissolve or
liquidate;

  


 

  

(q) (i) terminate, cancel, extend, materially amend or modify any Material
Contract or Lease or waive, assign (other than to the Company or a
Subsidiary), violate or release any rights, claims or benefits under such
Contract or Lease which rights, claims or benefits are material to the Company
and its Subsidiaries, taken as a whole, other than concessions made to
customers, suppliers or distributors in the ordinary course of business
consistent with past practice or automatic renewal of any Material Contracts
pursuant to its terms, or (ii) enter into any Contract which, if in existence
on the date hereof, would constitute a Material Contract of the type described
in clauses (iii), (vi), (viii) or (xii) of Section 4.14(a);

  


 

  

(r) sell, transfer or otherwise dispose of any assets to any equityholder or
affiliate of the Company or its Subsidiaries or any of their respective
directors, officers or employees;

  


 

  

(s) with the intent of manipulating Net Working Capital so as to increase the
purchase price payable to the Shareholders hereunder, engage in the practice
of "channel

  

  

 

44  

  

  

stuffing" (i.e., materially accelerating the timing or amount of sales in
excess of those that would have been sold in the ordinary course of business);

  


 

  

(t) (i) purchase any real property; (ii) lease or sublease (other than
pursuant to the Leases) from any third party any real property requiring rent
payments in excess of $100,000 annually; or (iii) lease or sublease to any
third party any real property other than any unused space in any Owned Real
Property or Leased Real Property;

  


 

  

(u) except in the ordinary course of business, consistent with past practice
and not with the incurrence of debt, grant, modify, fail to maintain, fail to
prosecute, cancel, abandon, dispose of or terminate any rights relating to
Intellectual Property or otherwise permit any rights relating to Intellectual
Property to lapse; or

  


 

  

(v) agree or make any commitment to take any of the actions prohibited by this
_Section 6.1_.

  


 

  

6.2 _Payoff Letters_. By no later than the second (2nd) Business Day prior to
Closing, the Company shall deliver to Parent copies of Payoff Letters for the
Funded Debt.

  


 

  

6.3 _Company Transaction Expense Direction Notice_. On or prior to the second
(2nd) Business Day preceding the Closing Date, the Company shall provide
Parent with a written notice (the " _Company Transaction Expense Direction
Notice_ ") setting forth wire transfer instructions for any Company
Transaction Expenses to be paid at the Closing.

  


 

  

ARTICLE 7. 
  ADDITIONAL AGREEMENTS

  


 

  

7.1 _Expenses_. Except as specifically contemplated herein with respect to
Company Transaction Expenses, _Section 3.4(d)_ with respect to the fees and
costs of the Arbitrator, whether or not the transactions contemplated hereby
are consummated, all costs and expenses incurred in connection with this
Agreement and the transactions contemplated hereby shall be paid by the party
incurring such expenses.

  


 

  

7.2 _Certain Tax Matters_.

  


 

  

(a) All transfer, documentary, sales, use, stamp, registration, conveyance,
recording and other such Taxes, and all other fees and charges in the nature
of a Tax (including any penalties and interest), incurred in connection with
consummation of the transactions contemplated by this Agreement (" _Transfer
Taxes_ ") shall be paid by Parent when due, and Parent will, at its own
expense, file all necessary Tax Returns and other documentation with respect
to Transfer Taxes.

  


 

  

(b) Each Shareholder (other than the ESOP, for which indemnification will be
provided solely from the Tax Return Escrow Account and the Tax Escrow Account)
shall indemnify Parent and each of its Affiliates, officers, directors,
employees or agents (collectively, the " _Parent Indemnified Parties_ ") from
and against all liabilities for (i) all Taxes of (or payable by) the Company
and its Subsidiaries attributable to taxable periods ending on or before the
Closing Date (a " _Pre-Closing Tax Period_ ") and (ii) with respect to any
taxable period beginning

  

  

 

45  

  

  

on or before and ending after the Closing Date (a " _Straddle Period_ "), all
Taxes of (or payable by) the Company and its Subsidiaries which are allocable,
pursuant to subsection (g) below, to the portion of such taxable period ending
on the Closing Date (a " _Pre-Closing Straddle Period_ "); _provided_ ,
_however_ , that there shall be no liability to the extent of the amount of
Taxes taken into account in determining Closing Net Working Capital;
_provided_ , _further_ , that the amount of Taxes allocable to any Pre-Closing
Tax Period or Pre-Closing Straddle Period shall be determined by taking into
account all Tax deductions that arise or become available as a result any
expenses or costs that in each case are (x) attributable to, incurred or
payable by the Company or any of its Subsidiaries in connection with the
transactions contemplated by this Agreement and (y) properly deductible by the
Company or any of its Subsidiaries in any Pre-Closing Tax Period or Pre-
Closing Straddle Period (the " _Transaction Tax Deductions_ ").

  


 

  

(c) Notwithstanding anything to the contrary contained herein,

  


 

  

(i) each Shareholder's aggregate liability pursuant to _Section 7.2(b)_ for
any Tax Return Excess and all Taxes other than Taxes shown as due and payable
on any Pre-Closing Tax Return shall be several and not joint and shall not
exceed such Shareholder's Fully Diluted Pro Rata Portion of $13,200,000;

  


 

  

(ii) the ESOP shall not be required to indemnify any Parent Indemnified Party
pursuant to _Section 7.2(b)_ other than out of the Tax Return Escrow Account
and the Tax Escrow Account;

  


 

  

(iii) Parent's sole and exclusive remedy against the ESOP for indemnification
under _Section 7.2_ shall be to assert claims against, (A) with respect to
Taxes shown as due and payable on any Pre-Closing Tax Return, the Tax Return
Escrow Account (except to the extent provided in clause (B)) and (B) with
respect to any Tax Return Excess and Taxes other than Taxes shown as due and
payable on any Pre-Closing Tax Return, the Tax Escrow Account; and

  


 

  

(iv) the Shareholders' indemnification obligation pursuant to _Section 7.2_
shall terminate, with respect to Taxes shown as due and payable on any Pre-
Closing Tax Return, on the Tax Return Escrow Release Date and, with respect to
all other Taxes, on the Tax Escrow Release Date.

  


 

  

(d) The Shareholders shall be entitled to any refund of any Taxes (including
estimated Taxes) received in cash by Parent, the Company or any of its
affiliates, and any credits in lieu of a refund, with respect to any Pre-
Closing Tax Period or Pre-Closing Straddle Period, including interest but
reduced by the amount of any Tax thereon, and shall be paid any such refund or
credit, including interest but reduced by the amount of any Tax thereon,
promptly upon receipt thereof in the case of a refund (or the filing of the
relevant Tax Return, in the case of a credit) by Parent, the Company or any of
their affiliates; _provided_ , _however_ , that (i) the Shareholders shall not
be entitled to any refund or credit to the extent such refund or credit is
attributable to a carryback of an item that is attributable to any taxable
period (or portion thereof) beginning after the Closing Date; (ii) the
Shareholders shall be entitled to a credit when and only to the extent the
credit actually reduces the unindemnified Tax liability of Parent and its
Subsidiaries (determined on a with and without basis); and (iii) the amount of
any payment to

  

  

 

46  

  

  

which the Shareholders would otherwise be entitled under this _Section 7.2(d)_
shall be reduced by the amount of any Taxes described in _Section 7.2(b)_ that
have been paid by Parent or any of its Subsidiaries (including, after the
Closing Date, the Company and its Subsidiaries) and for which none of the
Parent Indemnified Parties has been indemnified under this Agreement. If (x)
any such refund or credit is subsequently disallowed or (y) Parent or any of
its Subsidiaries subsequently pays any Taxes described in _Section 7.2(b)_ for
which none of the Parent Indemnified Parties is indemnified under this
Agreement, the Shareholders shall promptly repay to Parent the amount of any
payment previously paid by Parent under this _Section 7.2(d)_ , increased by
any interest or penalty imposed as a result of such disallowance in the case
of clause (x) and up to the amount of the unindemnified Taxes paid by Parent
or any of its Subsidiaries in the case of clause (y). The determination of the
amount of any refund of any Taxes, and any credits in lieu of a refund,
allocable to a Pre-Closing Straddle Period shall be made in accordance with
the allocation of Taxes to a Pre-Closing Straddle Period under subsection (g)
below. The Shareholders' Representative shall have the right to determine
whether any claim for refund for such Taxes shall be made on behalf of the
Company or any of its Subsidiaries. If the Shareholders' Representative elects
to make a claim for refund, Parent, the Company and any of its Subsidiaries
shall cooperate fully in connection therewith.

  


 

  

(e) The Shareholders' Representative shall file or cause to be filed when due
all Tax Returns with respect to the Company and its Subsidiaries for any Pre-
Closing Tax Period. All Tax Returns filed by the Shareholders' Representative
will correctly reflect the income, business, assets, operations, activities
and status of the Company and its Subsidiaries and any other information
required to be shown therein consistent with past practice, except as
otherwise required by Law. The Shareholders' Representative shall provide a
copy of each such Tax Return filed after the Closing Date to Parent for its
review and comment not later than thirty (30) calendar days prior to the
deadline for filing each such Tax Return and shall make all changes to each
such Tax Return reasonably requested by Parent.

  


 

  

(f) Parent shall prepare or cause to be prepared and file or cause to be filed
all Tax Returns of the Company and its Subsidiaries for any Straddle Period.
All Tax Returns filed by Parent will correctly reflect the income, business,
assets, operations, activities and status of the Company and its Subsidiaries
and any other information required to be shown therein consistent with past
practice, except as otherwise required by Law. Parent shall provide a copy of
each such Tax Return to the Shareholders' Representative for its review and
comment not later than thirty (30) calendar days prior to the deadline for
filing each such Tax Return, and shall make all changes to each such Tax
Return reasonably requested by the Shareholders' Representative.

  


 

  

(g) The amount of Taxes allocable to a Pre-Closing Straddle Period shall be
determined (i) in the case of Taxes imposed on a periodic basis (such as
property Taxes), on a daily pro rata basis and (ii) in the case of other
Taxes, based on an interim closing of the books as of the close of business on
the Closing Date (and, in the case of any Taxes attributable to the ownership
of an equity interest in a partnership, other "flow-through" entity or
"controlled foreign corporation" (within the meaning of Section 957(a) of the
Code or any analogous provision of state, local or foreign Law), as if the
taxable period of such entity ended as of the close of business on the Closing
Date); _provided_ , that such Tax liability shall be determined by taking into
account Transaction Tax Deductions that would be properly deductible in a Pre-

  

  

 

47  

  

  

Closing Straddle Period if such Pre-Closing Straddle Period were an actual
taxable period that ended on (and included) the Closing Date (assuming, for
this purpose, that the safe harbor election provided for in IRS Revenue
Procedure 2011-29 is made with respect to any Transaction Tax Deduction that
constitutes a "success-based fee".

  


 

  

(h) Following the Closing, without the Shareholders' Representative's prior
written consent (which consent shall not be unreasonably withheld, conditioned
or delayed), neither Parent, the Company nor any of their affiliates shall
file or amend any Tax Return of the Company or any of its Subsidiaries, or
make or change any Tax election relating to the Company or any of its
Subsidiaries, in each case, for any taxable period, or portion thereof,
beginning on or prior to the Closing Date.

  


 

  

(i) Each of Parent, the Company, the Shareholders' Representative and their
affiliates will provide the other parties with such assistance as may
reasonably be requested by any of them in connection with the preparation of
any Tax Return, any audit or other examination by any taxing authority, any
judicial or administrative proceedings relating to liability for Taxes, or any
other claim under this Agreement relating to Tax, and each will retain and
provide the others with any records or information that may be relevant to any
such Tax Return, audit or examination, proceeding or claim. Such assistance
shall include making employees available on a mutually convenient basis to
provide additional information and explanation of any material provided
hereunder and shall include providing copies of any relevant Tax Returns and
supporting work schedules. The party requesting assistance hereunder shall
reimburse the other parties for reasonable third-party out-of-pocket expenses
incurred in providing such assistance. Without limiting the generality of the
foregoing, Parent shall retain, and shall cause the Company to retain until
the applicable statutes of limitations (including any extensions) have
expired, copies of all Tax Returns, supporting work schedules, and other
records or information that may be relevant to such returns for all taxable
periods beginning on or before the Closing.

  


 

  

(j) The Company shall request, prior to Closing, valid sales Tax exemption
certificates from each of its thirty (30) largest U.S. customers (measured by
sales revenue) in each state where delivery of product is made.

  


 

  

(k) The parties shall treat any payment made under this _Section 7.2_ as an
adjustment to the Adjusted Base Consideration for Tax purposes.

  


 

  

7.3 _Publication/Distribution of Agreement_. So long as this Agreement is in
effect, none of Parent, the Company, the Shareholders or any of their
respective affiliates shall publish, distribute or make any public statements
with respect to this Agreement (including the disclosure of this Agreement or
its terms) or the transactions contemplated hereby without the prior approval
of the other parties hereto, except as may be required (a) to obtain the
consents and approvals, and to provide such notices, necessary to consummate
the transactions contemplated by this Agreement or (b) by Law or stock
exchange rules applicable to Parent, the Company, the Shareholders or any of
their respective affiliates (and only to the extent so required), _provided_ ,
_however_ , that in such event the parties hereto shall, if reasonably
practicable and permitted by applicable Law, consult with each other regarding
the content thereof and shall consider in good faith any redactions or
revisions reasonably requested by the other party. Each party hereto

  

  

 

48  

  

  

acknowledges that the ESOP shall have the right to disclose this Agreement and
any agreements, instruments and documents contemplated hereby to the ESOP
participants. Notwithstanding the foregoing, each of the Parties may make
public statements regarding this Agreement or the transactions contemplated
hereby so long as any such statements are not materially inconsistent with
previous press releases, public disclosure or public statements made in
accordance with this Agreement and do not reveal material, non-public
information regarding the other Parties, this Agreement or the transactions
contemplated hereby.

  


 

  

7.4 _Access to Information; Confidentiality_.

  


 

  

(a) Prior to the Closing, upon reasonable prior written notice and subject to
applicable Laws relating to the exchange of information and confidentiality
obligations applicable to information furnished to the Company or any of its
Subsidiaries by third parties that may be in the Company's or any of its
Subsidiaries' possession from time to time (it being agreed that the Company
shall, and shall cause its Subsidiaries to, make reasonable and appropriate
substitute disclosure arrangements under circumstances in which such Laws or
confidentiality obligations apply), the Company shall, and shall cause each of
the Company's Subsidiaries to, afford to the Representatives of Parent, during
normal business hours and in a manner as to not unreasonably interfere with
the normal operation of the Company and its Subsidiaries, during the period
prior to the Closing Date, reasonable access to the Company's and each of its
Subsidiaries' properties, assets, books, Contracts and records, and to their
officers, accountants, counsel and other Representatives and, during such
period, the Company shall, and shall cause its Subsidiaries to, make available
to Parent such information concerning their businesses, properties and
personnel as Parent may reasonably request in connection with the consummation
of the transactions contemplated by this Agreement; _provided_ , _however_ ,
that (i) Parent shall not perform, or request or cause to be performed,
intrusive soil or groundwater sampling at any property of the Company or its
Subsidiaries, (ii) such right shall not apply to information subject to an
attorney-client privilege (to the extent disclosure would jeopardize such
privilege) and (iii) the Company and its Subsidiaries need not supply any
information which, in the reasonable judgment of the Company or any of its
Subsidiaries is under a contractual or legal obligation not to supply;
_provided_ , _however_ , that, at Parent's reasonable request, the Company
shall use its commercially reasonable efforts to seek the consent of any party
whose consent is required to remove any contractual restriction on disclosure
to Parent. The Company shall have the right to have one or more of its
Representatives present at all times during any such reviews, examinations or
discussions. Prior to the Closing, without the prior written consent of the
Company (not to be unreasonably withheld, conditioned or delayed), Parent
shall not, and Parent shall cause its Representatives not to, contact any
customers, suppliers or competitors of the Company or its Subsidiaries
regarding the business, operations or prospects of the Company or regarding
this Agreement or the transactions contemplated hereby; _provided_ , however,
that the Company and Parent shall cooperate in good faith to develop and
implement a customer and supplier communication plan relating to the
transactions contemplated by this Agreement.

  


 

  

(b) Prior to the Closing, (i) any information provided to or obtained by
Parent pursuant to this _Section 7.4_ or any other provision of this Agreement
will be subject to the Confidentiality Agreement and shall be held by Parent
in accordance with and be subject to the terms and conditions of the
Confidentiality Agreement, and (ii) Parent agrees to be bound by

  

  

 

49  

  

  

and comply with the provisions set forth in the Confidentiality Agreement as
if such provisions were set forth herein, which provisions are hereby
incorporated herein by reference.

  


 

  

(c) From and after the Closing, for any reasonable business purpose relating
to the Shareholders' ownership of the capital stock of the Company or any of
its Subsidiaries, including preparation of governmental or regulatory
reporting obligations, for a period of seven (7) years (or such longer period
as may be required by applicable Laws) after the Closing, (i) Parent shall
cause the Company and its Subsidiaries to retain the books and records
relating to the Company and its Subsidiaries with respect to periods prior to
the Closing in accordance with Parent's customary internal document retention
practices, and (ii) upon reasonable advance notice and subject to applicable
Laws relating to the exchange of information and confidentiality obligations
applicable to information furnished to Parent, the Company or any of their
respective Subsidiaries by third parties that may be in any of their
possession from time to time (it being agreed that Parent shall cause the
Company and its Subsidiaries to make reasonable and appropriate substitute
disclosure arrangements under circumstances in which such Laws or
confidentiality obligations apply), Parent and the Company shall, and shall
cause each of the Company's Subsidiaries to, afford to the Shareholders and
their respective Representatives, during normal business hours following the
Closing Date, and in a manner as to not unreasonably interfere with the normal
operation of Parent, the Company and their respective Subsidiaries, reasonable
access to the Company's and each of its Subsidiaries' properties, books,
Contracts and records, and to their officers, employees, accountants, counsel
and other Representatives and, during such period, the Company shall, and
shall cause its Subsidiaries to, make available to the Shareholders all
information concerning their businesses, properties and personnel as they may
reasonably request for the purposes described above; _provided_ , _however_ ,
that (x) such right shall not apply to information subject to an attorney-
client privilege (to the extent disclosure would jeopardize such privilege),
(y) this _Section 7.4(c)_ shall not apply to Tax Returns and related
information which shall be governed by _Section 7.2(g)_ and (z) Parent, the
Company and its Subsidiaries need not supply any information which, in the
reasonable judgment of Parent, the Company or any of their respective
Subsidiaries, is under a contractual or legal obligation not to supply;
provided however that at the reasonable request of the Shareholder
Representative, the Company shall use its commercially reasonable efforts to
seek the consent of any party whose consent is required to remove any
contractual restriction on disclosure to the Shareholders. Parent shall have
the right to have one or more of its Representatives present at all times
during any such reviews, examinations or discussions.

  


 

  

(d) For a period of five years following the Closing Date (and, in the case of
books and records of the Company or any Subsidiary provided or otherwise made
available to any Shareholder or any of its Representatives following the
Closing Date pursuant to any provision of this Agreement, a period of five
years following the date such books and records are provided or otherwise made
available), each Shareholder shall, and shall cause each of its affiliates to,
(i) treat all confidential information relating to the Company and the
Subsidiaries as confidential, preserve the confidentiality thereof, and not
use or disclose to any Person such confidential information and (ii) cause its
Representatives who have had access to such information to keep it
confidential and not to use or disclose to any Person any such information,
unless such information (A) is or becomes publicly available or is now or
hereafter disclosed in a manner making it publicly available, in each case
through no act or omission in violation hereof of such Shareholder or its
affiliates or Representatives, or (B) is required by applicable Law;

  

  

 

50  

  

  

 _provided_ that, with respect to Trade Secrets of the Company or any
Subsidiary, the foregoing covenant shall survive indefinitely. If the
disclosure of such information is required by applicable Law, such Shareholder
shall cooperate with and, to the extent reasonably practicable and not
prohibited by Law, provide Parent an opportunity to object to the disclosure
and shall give Parent as much prior written notice as is reasonably
practicable under the circumstances. If requested by Parent, such Shareholder
shall use commercially reasonable efforts, at Parent's expense, to obtain
reliable assurance that confidential treatment will be accorded to any such
information required by applicable Law to be disclosed.

  


 

  

7.5 _Consents; Further Assurances_.

  


 

  

(a) Subject to the terms and conditions of this Agreement, each of the parties
hereto, shall, and shall cause their respective affiliates to, use their
respective reasonable best efforts (i) to take, or cause to be taken, all
actions necessary, proper or advisable to comply promptly with all legal
requirements that may be imposed on such parties or their Subsidiaries with
respect to the transactions contemplated hereby (including making all legally
required filings) and, subject to the conditions set forth in _ARTICLE 8_ , to
consummate the transactions contemplated hereby as promptly as practicable and
(ii) to obtain (and to cooperate with the other parties to obtain) as promptly
as practicable any consent, authorization, order or approval of, or any
exemption by, any Governmental Entity and any other third party that is
required to be obtained by them or any of their respective affiliates in
connection with the transactions contemplated hereby, and to comply with the
terms and conditions of any such consent, authorization, order or approval. In
connection therewith, each of the parties shall, and shall cause their
respective affiliates to provide, such information and communications to
Governmental Entities as such Governmental Entities may request.

  


 

  

(b) Without limitation of the foregoing, Parent on the one hand, and the
Company on the other hand, undertakes and agrees to file as soon as
practicable, but in all cases, within ten (10) Business Days following the
date hereof, a Notification and Report Form under the HSR Act with the United
States Federal Trade Commission (the " _FTC_ ") and the Antitrust Division of
the United States Department of Justice (the " _Antitrust Division_ "). Each
of Parent and the Company, as applicable, shall (x) respond as promptly as
practicable to any inquiries or requests for additional information or
documentation received from the FTC, the Antitrust Division or any other
Governmental Entity, and (y) not extend any waiting period under the HSR Act
or any other Antitrust Laws or enter into any agreement with the FTC, the
Antitrust Division or any other Governmental Entity not to consummate the
transactions contemplated by this Agreement, except with the prior written
consent of the other parties hereto. Parent shall offer to take (and if such
offer is accepted, commit to take) all steps which it is capable of taking to
avoid or eliminate impediments under any Antitrust Laws that may be asserted
by the FTC, the Antitrust Division or any other Governmental Entity with
respect to the transactions contemplated by this Agreement so as to enable the
Closing to occur as promptly as practicable following the date of this
Agreement and, in any event, prior to the Outside Date, and shall defend
through litigation on the merits any claim asserted in any court by any party,
including appeals. Without limiting the foregoing, Parent shall propose,
negotiate, offer to commit and effect (and if such offer is accepted, commit
to and effect), by consent decree, hold separate order or otherwise, the sale,
divestiture or disposition of such assets or businesses of Parent or its
Subsidiaries (including the Company or any of its Subsidiaries) or otherwise
offer to take or

  

  

 

51  

  

  

offer to commit to take any action which it is capable of taking and if the
offer is accepted, take or commit to take such action that limits its freedom
of action with respect to, or its ability to retain, any of the businesses,
services or assets of Parent or its Subsidiaries, in order to avoid the entry
of, or to effect the dissolution of, any injunction, temporary restraining
order or other Order in any suit or proceeding, which would otherwise have the
effect of preventing or delaying the Closing beyond the Outside Date. At the
request of Parent, the Company shall agree to divest, hold separate or
otherwise take or commit to take any action that limits its freedom of action
with respect to, or its ability to retain, any of the businesses, services or
assets of the Company or any of its Subsidiaries; _provided_ that any such
action shall be conditioned upon the consummation of the Closing and the
transactions contemplated hereby.

  


 

  

(c) Without limitation of the foregoing subsection (a), in connection with the
transactions contemplated by this Agreement, the Company shall, at its sole
cost and expense, comply with any requirements of ISRA and, in furtherance of
the foregoing, the Company shall (i) within five (5) Business Days after
execution of this Agreement, make any required filings or notifications (such
as a General Information Notice, as defined under ISRA) to the New Jersey
Department of Environmental Protection (" _NJDEP_ "), (ii) promptly retain a
Licensed Site Remediation Professional (as defined under ISRA) at Ramboll
Environ, Inc. or other technical environmental consulting firm reasonably
acceptable to Parent to conduct any required Preliminary Assessment (as
defined under ISRA) and such other investigation as may be required by ISRA,
and (iii) prior to Closing, for any property subject to ISRA, submit to NJDEP,
prior to Closing, a Remediation Certification (as defined under ISRA) or such
authorization as may be required by N.J.A.C.  7:26B-1.8 and take such other
commercially reasonable steps required to complete the transactions
contemplated by this Agreement; _provided_ that the Company shall provide
Parent with a reasonable opportunity, for five (5) Business Days or such
shorter time period as may be required, to review and comment on any draft
reports prepared, issued or any other proposed ISRA forms or submissions prior
to any submission to or filing with the NJDEP made in furtherance of this
_Section 7.5(c)_.

  


 

  

(d) Each of the parties shall promptly furnish to the other copies of any
notices or written communications, and a written summary of any oral
communications, in each case received by such party or any of its affiliates
from any third party or any Governmental Entity with respect to the
transactions contemplated by this Agreement, and each party shall permit
counsel to the other party an opportunity to review in advance, and shall
consider in good faith the views of such counsel in connection with, any
proposed written communications (including, for the avoidance of doubt, any
filings and/or notices) by any other party or its affiliates to any third
party or any Governmental Entity, including the FTC and the Antitrust
Division, concerning the transactions contemplated by this Agreement. Each
party agrees to provide the other parties and its counsel the opportunity, on
reasonable advance notice, to participate in any substantive meetings or
discussions, either in Person or by telephone, between such party and/or any
of its affiliates, agents or advisors, on the one hand, and any third party or
Governmental Entity, including the FTC and the Antitrust Division, on the
other hand, concerning or in connection with the transactions contemplated
hereby.

  


 

  

(e) Except as otherwise specifically provided in this Agreement (including
_Section 7.5(b)_), in no event shall any party hereto be obligated to bear any
expense or pay any fee or grant any concession in connection with obtaining
any consents, authorizations or

  

  

 

52  

  

  

approvals required in order to consummate the transactions contemplated herein
and the Company and its Subsidiaries shall not be entitled to bear any such
expense or pay any such fee or grant any such concession without Parent's
prior written consent.

  


 

  

7.6 _Directors ' and Officers' Insurance; Company Release_.

  


 

  

(a) For a period of six (6) years after the Closing, the provisions of the
constituent documents of the Company and its Subsidiaries concerning the
elimination of liability and indemnification of directors and/or other Persons
shall not be amended in any manner that would adversely affect the rights
thereunder of any Person that is as of the date hereof or the Closing covered
as an indemnitee under any such elimination of liability or indemnification
provisions. Notwithstanding anything in this Agreement to the contrary, if any
claim, action, suit, proceeding or investigation (whether arising before, at
or after the Closing Date) is made against any directors and/or other Persons
entitled to indemnification under such constituent documents on or prior to
the sixth (6th) anniversary of the Closing, the provisions of this _Section
7.6(a)_ shall continue in effect until the final disposition of such claim,
action, suit, proceeding or investigation. If the Company or any of its
Subsidiaries or their respective successors or assigns (i) shall consolidate
with or merge into any other Person and shall not be the continuing or
surviving corporation or entity of such consolidation or merger, or (ii) shall
transfer all or substantially all of its properties and assets to any Person,
then, and in each such case, proper provisions shall be made so that the
successors and assigns of the Company and its Subsidiaries shall assume all of
the obligations set forth in this _Section 7.6(a)_.

  


 

  

(b) Effective upon the Closing, except for claims of, or causes of action
arising from Fraud, Parent and the Company, and each of their respective
affiliates, successors and assigns (which, for the avoidance of doubt, shall
not include the shareholders of the Company immediately prior to the Closing)
(collectively, the " _Releasing Parties_ "), shall be deemed to have remised,
released and forever discharged the officers and directors of the Company and
each of its Subsidiaries (collectively, the " _Released Parties_ ") of and
from any and all claims which the Releasing Parties, or any of them, now have,
ever had, or at the Closing may have, or hereafter can, shall or may have,
against the Released Parties in their capacities as officers and directors of
the Company and each of its Subsidiaries, or any of them, for, upon or by
reason of any matter, cause or thing whatsoever, from the beginning of time
through the Closing Date, _provided_ , _however_ , that such release shall not
cover claims or liabilities for amounts owed pursuant to, or other rights set
forth in, or other claims arising in connection with this Agreement or any
agreement ancillary to this Agreement or any of the Contracts set forth in
Section 4.15 of the Company Disclosure Schedule.. As of the Closing Date,
Parent, on behalf of each of the Releasing Parties, expressly acknowledges
that it has had, or has had and waived, the opportunity to be advised by
independent legal counsel.

  


 

  

(c) Parent, on behalf of each of the Releasing Parties, hereby represents,
warrants and covenants to each Released Party that there has not been and will
not be any assignment or other transfer of any right or interest in any claims
that any Releasing Party ever had, has or may have against the Released
Parties, and hereby agrees to indemnify and hold each Released Party harmless
from any claims and Losses directly or indirectly incurred by any of the
Released Parties as a result of any Person asserting any right or interest
pursuant to any such purported assignment or transfer of any such right or
interest.

  

  

 

53  

  

  

(d) Parent, on behalf of each of the Releasing Parties, hereby agrees that if
any Releasing Party hereafter commences, joins in or in any manner seeks
relief through any suit arising out of, based upon or relating to any of the
claims released hereunder, or in any manner asserts against any Released Party
any of the claims released hereunder, then such Releasing Parties will pay to
such Released Party, in addition to any other Losses, direct or indirect, all
attorneys' fees incurred in defending or otherwise responding to such suit or
claims.

  


 

  

(e) Prior to 12:01 a.m. on the Closing Date, the Company shall procure, with
respect to acts or omissions occurring prior to the Closing, six (6) year pre-
paid "tail" policies (the " _D andO Insurance_"), covering all present and
former officers and directors of the Company and those present and former
officers, directors and managers of its Subsidiaries who are currently covered
by directors' and officers' liability insurance policies, on terms with
respect to coverage and amount no less favorable than those of such policies
in effect on the date hereof. To the extent not fully paid prior to 12:01 a.m.
on the Closing Date, the aggregate premium and costs relating to the
procurement by the Company of the DandO Insurance shall be a Company Transaction
Expense.

  


 

  

(f) The provisions of this _Section 7.6_ are (i) intended to be for the
benefit of, and shall be enforceable by, each Person released or entitled to a
benefit hereunder, and each such person's heirs, representatives, successors
and assigns, it being expressly agreed that such Persons shall be third-party
beneficiaries of this _Section 7.6_. The Company shall not (and Parent shall
cause the Company not to) amend the provisions of this _Section 7.6_ in a
manner that would adversely affect any such third-party beneficiary without
the prior written consent of such third-party beneficiary. With respect to any
claim by a third-party beneficiary under this _Section 7.6_, no Releasing
Party may assert by way of defense, set-off or counterclaim, any claim
against, or Losses owing by, the Shareholders or any other third-party
beneficiary.

  


 

  

(g) The Company shall (and Parent shall cause the Company to), from time to
time following the Closing, execute and deliver such other documents and
instruments and take such other actions as may be reasonably requested by any
Released Party to implement the provisions of this _Section 7.6_.

  


 

  

7.7 _Shareholder Release_.

  


 

  

(a) Effective upon the Closing, each Shareholder, solely in such Person's
capacity as a Shareholder, on behalf of itself and each of its affiliates,
successors and assigns (collectively, the " _Shareholder Releasing Parties_
"), shall be deemed to have remised, released and forever discharged the
Company and each of its Subsidiaries and each of the officers and directors of
the Company and each of its Subsidiaries (collectively, the " _Shareholder
Released Parties_ ") of and from any and all claims which the Shareholder
Releasing Parties, or any of them, now have, ever had, or at the Closing may
have, or hereafter can, shall or may have, against the Shareholder Released
Parties, or any of them, for, upon or by reason of any matter, cause or thing
whatsoever, from the beginning of time through the Closing Date, _provided_ ,
_however_ , that such release shall not cover claims or liabilities for
amounts owed pursuant to, or other rights set forth in, or other claims
arising in connection with this Agreement or any agreement ancillary to this
Agreement. For the avoidance of doubt, such release shall not remise, release
or discharge any claim or right of such Shareholder Releasing Party under any
Contract with any Shareholder

  

  

 

54  

  

  

Released Party or any claim or right to indemnification by the Company and its
Subsidiaries for service by such Shareholder Releasing Party as an officer,
director, employee, agent or similar capacity of the Company, any of its
Subsidiaries or any related enterprise. As of the Closing Date, each
Shareholder, on behalf of each of the applicable Shareholder Releasing
Parties, expressly acknowledges that it has had, or has had and waived, the
opportunity to be advised by independent legal counsel.

  


 

  

(b) Each Shareholder, on behalf of each of the applicable Shareholder
Releasing Parties, hereby represents, warrants and covenants to each
Shareholder Released Party that there has not been and will not be any
assignment or other transfer of any right or interest in any claims that any
Shareholder Releasing Party ever had, has or may have against the Shareholder
Released Parties, and hereby agrees to indemnify and hold each Shareholder
Released Party harmless from any claims and Losses directly or indirectly
incurred by any of the Shareholder Released Parties as a result of any Person
asserting any right or interest pursuant to any such purported assignment or
transfer of any such right or interest.

  


 

  

(c) Each Shareholder, on behalf of each of the applicable Shareholder
Releasing Parties, hereby agrees that if any Shareholder Releasing Party
hereafter commences, joins in or in any manner seeks relief through any suit
arising out of, based upon or relating to any of the claims released
hereunder, or in any manner asserts against any Shareholder Released Party any
of the claims released hereunder, then such Shareholder Releasing Parties will
pay to such Shareholder Released Party, in addition to any other Losses,
direct or indirect, all attorneys' fees incurred in defending or otherwise
responding to such suit or claims.

  


 

  

(d) The provisions of this _Section 7.7_ are (i) intended to be for the
benefit of, and shall be enforceable by, each Person released or entitled to a
benefit hereunder, and each such person's heirs, representatives, successors
and assigns, it being expressly agreed that such Persons shall be third-party
beneficiaries of this _Section 7.7_. This _Section 7.7_ shall not be amended
in a manner that would adversely affect any such third-party beneficiary
without the prior written consent of such third-party beneficiary. With
respect to any claim by a third-party beneficiary under this _Section 7.7_, no
Shareholder Releasing Party may assert by way of defense, set-off or
counterclaim, any claim against, or Losses owing by, Parent or any other
third-party beneficiary.

  


 

  

(e) Each Shareholder shall, from time to time following the Closing, execute
and deliver such other documents and instruments and take such other actions
as may be reasonably requested by any Shareholder Released Party to implement
the provisions of this _Section 7.7_.

  


 

  

7.8 _R andW Insurance_. Parent shall cause the RandW Insurance to explicitly
provide that the provider of the RandW Insurance will not have the right to, and
will not, pursue any subrogation or contribution rights or any other claims
against the Shareholders in connection with any claim made by the Parent
Indemnified Parties thereunder, except in the case of claims of, or causes of
action arising from, Fraud. The cost of the RandW Insurance and any fees, costs
or deductibles associated therewith shall be borne solely by Parent. Parent
shall not amend, modify or terminate the RandW Insurance or any provisions
thereof in any manner that may adversely affect in any material respect the
Shareholders, including any amendment,

  

  

 

55  

  

  

modification or termination of the provisions of the RandW Insurance in respect
of the restriction described in the preceding sentence.

  


 

  

7.9 _280G Vote_. Prior to the Closing, to the extent the right of any
"disqualified individual" (as defined in Treasury Regulation Section 1.280G-1)
with respect to the Company (each, a " _Disqualified Individual_ ") to receive
any payments would constitute a "parachute payment" within the meaning of
Section 280G(b)(2)(A)(i) of the Code and any regulations promulgated
thereunder, the Company shall take all necessary actions (including obtaining
any required waivers or consents from any Disqualified Individual to waive
such Disqualified Individual's right to the portion of such payment that would
constitute an "excess parachute payment" within the meaning of Section
280G(b)(1) of the Code) to submit such payments to a vote meeting the
requirements of Section 280G(b)(5)(B)(ii) of the Code and any regulations
promulgated thereunder. The Company shall forward to Parent prior to
submission copies of all documents prepared by the Company in connection with
this _Section 7.9_ and shall incorporate any reasonable comments that are made
by Parent.

  


 

  

7.10 _Exclusive Dealing_.

  


 

  

(a) During the period from the date of this Agreement through the earlier of
the Closing or the termination of this Agreement in accordance with its terms,
the Company and each Shareholder shall not, and shall instruct its
Representatives not to, and the Company shall not permit any of its
Subsidiaries to, directly or indirectly: (i) knowingly solicit, encourage,
initiate or engage with respect to any inquiries or the making of any proposal
from a Person or group of Persons other than Parent and its affiliates and
Representatives that may constitute, or could reasonably be expected to lead
to, an Alternative Transaction; (ii) enter into or participate in any
discussions or negotiations with any Person or group of Persons other than
Parent and its affiliates and Representatives regarding, or otherwise pursue,
an Alternative Transaction; (iii) furnish any non-public information relating
to the Company or any of its Subsidiaries or their respective assets or
businesses, or afford access to the assets, business, properties, books or
records of the Company or any of its Subsidiaries to any Person or group of
Persons other than Parent and its affiliates and Representatives, in all cases
for the purpose of assisting with or facilitating an Alternative Transaction;
or (iv) enter into an Alternative Transaction or any Contract, including any
letter of intent, term sheet or other similar document, relating to an
Alternative Transaction. The Company shall cease all discussions and
negotiations concerning an Alternative Transaction. During the period from the
date of this Agreement through the earlier of the Closing or the termination
of this Agreement in accordance with its terms, the Company shall promptly
advise Parent in writing of any proposed Alternative Transaction or any
inquiry or proposal that could reasonably be expected to lead to an
Alternative Transaction and keep Parent reasonably informed on a current basis
of the status and details of such proposal or inquiry.

  


 

  

(b) For purposes of this _Section 7.10_ , an "Alternative Transaction" is any
(i) direct or indirect acquisition by any Person or group of Persons other
than Parent or its affiliates of assets of the Company or any of its
Subsidiaries (including any equity interests of any of its Subsidiaries) equal
to ten percent (10%) or more of the fair market value of the Company's
consolidated assets or to which ten percent (10%) or more of the Company's net
revenues or net income on a consolidated basis are attributable, (ii) direct
or indirect acquisition by any Person or

  

  

 

56  

  

  

group of Persons other than Parent or its affiliates of any of the capital
stock of the Company or any of its Subsidiaries, or (iii) merger,
consolidation, other business combination or similar transaction involving the
Company or any of its Subsidiaries pursuant to which any Person or group of
Persons other than Parent or its affiliates would own ten percent (10%) or
more of the consolidated assets, net revenues or net income of the Company and
the Subsidiaries, taken as a whole.

  


 

  

7.11 _Restrictive Covenant_.

  


 

  

(a) For two years following the Closing Date, each Shareholder (other than the
ESOP) hereby agrees that it will not (i) directly or indirectly solicit or
seek to induce or encourage any employee of the Company or any its
Subsidiaries to leave his or her employment or position with the Company, (ii)
hire any person who was an employee of the Company or any of its Subsidiaries
or (iii) interfere with, disrupt or attempt to disrupt any past, present or
prospective relationship, contractual or otherwise, between the Company or any
of its Subsidiaries, on the one hand, and any of their respective customers,
partners, distributors, resellers, suppliers or employees, on the other hand.
Notwithstanding the foregoing, the restrictions set forth in clause (i) and
(ii) of this _Section 7.11(a)_ will not prohibit any Shareholder from (A)
general advertising of employment opportunities including in any newspaper,
trade journal or other publication or any Internet website posting, in each
case that is not specifically directed at employees of the Company or its
Subsidiaries, (B) participating in any third-party hiring fair or similar
event open to the public or (C) soliciting, negotiating with, offering
employment to or employing any Person who left the employment of the Company
at least 90 days prior to the date that such Person is first solicited or
offered employment without any prior solicitation or encouragement by Parent
or its affiliates in violation of this _Section 7.11(a)_.

  


 

  

(b) In the event that any covenant contained in _Section 7.11(a)_ should ever
be adjudicated to exceed the time or other limitations permitted by any
applicable Law in any jurisdiction, then any court is expressly empowered to
reform such covenant, and such covenant shall be deemed reformed, in such
jurisdiction to the maximum time or other limitations permitted by such
applicable Law. The covenants and provisions contained in _Section 7.11(a)_
and each provision hereof are several and distinct covenants and provisions.
The invalidity or unenforceability of any such covenant or provision as
written shall not invalidate or render unenforceable the remaining covenants
or provisions hereof, and any such invalidity or unenforceability in any
jurisdiction shall not invalidate or render unenforceable such covenant or
provision in any other jurisdiction.

  


 

  

7.12 _Continued Existence_. During the period from the Closing Date until the
later of the Indemnity Escrow Release Date and the Tax Escrow Release Date,
each Company Shareholder (other than the ESOP) shall (a) maintain its legal
existence in accordance with applicable Law and (b) maintain sufficient
capital to satisfy its obligations, including its obligations pursuant to this
Agreement, as they become due. Notwithstanding the foregoing, however, for
bona fide estate planning purposes, each Company Shareholder (other than the
ESOP) may transfer all or a portion of its assets to another Person provided
that the transferee (i) maintains sufficient capital to satisfy its
obligations, including its obligations pursuant to this Agreement, as they
become due and (ii) expressly assumes the obligations of such Company

  

  

 

57  

  

  

Shareholder pursuant to this Agreement (it being understood that no such
assumption shall relieve such Company Shareholder of its obligations
hereunder).

  


 

  

7.13 _ESOP Matters_. Prior to the Closing Date, the Company shall take all
reasonable actions necessary, in accordance with ERISA, the Code and the ESOP,
to adopt resolutions and amend the ESOP, effective in all respects as of the
Closing and in form and substance reasonably satisfactory to Parent to provide
that, effective upon the Closing Date, the ESOP no longer is an "employee
stock ownership plan" within the meaning of Section 4975 of the Code. At or
prior to the Closing Date, the Company shall adopt any other amendments to the
ESOP as are necessary to reflect and effect the Transactions, subject to
compliance with applicable requirements of the Code, ERISA and the ESOP and
provided that such amendments are in form and substance reasonably
satisfactory to Parent. Parent shall maintain the ESOP, as amended in
accordance with this subparagraph, or as merged into and made a part of a
differing defined contribution qualified retirement plan sponsored by the
Parent or an affiliate, until the later of the Indemnity Escrow Release Date
and the Tax Escrow Release Date. Furthermore, Parent shall amend the ESOP as
soon as reasonably practicable following the Closing Date to permit in-service
distributions from the ESOP in an amount equal to at least 50% of each ESOP
participant's account balance.

  


 

  

7.14 _Resignations_. The Company shall obtain and deliver to Parent letters of
resignation effective as of the Closing from (a) each of the directors of the
Company and (b) each of the officers of the Company that Parent specifies in
writing to the Company at least three Business Days prior to the Closing Date,
which letters shall only apply to status as an officer or director but not as
an employee.

  


 

  

ARTICLE 8. 
  CONDITIONS PRECEDENT

  


 

  

8.1 _Conditions to Each Party 's Obligation To Effect the Transactions_. The
respective obligation of each party hereto to effect the transactions
contemplated by this Agreement is subject to the satisfaction or waiver on or
prior to the Closing Date of the following conditions:

  


 

  

(a) _Regulatory Approvals_. The waiting period applicable to the consummation
of the transactions contemplated hereby under the HSR Act (or any extension
thereof) shall have expired or early termination thereof shall have been
granted.

  


 

  

(b) _No Injunctions or Restraints_. No temporary restraining order,
preliminary or permanent injunction or other Order issued by any Governmental
Entity of competent jurisdiction or other legal restraint or prohibition
enjoining or otherwise preventing or prohibiting the consummation of the
transactions contemplated hereby shall have been entered after the date hereof
and shall be in effect and no Legal Proceeding brought by any Governmental
Entity shall be pending that seeks to impose any such legal restraint or
prohibition.

  


 

  

(c) _ESOP Fairness Opinion_. The ESOP Trustee shall have received an updated
and final Fairness Opinion as of the Closing Date, in the form attached hereto
as _Exhibit E_.

  

  

 

58  

  

  

8.2 _Conditions to Obligations of Parent_. The obligations of Parent to effect
the transactions contemplated hereby are further subject to the satisfaction
or waiver by Parent on or prior to the Closing Date of the following
conditions:

  


 

  

(a) _Representations and Warranties_. (i) The Company Fundamental
Representations shall be true and correct in all material respects as of the
date hereof and as of the Closing Date as though made on and as of the Closing
Date (except with respect to representations and warranties that address
matters only as of a particular date, which need only be true and correct as
of such date), (ii) the representations and warranties set forth in _ARTICLE
4_ (other than those described in clause (i) above) shall be true and correct
(without giving effect to qualifications or limitations as to "materiality,"
"Company Material Adverse Effect" or words of similar import as set forth
therein) as of the date hereof and as of the Closing Date as though made on
and as of the Closing Date (except with respect to representations and
warranties that address matters only as of a particular date, which need only
be true and correct as of such date), except to the extent that the failure to
be true and correct has not had or would not reasonably be expected to have a
Company Material Adverse Effect, (iii) the Shareholder Fundamental
Representations shall be true and correct in all material respects as of the
date hereof and as of the Closing Date as though made on and as of the Closing
Date (except with respect to representations and warranties that address
matters only as of a particular date, which need only be true and correct as
of such date) and (iv) the representations and warranties set forth in
_Section 3.6_ (other than those described in clause (iii) above) shall be true
and correct (without giving effect to qualifications or limitations as to
"materiality," "material adverse effect" or words of similar import as set
forth therein) as of the date hereof and as of the Closing Date as though made
on and as of the Closing Date (except with respect to representations and
warranties that address matters only as of a particular date, which need only
be true and correct as of such date), except to the extent that the failure to
be true and correct has not had or would not reasonably be expected to
materially adversely affect or delay the Shareholder's performance under this
Agreement or the consummation of the transactions contemplated by this
Agreement.

  


 

  

(b) _Performance of Obligations of the Company and the Shareholders_. The
Company and the Shareholders shall have performed or complied in all material
respects the obligations required to be performed or complied with by it under
this Agreement at or prior to the Closing Date.

  


 

  

(c) _No Company Material Adverse Effect_. Since the date hereof, there shall
not have been any change, effect, event, state of facts, development or
occurrence that has had or would reasonably be expected to have a Company
Material Adverse Effect.

  


 

  

(d) _FIRPTA Certificate_. An officer of the Company, and Atom shall have
executed and delivered to Parent a certificate, substantially in the form of
_Exhibits C_ and _D_ , respectively, that satisfies the requirements of
Treasury Regulation Section 1.1445-2(c)(3).

  


 

  

(e) _Officer 's Certificate_. An officer of the Company shall have executed
and delivered to Parent on behalf of the Company a certificate certifying that
the conditions set forth in _Section 8.2(a)(i) and (ii)_, _Section 8.2(b)_ and
_Section 8.2(c)_ have been satisfied. Each of the Shareholders shall have
executed and delivered to Parent on behalf of such Shareholder a

  

  

 

59  

  

  

certificate certifying that the conditions set forth in Sections 8.2(a)(iii)
and (iv) and Section 8.2(b) with respect to such Shareholder have been
satisfied.

  


 

  

8.3 _Conditions to Obligation of the Company and the Shareholders_. The
obligation of the Company and the Shareholders to effect the transactions
contemplated hereby is further subject to the satisfaction or waiver by the
Company on or prior to the Closing Date of the following conditions:

  


 

  

(a) _Representations and Warranties_. (i) the Parent Fundamental
Representations shall be true and correct in all material respects as of the
date hereof and as of the Closing Date as though made on and as of the Closing
Date (except with respect to representations and warranties that address
matters only as of a particular date, which need only be true and correct as
of such date) and (ii) each of the representations and warranties of Parent
set forth in _ARTICLE 5_ (other than those described in clause (i) above)
shall be true and correct (without giving effect to qualifications or
limitations as to "materiality," "Parent Material Adverse Effect" or words of
similar import as set forth therein) as of the date hereof and as of the
Closing Date as though made on and as of the Closing Date (except with respect
to representations and warranties that address matters only as of a particular
date, which need only be true and correct as of such date), except to the
extent that the failure to be true and correct has not had or would not
reasonably be expected to have a Parent Material Adverse Effect.

  


 

  

(b) _Performance of Obligations of Parent_. Parent shall have performed in all
material respects the obligations required to be performed by it under this
Agreement at or prior to the Closing Date.

  


 

  

(c) _Officer 's Certificate_. An officer of Parent shall have executed and
delivered to the Company on behalf of Parent a certificate certifying that
Parent has satisfied the conditions set forth in _Section 8.3(a)_ and _Section
8.3(b)_.

  


 

  

8.4 _Frustration of Closing Conditions_. None of Parent, the Company or the
Shareholders may rely on the failure of any condition to its obligation to
consummate the transactions contemplated hereby set forth in _Section 8.1_ ,
_Section 8.2_ or _Section 8.3_, as the case may be, to be satisfied if a
material cause of such failure was the failure of such party to perform any of
its obligations under this Agreement.

  


 

  

ARTICLE 9. 
  TERMINATION, AMENDMENT AND WAIVER

  


 

  

9.1 _Termination_. This Agreement may be terminated and the transactions
contemplated hereby may be abandoned at any time prior to the Closing Date:

  


 

  

(a) by mutual written consent of the Company and Parent;

  


 

  

(b) by either the Company or Parent if any Governmental Entity of competent
jurisdiction shall have issued an Order or taken any other action after the
date hereof permanently enjoining, restraining or otherwise prohibiting the
transactions contemplated hereby and such Order or other action shall have
become final and nonappealable;

  

  

 

60  

  

  

(c) by either the Company or Parent if the transactions contemplated by this
Agreement shall not have been consummated on or before July 13, 2017 (such
date, the " _Outside Date_ "); and _provided_ , _further_ , that the right to
terminate this Agreement under this _Section 9.1(c)_ shall not be available to
or on behalf of any party whose action or failure to act has been a material
cause of or resulted in the failure of the Closing to be consummated on or
prior to such date;

  


 

  

(d) by either the Company or Parent if there shall have been a breach by
Parent, on the one hand, or by the Company, on the other hand, of any of its
representations, warranties, covenants or obligations contained in this
Agreement, which breach would result in the failure to satisfy one or more of
the conditions set forth in _Section 8.2_ (in the case of a breach by the
Company) or _Section 8.3_ (in the case of a breach by Parent), and in any such
case such breach shall be incapable of being cured or, if capable of being
cured, shall not have been cured prior to the earlier of (i) forty-five (45)
Business Days after providing written notice of such breach to the breaching
party and (ii) the Outside Date;

  


 

  

(e) by the Company if (i) all of the conditions set forth in _Section 8.1_ and
_Section 8.2_ have been satisfied (other than those that require deliveries or
are tested at the time of Closing, which conditions would have been satisfied
if the Closing had occurred at the time of such termination or the failure of
which to be satisfied is in any material part due to a breach by Parent of any
of its representations, warranties, covenants or agreements contained in this
Agreement), (ii) the Company has confirmed by written notice to Parent that
all conditions set forth in _Section 8.3_ have been satisfied (other than
those that require deliveries or are tested at the time of Closing, which
conditions would have been satisfied if the Closing had occurred at the time
of such termination) or that it would be willing to waive any unsatisfied
conditions in _Section 8.3_ and (iii) Parent fails to consummate the Closing
within two (2) Business Days following the time specified in _Section 2.2_ for
the Closing to occur; and

  


 

  

(f) by Parent if (i) all of the conditions set forth in _Section 8.1_ and
_Section 8.3_ have been satisfied (other than those that require deliveries or
are tested at the time of Closing, which conditions would have been satisfied
if the Closing had occurred at the time of such termination or the failure of
which to be satisfied is in any material part due to a breach by the Company
of any of its representations, warranties, covenants or agreements contained
in this Agreement), (ii) Parent has confirmed by written notice to the Company
that all conditions set forth in _Section 8.2_ have been satisfied (other than
those that require deliveries or are tested at the time of Closing, which
conditions would have been satisfied if the Closing had occurred at the time
of such termination) or that it would be willing to waive any unsatisfied
conditions in _Section 8.2_ and (iii) the Company fails to consummate the
Closing within two (2) Business Days following the time specified in _Section
2.2_ for the Closing to occur.

  


 

  

Any proper termination of this Agreement pursuant to this _Section 9.1_ shall
be effective immediately upon the delivery of written notice of the
terminating party to the other parties.

  


 

  

9.2 _Effect of Termination_. In the event of termination of this Agreement by
either the Company or Parent as provided in _Section 9.1_ , this Agreement
shall forthwith become void and have no effect, without any liability or
obligation on the part of any party hereto or its respective affiliates,
directors, officers, employees, shareholders, partners, members or other

  

  

 

61  

  

  

Representatives, other than pursuant to the provisions of _Section 7.1_
(Expenses), _Section 7.3_ (Publication/Distribution of Agreement), this
_Section 9.2_ (Effect of Termination), and _ARTICLE 11_ (General Provisions)
(which Sections and Articles shall survive any termination of this Agreement);
_provided_ that no such termination of this Agreement shall relieve or
otherwise affect the liability of any party hereto for any willful and
intentional breach of this Agreement by such party prior to such termination
or any Fraud by or on behalf of such party. For purposes hereof, a "willful
and intentional breach" shall mean a material breach of any representation,
warranty, covenant or other agreement set forth in this Agreement that is a
consequence of an act undertaken or failure to act by the breaching party with
the actual knowledge that the taking of such act or failure to act would cause
a breach of this Agreement.

  


 

  

ARTICLE 10. 
  INDEMNIFICATION

  


 

  

10.1 _Indemnification of Parent Indemnitees._

  


 

  

(a) From and after the Closing, subject to this Article 10, each Shareholder
(other than the ESOP, for which indemnification will be provided solely from
the Indemnity Escrow Account) shall indemnify Parent, its affiliates and each
of their respective officers, directors, managers, employees, stockholders,
members, controlling Persons, agents, successors, permitted assignees, and
other Representatives (the " _Parent Indemnitees_ ") against, from and in
respect of, and hold it harmless from, and compensate and reimburse it for,
any Loss (other than a Loss which is indemnifiable under _Section 7.2(b)_ )
suffered or incurred by such Parent Indemnitee arising from or in connection
with:

  


 

  

(i) any failure of any Company Fundamental Representation or any Shareholder
Fundamental Representation of such Shareholder to be true and correct as of
the Closing Date as though made on and as of the Closing Date (except with
respect to representations and warranties that address matters only as of a
particular date, which representations and warranties need only be true and
correct as of such date);

  


 

  

(ii) any breach of any covenant or agreement of such Shareholder or, prior to
the Closing, the Company or any of its Subsidiaries contained in this
Agreement, but excluding the covenant or agreement in _Section 7.5(c)_
regarding ISRA;

  


 

  

(iii) to the extent not paid to Parent from the Purchase Price Escrow Account,
the Adjustment Amount; and

  


 

  

(iv) any foreclosure upon, or exercise of rights by a Governmental Entity in
respect of, the estate tax Lien described in _Section 3.6(b)(i) of the Company
Disclosure Schedule_.

  


 

  

(b) The obligation to provide for indemnification under _Section 10.1(a)_ ,
other than with respect to the failure of a Shareholder Fundamental
Representation to be true and correct, shall be proportionate to such
Shareholder's Fully Diluted Pro Rata Portion of the applicable Losses (such
that the total amount of such indemnity is equal to 100% of the applicable
Losses). The obligation to provide indemnification in the case of the failure
of a Shareholder Fundamental Representation to be true and correct shall be
borne solely by the

  

  

 

62  

  

  

applicable Shareholder to whom such representation relates and the obligation
to provide indemnification pursuant to _Section 10.1(a)(iv)_ shall be borne
solely by the Shareholders holding the Common Stock subject to the estate tax
Lien described in Section _3.6(b)(i) of the Company Disclosure Schedule_. Each
Shareholder's obligation to provide indemnification pursuant to _Section 10.1_
shall be several and not joint.

  


 

  

(c) Parent's sole and exclusive remedy for indemnification claims under
_Section 10.1(a)_ against the ESOP shall be to assert, otherwise in accordance
with the terms of this Agreement, claims against the Indemnity Escrow Account
and the ESOP shall not otherwise have any indemnification obligation to any
Parent Indemnitee.

  


 

  

(d) Except in the case of Fraud and except with respect to any liability
pursuant to Section 10.1(a)(iv), each Shareholder's aggregate liability
pursuant to _Section 10.1(a)_ shall not exceed such Shareholder's Fully
Diluted Pro Rata Portion of $13,200,000.

  


 

  

10.2 _Indemnification by Parent_.

  


 

  

(a) From and after the Closing, Parent shall indemnify each Shareholder, its
affiliates and each of their respective officers, directors, managers,
employees, stockholders, members, controlling Persons, agents, successors,
permitted assignees and other Representatives (the " _Shareholder Indemnitees_
") against, from and in respect of, and hold it harmless from, and compensate
and reimburse it for, any Loss suffered or incurred by such Shareholder
Indemnitee arising from or in connection with:

  


 

  

(i) any failure of (x) any Parent Fundamental Representation to be true and
correct as of the Closing Date as though made on and as of the Closing Date
(except with respect to representations and warranties that address matters
only as of a particular date, which representations and warranties need only
be true and correct as of such date); or (y) any representation or warranty
contained in any certificate or document delivered pursuant hereto to be true
and correct as of the date of delivery to the Company or the Shareholders;

  


 

  

(ii) any breach of any covenant or agreement of Parent contained in this
Agreement; and

  


 

  

(iii) failure to comply with any requirements of ISRA (as it may be amended
after the Closing) arising from the transactions contemplated by this
Agreement.

  


 

  

(b) Except in the case of Fraud, Parent shall not be required to indemnify any
Shareholder Indemnitee and shall not have any liability pursuant to _Section
10.2(a)(i)_ for any amount in excess of $13,200,000.

  


 

  

10.3 _Calculation of Losses_. The amount of any Loss for which indemnification
is provided under this _ARTICLE 10_ shall be net of any amounts actually
recovered by the indemnified party (after giving effect to any applicable
deductible, retention, collection costs, retrospectively rated premiums and
increase in future premiums as a result of or incurred in connection with the
claim) under insurance policies (including the Representation and Warranty
Insurance) with respect to such Loss. Parent shall, and shall cause the other
Parent Indemnitees to, use commercially reasonable efforts to seek all
available recovery under all insurance policies

  

  

 

63  

  

  

covering any such Loss including but not limited to the RandW Insurance. In the
event that an insurance or other recovery is made by any Parent Indemnitee
with respect to any Loss for which any such Parent Indemnitee has been
indemnified hereunder, then a refund for such amount (after giving effect to
any applicable deductible, retention, collection costs, retrospectively rated
premiums and increase in future premiums as a result of or incurred in
connection with the claim) shall be promptly made to the applicable
indemnifying party. Parent waives, to the extent permitted under its
applicable insurance policies, any subrogation rights that its insurer may
have with respect to any indemnifiable Losses.

  


 

  

10.4 _Termination of Indemnification_. The obligations to indemnify, hold
harmless, compensate and reimburse any person (i) pursuant to _Section
10.1(a)(i)_ or _10.2(a)(i)_ shall terminate when the applicable representation
or warranty terminates pursuant to _Section 11.1_, (ii) pursuant to _Section
10.1(a)(ii)_ or _10.2(a)(ii)_ shall terminate 60 days after the expiration of
the applicable statute of limitations (including all extensions thereof with
respect to such Contract or agreement), (iii) pursuant to _Section
10.2(a)(iii)_ shall terminate 60 days after the expiration of the statute of
limitations applicable to any failure to comply with any requirements of ISRA
(as it may be amended after the Closing) arising from the transactions
contemplated by this Agreement, and (iv) pursuant to the other clauses of
_Section 10.1_ shall not terminate; _provided_ , _however_ , that such
obligations to indemnify, hold harmless, compensate and reimburse shall not
terminate with respect to any item as to which the person to be indemnified
shall have, before the expiration of the applicable period, previously made a
claim by delivering a notice of such claim (stating in reasonable detail the
basis of such claim) pursuant to _Section 10.5_ to the party to be providing
the indemnification.

  


 

  

10.5 _Procedures_.

  


 

  

(a) _Third Party Claims_. In order for a person (the " _indemnified party_ ")
to be entitled to any indemnification provided for under _Section 7.2_ ,
_10.1_ or _10.2_ in respect of, arising out of or involving a claim made by
any person against the indemnified party (a " _Third Party Claim_ "), such
indemnified party must notify Parent (if the indemnified party is a
Shareholder Indemnitee) and the Shareholders' Representative (if the
indemnified party is a Parent Indemnitee) (such party, the " _indemnifying
party representative_ ") in writing (and in reasonable detail) of the Third
Party Claim within 10 Business Days after receipt by such indemnified party of
written notice of the Third Party Claim; _provided_ , _however_ , that,
subject to _Sections 10.4_ and _11.1_ , failure to give such notification
shall not affect the indemnification provided hereunder except to the extent
the indemnifying party shall have been actually prejudiced in any material
respect as a result of such failure. Thereafter, the indemnified party shall
deliver to the indemnifying party representative copies of all written notices
and documents (including court papers) received by the indemnified party
relating to the Third Party Claim.

  


 

  

(b) _Assumption_. If a Third Party Claim is made against an indemnified party,
the indemnifying party representative, at its sole cost and expense, shall be
entitled to assume the defense thereof with counsel selected by the
indemnifying party representative; _provided_ , _however_ , that if such
counsel is reasonably objected to by the indemnified party on the basis of an
actual conflict with such indemnified party, the Indemnifying Party shall
thereafter assume the defense with counsel that does not have an actual
conflict with such indemnified party. Subject to the limitations set forth in
this Section the indemnifying party representative shall be

  

  

 

64  

  

  

entitled to assume the defense of such Third Party Claim with such counsel if
it gives notice of its intention to do so to such indemnified party within 30
days of the receipt of notice of the Third Party Claim required by _Section
10.5(a);_ _provided_ that, prior to assuming control of such defense, the
indemnifying party representative shall acknowledge that assuming that the
claims made are true it would have an indemnity obligation for any Loss
resulting from such Third Party Claim as provided under _Section 7.2_ or this
_ARTICLE 10_ (it being understood that such acknowledgment would be based on
the facts known at the time it is made). The indemnifying party representative
shall not be entitled to assume or control the defense of any Third Party
Claim, and shall pay the fees and expenses of a single firm of principal
counsel retained by the indemnified party in connection therewith, if (x) the
indemnifying party representative does not deliver the acknowledgment
described in the immediately preceding sentence of this _Section 10.5(b)_
within 30 days of receipt of notice of the claim pursuant hereto; (y) the
claim arises in connection with any criminal proceeding, action, indictment,
allegation or investigation; or (z) the indemnifying party representative has
failed or is failing to prosecute or defend vigorously the claim. If the
indemnifying party representative assumes such defense, the indemnified party
shall have the right to participate in the defense thereof and to employ
counsel (not reasonably objected to by the indemnifying party representative)
separate from the counsel employed by the indemnifying party representative,
it being understood that the indemnifying party representative shall control
such defense. The indemnifying party representative shall be liable for the
fees and expenses of a single firm of principal counsel employed by the
indemnified party. If the indemnifying party representative chooses to defend
or prosecute a Third Party Claim, all the indemnified parties shall cooperate
in the defense or prosecution thereof. Such cooperation shall include the
retention and (upon the indemnifying party representative's request) the
provision to the indemnifying party representative of records and information
that are reasonably relevant to such Third Party Claim, and making employees
available on a mutually convenient basis to provide additional information and
explanation of any material provided hereunder. Whether or not the
indemnifying party representative assumes the defense of a Third Party Claim,
the indemnified party shall not admit any liability with respect to, or
settle, compromise or discharge, such Third Party Claim without the
indemnifying party representative's prior written consent. If the indemnifying
party representative assumes the defense of a Third Party Claim, the
indemnified party shall agree to any settlement, compromise or discharge of a
Third Party Claim that the indemnifying party representative may recommend and
which (i) by its terms obligates the indemnifying party to pay the full amount
of the liability in connection with such Third Party Claim, (ii) expressly and
unconditionally releases the indemnified party completely in connection with
such Third Party Claim, (iii) does not impose any injunctive or other
equitable relief on the indemnified party and (iv) does not include any
admission or finding of any violation of applicable Law by or otherwise
expressly disparage the indemnified party.

  


 

  

(c) _Other Claims_. In the event any indemnified party should have a claim
against any indemnifying party under _Section 10.1_ or _10.2_ that does not
involve a Third Party Claim being asserted against or sought to be collected
from such indemnified party, the indemnified party shall deliver notice of
such claim with reasonable promptness to the indemnifying party
representative. Subject to _Sections 10.4_ and _11.1_ , the failure by any
indemnified party to so notify the indemnifying party representative shall not
relieve the indemnifying party from any liability that it may have to such
indemnified party under _Section 10.1_ or _10.2_ , except to the extent that
the indemnifying party representative demonstrates that it has been actually
prejudiced in any material respect by such failure.

  

  

 

65  

  

  

10.6 _Release from Indemnity Escrow Account_. Upon resolution of any claim by
any Parent Indemnitee for indemnification claims pursuant to _Section 10.1(a)_
that is properly claimed against the Indemnity Escrow Account (including any
Interim Outstanding Claims and Outstanding Claims), Parent and the
Shareholders' Representative shall promptly provide joint written instructions
to the Escrow Agent to release from the Indemnity Escrow Account, as
applicable, (i) to Parent, an amount equal to the ESOP's Fully Diluted Pro
Rata Portion of the amount of such claim resolved in favor of the Parent
Indemnitee and (ii) to the extent such claim is resolved at or after the
Indemnity Escrow Release Date, to the ESOP, an amount equal to the ESOP's
Fully Diluted Pro Rata Portion of the amount of such claim resolved in favor
of the Shareholders. At such time as all Outstanding Claims have been
resolved, Parent and the Shareholders' Representative shall promptly provide
joint written instructions to the Escrow Agent to release from the Indemnity
Escrow Account to the ESOP the remainder of the amounts in the Indemnity
Escrow Account.

  


 

  

10.7 _Release from Tax Return Escrow Account_. Upon resolution of any claim by
any Parent Indemnified Party for indemnification in accordance with _Section
7.2(b)_ and _(c)_ for Taxes shown as due and payable on any Pre-Closing Tax
Return that is properly claimed against the Tax Return Escrow Account
(including any Outstanding Tax Return Claims), Parent and the Shareholders'
Representative shall promptly provide joint written instructions to the Escrow
Agent to release from the Tax Return Escrow Account, as applicable, (i) to
Parent, an amount equal to the ESOP's Fully Diluted Pro Rata Portion of the
amount of such claim resolved in favor of the Parent Indemnified Party and
(ii) to the extent such claim is resolved at or after the Tax Return Escrow
Release Date, to the ESOP, an amount equal to the ESOP's Fully Diluted Pro
Rata Portion of the amount of such claim resolved in favor of the
Shareholders. At such time as all Outstanding Tax Return Claims have been
resolved, Parent and the Shareholders' Representative shall promptly provide
joint written instructions to the Escrow Agent to release from the Tax Return
Escrow Account to the ESOP the remainder of the amounts in the Tax Return
Escrow Account, if any.

  


 

  

10.8 _Release from Tax Escrow Account_. Upon resolution of any claim by any
Parent Indemnified Party for indemnification in accordance with _Section
7.2(b)_ and _(c)_ for any Tax Return Excess or Taxes other than Taxes shown as
due and payable on any Pre-Closing Tax Return that is properly claimed against
the Tax Escrow Account (including any Outstanding Tax Claims), Parent and the
Shareholders' Representative shall promptly provide joint written instructions
to the Escrow Agent to release from the Tax Escrow Account, as applicable, (i)
to Parent, an amount equal to the ESOP's Fully Diluted Pro Rata Portion of the
amount of such claim resolved in favor of the Parent Indemnified Party and
(ii) to the extent such claim is resolved at or after the Tax Escrow Release
Date, to the ESOP, an amount equal to the ESOP's Fully Diluted Pro Rata
Portion of the amount of such claim resolved in favor of the Shareholders. At
such time as all Outstanding Tax Claims have been resolved, Parent and the
Shareholders' Representative shall promptly provide joint written instructions
to the Escrow Agent to release from the Tax Escrow Account to the ESOP the
remainder of the amounts in the Tax Escrow Account, if any.

  


 

  

10.9 _Damages_. Notwithstanding anything contrary in this Agreement, no party
hereto shall have any liability for any exemplary or punitive damages, in each
case, other than for exemplary or punitive damages paid to a third party in
connection with any Third Party Claim.

  

  

 

66  

  


 

  

10.10 _Tax Treatment_. The parties shall treat any payment made under this
Article 10 as an adjustment to the Adjusted Base Consideration for Tax
Purposes.

  


 

  

ARTICLE 11. 
  GENERAL PROVISIONS

  


 

  

11.1 _Survival of Representations, Warranties and Agreement_. The
representations, warranties and agreements in this Agreement and any
certificate delivered pursuant hereto by any Person shall survive the Closing
as follows: (a) the representations and warranties, other than the Company
Fundamental Representations, the Shareholder Fundamental Representations and
the Parent Fundamental Representations, shall not survive the Closing; and (b)
the Company Fundamental Representations, the Parent Fundamental
Representations, the Shareholder Fundamental Representations and the covenants
and agreements shall survive until 60 days after the last date on which the
right to assert any claim under _Section 10.1(a)_ of this Agreement expires
under the relevant statute of limitation (including all extension thereof). It
is understood that nothing in this _Section 11.1_ is intended to affect or
limit the ability of Parent to recover under the RandW Insurance for any matters
covered thereunder), and that this _Section 11.1_ shall not limit any covenant
or agreement of the parties hereto which by its terms contemplates
performance, or creates rights or remedies, after (a) the Closing, including,
without limitation, those contained in this _ARTICLE 10_ , _Section 7.2_,
_Section 7.4_ , _Section 7.6_ and _Section 7.7_ or (b) the termination of this
Agreement, pursuant to _ARTICLE 9._

  


 

  

11.2 _Exclusive Remedy_.

  


 

  

(a) Notwithstanding anything in this Agreement to the contrary, other than
claims of, or causes of action arising from Fraud, from and after the Closing,
Parent Indemnitees shall be entitled to recovery solely and exclusively from
the RandW Insurance for any and all Losses arising out of any breaches of the
representations and warranties of the Company and the Shareholders (other than
Company Fundamental Representations and Shareholder Fundamental
Representations), in each case made in this Agreement or in any certificate or
document delivered pursuant hereto.

  


 

  

(b) Except as set forth in _Section 11.2(a)_ and notwithstanding anything in
this Agreement to the contrary, other than claims of, or causes of action
arising from Fraud, from and after the Closing, the sole and exclusive remedy
of Parent Indemnitees and the Shareholder Indemnitees with respect to any and
all claims arising out of or relating to Parent's investigation of the
Company, this Agreement, the negotiation and execution of this Agreement or
any certificate or other document made or delivered pursuant to this Agreement
(except to the extent otherwise expressly set forth herein or therein) or the
performance by the parties hereto of its or their terms, shall be the
indemnification provisions set forth in _Section 7.2_ , _Section 7.7_ or
_ARTICLE 10_ and in no event shall any Shareholder be liable for any other
indemnification or other payment to Parent under or in connection with this
Agreement, other than (i) for the Adjustment Amount as set forth in _Section
3.4_ and (ii) pursuant to the express terms of the Escrow Agreement. Other
than claims of, or causes of action arising from Fraud, in no event shall the
Parent Indemnitees or the Shareholder Indemnitees have any right to seek any
indemnification, payment or any other recourse of any type, under or in
connection with, this Agreement or otherwise from any Shareholder or Parent,
except as set forth in this _Section_

  

  

 

67  

  

  

 _11.2(b)_. Notwithstanding anything to the contrary herein, this Section
11.2(b) shall not limit the rights (including the right to pursue all
available remedies) or obligations of Parent, its Subsidiaries (including, for
the avoidance of doubt, the Company and its Subsidiaries) or any other party
to any of the Contracts listed in Section 4.15 of the Company Disclosure
Schedule under any such Contracts.

  


 

  

(c) If any Shareholder or other Person commits or has committed Fraud,
including in respect of _Section 3.6_ , the liability of, or other remedy with
respect to, such Shareholder or other Person under applicable Law (whether
statutory or common Law) in connection with such Fraud shall be determined by
applicable Law. If Fraud is committed in the making of the representations and
warranties pursuant to Article 4 or is committed by a Specified Person in
respect of the transactions contemplated hereby, the Shareholders (other than
the ESOP) shall have several and not joint liability for the Losses arising
from such Fraud (whether or not such Shareholder committed or participated in
such Fraud) and each Shareholder (other than the ESOP) shall be obligated
solely for such Shareholder's Fully Diluted Pro Rata Portion of Losses arising
from such Fraud.

  


 

  

(d) Parent acknowledges and agrees that notwithstanding anything in this
Agreement to the contrary, the Parent Indemnitees shall have no recourse
against the ESOP or the ESOP's trustee, for claims of, or causes of action
arising from, Fraud.

  


 

  

11.3 _Notices_. All notices, requests, claims, demands and other
communications under this Agreement shall be in writing and shall be deemed
given (a) when received if delivered personally, (b) on the next Business Day
if sent by overnight courier for next Business Day delivery (providing proof
of delivery), (c) on receipt of confirmation if sent by facsimile, (d) in five
(5) Business Days if sent by United States registered or certified mail,
postage prepaid (return receipt requested), or (e) upon receipt of delivery
confirmation if sent by email to the other parties at the following addresses
(or at such other address for a party as shall be specified by like notice):

  


 

  


 

  

(a) if to Parent or, following the Closing, the Company:

  

  

Ashland Global Holdings, Inc.

  

50 East RiverCenter Boulevard,

  

Covington, Kentucky 41011

  

Attention: Peter Ganz

  

Email: Pganz@ashland.com 
  
 with a copy to: 
  
  Cravath, Swaine and Moore LLP

  

Worldwide Plaza

  

825 Eighth Avenue

  

New York, NY 10019

  

Attention: Thomas E. Dunn 
 Facsimile No.: (212) 474-3700 
  Email: tdunn@cravath.com

  

  

 

68  

  

  

(b) if to the Company or the Shareholders, to:

  


 

  

Pharmachem Laboratories Inc.

  

265 Harrison Avenue

  

Kearny, New Jersey 07032

  

Attention: Colin MacIntyre

  

Facsimile No.: 201.991.5674

  

Email: cmacintyre@pharmachemlabs.com 
  
 with a copy to: 
  
 Arnold and Porter Kaye Scholer LLP 
 250 West 55th Street 
 New York, New York 10019-9710 
 Attention: Derek Stoldt, Aaron Gardner and John Geelan 
 Facsimile No.: (212) 836-6532, (212) 836-6574 and (212) 836-6421 
  Email: derek.stoldt@apks.com, aaron.gardner@apks.com and

  

john.geelan@apks.com

  


 

  

(c) if to the Shareholders' Representative:

  


 

  

Raich Ende Malter and Co. LLP

  

175 Broadhollow Road, Suite 250

  

Melville, NY 11747

  

Attention: Howard P. Tatz

  

Facsimile No.: (516) 228-9122

  

Email: htatz@rem-co.com 
 

  

  

and

  

  

Catherine Holmes

  

15 Saddle Ridge Road

  

Ho-Ho-Kus, New Jersey 07423

  

Email: catherinefiscoholmes@gmail.com 
 

  

  

with copies to:

  

  

Arnold and Porter Kaye Scholer LLP 
 250 West 55th Street 
 New York, New York 10019-9710 
 Attention: Derek Stoldt, Aaron Gardner and John Geelan 
 Facsimile No.: (212) 836-6532, (212) 836-6574 and (212) 836-6421 
 Email: derek.stoldt@apks.com, aaron.gardner@apks.com and 
  john.geelan@apks.com

  


 

  

and

  

  

 

69  

  

  

Greenberg Traurig, P.A. 
 5100 Town Center Circle, Suite 400 
 Boca Raton, Florida 33486 
 Attention: Jeffrey S. Kahn 
 Facsimile No.: (561) 367 6235 
 Email: KahnJ@gtlaw.com

  


 

  

11.4 _Counterparts_. This Agreement may be executed in one or more
counterparts, all of which shall be considered one and the same agreement and
shall become effective when one or more counterparts have been signed by each
of the parties hereto and delivered to the other parties hereto. The exchange
of a fully executed Agreement (in counterparts or otherwise) by facsimile or
by electronic delivery in .pdf format shall be sufficient to bind the parties
hereto to the terms and conditions of this Agreement.

  


 

  

11.5 _Entire Agreement; No Third-Party Beneficiaries_. Except for the
Confidentiality Agreement, which the parties hereto agree shall terminate and
be of no further force and effect as of the Closing, this Agreement (including
the documents and instruments referred to herein) constitutes the entire
agreement between the parties hereto, and supersedes all prior agreements and
understandings, both written and oral, between the parties hereto with respect
to the subject matter hereof. Neither this Agreement nor any other agreements
contemplated hereby, is intended to confer upon any Person other than the
parties hereto any legal or equitable rights or remedies except as provided in
_Section 7.6(f)_, _Section 7.7(d)_ and _Section 11.16_.

  


 

  

11.6 _Amendment_. This Agreement may be amended by the parties hereto at any
time by an instrument in writing signed on behalf of each of the parties
hereto.

  


 

  

11.7 _Extension; Waiver_. At any time prior to the Closing, each party hereto
may (a) extend the time for the performance of any of the obligations or other
acts of the other parties hereto, (b) to the extent permitted by Law, waive
any inaccuracies in the representations and warranties contained in this
Agreement by any other party or in any document, certificate or writing
delivered pursuant hereto by any other applicable party, or (c) waive
compliance with any of the covenants, agreements or conditions contained in
this Agreement. Any agreement on the part of a party to any such extension or
waiver shall be valid only if set forth in an instrument in writing signed on
behalf of such party. The failure of any party to this Agreement to assert any
of its rights under this Agreement or otherwise shall not constitute a waiver
of such rights.

  


 

  

11.8 _Governing Law_. This Agreement and the agreements, instruments and
documents contemplated hereby shall be exclusively governed by, and construed
in accordance with, the Laws of the State of Delaware regardless of the Laws
that might otherwise govern under applicable principles of conflict of laws
thereof.

  


 

  

11.9 _Assignment; Binding Effect_. Neither this Agreement nor any of the
rights, interests or obligations hereunder shall be assigned (in whole or in
part) by any of the parties hereto (whether by operation of Law or otherwise)
without the prior written consent of the other parties, and any such
assignment without such consent shall be null and void and of no effect;
_provided_ , _however_ , that Parent may, without the consent of any other
party, assign its rights, interests and obligations under this Agreement to
Ashland Global Holdings Inc. or any of its

  

  

 

70  

  

  

Subsidiaries but no such assignment shall relieve Parent of its obligations
hereunder. No assignment by any party shall relieve such party of any of its
obligations hereunder. Subject to the preceding sentences, this Agreement
shall be binding upon, and shall inure to the benefit of, and shall be
enforceable by the parties hereto and their respective successors and assigns.

  


 

  

11.10 _Shareholders ' Representative_.

  


 

  

(a) _Powers_. The Shareholders' Representative is hereby appointed as the
Shareholders' true and lawful attorney-in-fact and agent, with full powers of
substitution and substitution, in the Shareholders' name, place and stead, in
all capacities regarding any matter under this Agreement or otherwise relating
to this Agreement, including for the purposes of: (i) making decisions with
respect to the determination of the calculations set forth in the Pre-Closing
Statement and Post-Closing Statement; (ii) entering into any settlement or
submitting any dispute relating to the Post-Closing Statement; (iii) taking
any action that may be necessary or desirable, as determined by the
Shareholders' Representative, in its sole discretion, in connection with the
termination of this Agreement in accordance with the terms hereof; (iv) taking
any action that may be necessary or desirable, as determined by the
Shareholders' Representative, in its sole discretion, in connection with the
closing of the transactions hereunder, including to determine the amount of
the Reserve to be retained and the amount, timing and circumstances of any
distribution from the Reserve; (v) taking any and all actions that may be
necessary or desirable, as determined by the Shareholders' Representative, in
its sole discretion, in connection with any amendment to this Agreement in
accordance with the terms hereof; (vi) accepting notices on behalf of
Shareholders; (vii) executing and delivering, on behalf of the Shareholders,
any and all notices, documents or certificates to be executed by the
Shareholders, in connection with the transactions contemplated by this
Agreement; (viii) making any payments or paying any expenses under or in
connection with this Agreement; (ix) granting any consent or approval on
behalf of the Shareholders or any of them; (x) entering into any settlement,
modifying any indemnification or reimbursement obligation, or instituting or
defending any litigation relating to any claim for Losses against the
Shareholders or any of them; and (xi) taking any and all actions and doing any
and all other things provided in, contemplated by or related to this Agreement
or the actions contemplated hereby to be performed on behalf of any
Shareholder. As the representative of the Shareholders, the Shareholders'
Representative shall act as the agent for each Shareholder and shall have
authority to bind each such Shareholder, and Parent may rely on such
appointment and authority until the receipt of notice of the appointment of a
successor upon two (2) Business Days' prior written notice by the existing
Shareholders' Representative to Parent. The grant of authority described
herein (i) is coupled with an interest and is irrevocable and survives the
death, incompetency, bankruptcy or liquidation of any Shareholder and (ii)
survives the consummation of the transactions contemplated hereby.

  


 

  

(b) _Reserve_. In order to cover expenses of the Shareholders' Representative
and potential obligations under _Section 3.3_ hereof, at Closing the
Shareholders' Representative shall establish a reserve (the " _Reserve_ ")
equal to the Reserve Amount with the funds paid by Parent to the Shareholders'
Representative pursuant to _Section 3.2(b)_. The Reserve Amount shall be
increased or decreased based upon interest earned thereon and distributions
made therefrom, or other amounts received or held by the Shareholders'
Representative. The Reserve may be held or disbursed by the Shareholders'
Representative in its discretion to cover any such

  

  

 

71  

  

  

expenses or potential obligations which may arise in connection with this
Agreement for payment after the Closing Date. Each Shareholder shall be
entitled to its Fully Diluted Pro Rata Portion of any amount released from the
Reserve to the Shareholders, except to the extent that the Shareholders'
Representative shall have paid a disproportionate amount of any expenses or
obligations on behalf of any Shareholder. The retention of amounts by the
Shareholders' Representative shall not be evidence that the Company, the
Shareholders or Parent has breached any provision of this Agreement or that
any amount is due or owing hereunder.

  


 

  

(c) _Liability_. The Shareholders' Representative will not be liable to any
Shareholder for any act done or omitted under this Agreement as the
Shareholders' Representative while acting in good faith, and any act taken or
omitted to be taken pursuant to the advice of counsel will be conclusive
evidence of such good faith.

  


 

  

11.11 _Specific Performance; Enforcement_.

  


 

  

(a) The parties hereto agree that irreparable damage may occur in the event
that any of the provisions of this Agreement were not performed in accordance
with their specific terms or were otherwise breached and that any breach of
this Agreement would not be adequately compensated by monetary damages. It is
accordingly agreed that the parties shall be entitled to an injunction or
injunctions or other equitable relief to prevent breaches of this Agreement
and to enforce specifically the terms and provisions of this Agreement in any
court identified in _Section 11.12_ , this being in addition to any other
remedy to which they are entitled at law or in equity, which right shall
include the right of the Company to cause the transactions contemplated by
this Agreement to be consummated. Any party seeking an injunction, a decree or
order of specific performance shall not be required to provide any bond or
other security in connection therewith and any such remedy shall be in
addition and not in substitution for any other remedy to which such party is
entitled at law or in equity.

  


 

  

(b) If a court of competent jurisdiction has declined to specifically enforce
the obligations of Parent to consummate the transactions contemplated hereby
pursuant to a claim for specific performance brought against Parent, the
Company may, for and on behalf of the Shareholders, seek and recover damages
(including damages based on loss of the economic benefits of the transactions
contemplated hereby to the Shareholders based on the consideration that would
have otherwise been payable to the Shareholders or otherwise) for any breach
of this Agreement by Parent, which right is hereby expressly acknowledged and
agreed to by Parent.

  


 

  

11.12 _Jurisdiction_.

  


 

  

(a) Each of the parties irrevocably (i) submits itself to the exclusive
jurisdiction of the Chancery Court of the State of Delaware (or in the event,
but only in the event, that such court does not have subject matter
jurisdiction over such action or proceeding, the Superior Court of the State
of Delaware or the United States District Court for the District of Delaware)
for the purpose of any litigation directly or indirectly based upon, relating
to or arising out of this Agreement or any of the transactions contemplated
hereby or the negotiation, execution or performance hereof or thereof, (ii)
agrees that it will not attempt to deny or defeat such personal jurisdiction
by motion or other request for leave from any such court and (iii) agrees that
it will not bring any action relating to this Agreement or the transactions

  

  

 

72  

  

  

contemplated hereby in any court other than the Chancery Court of the State of
Delaware (or in the event, but only in the event, that such court does not
have subject matter jurisdiction over such action or proceeding, in the
Superior Court of the State of Delaware or the United States District Court
for the District of Delaware). Each of the parties hereby irrevocably waives,
and agrees not to assert, by way of motion, as a defense, counterclaim or
otherwise, in any litigation with respect to this Agreement, (x) any claim
that it is not personally subject to the jurisdiction of the above-named
courts for any reason other than the failure to serve in accordance with this
_Section 11.12(a)_, (y) any claim that it or its property is exempt or immune
from jurisdiction of any such court or from any legal process commenced in
such courts (whether through service of notice, attachment prior to judgment,
attachment in aid of execution of judgment, execution of judgment or
otherwise) and (z) to the fullest extent permitted by the applicable Law, any
claim that (A) the suit, action or proceeding in such court is brought in an
inconvenient forum, (B) the venue of such suit, action or proceeding is
improper or (C) this Agreement, or the subject matter of this Agreement, may
not be enforced in or by such courts. Each of the parties hereby irrevocably
consents to service being made through the notice procedures set forth in
_Section 11.3_ and agrees that service of any process, summons, notice or
document by personal delivery to the respective addresses set forth in
_Section 11.3_ shall be effective service of process for any litigation in
connection with this Agreement or the transactions contemplated hereby.
Nothing in this _Section 11.12(a)_ shall affect the right of any party to
serve legal process in any other manner permitted by Law.

  


 

  

11.13 _WAIVER OF TRIAL BY JURY_. EACH PARTY HERETO AGREES THAT ANY CONTROVERSY
WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND
DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY
WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION
DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF
THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS
CONTEMPLATED HEREBY. EACH PARTY HERETO CERTIFIES AND ACKNOWLEDGES THAT (A) NO
REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HERETO HAS REPRESENTED,
EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF
LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) EACH PARTY HERETO
UNDERSTANDS AND HAS CONSIDERED THE IMPLICATION OF THIS WAIVER, (C) EACH PARTY
HERETO MAKES THIS WAIVER VOLUNTARILY AND (D) EACH PARTY HERETO HAS BEEN
INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL
WAIVERS AND CERTIFICATIONS IN THIS _SECTION 11.13_.

  


 

  

11.14 _Severability_. Whenever possible, each provision or portion of any
provision of this Agreement will be interpreted in such manner as to be
effective and valid under applicable Law, but if any provision or portion of
any provision of this Agreement is held by a court of competent jurisdiction
in a final and non-appealable Order to be invalid, illegal or unenforceable in
any respect under any applicable Law or rule in any jurisdiction, such
invalidity, illegality or unenforceability will not affect any other provision
or portion of any provision in such jurisdiction, and this Agreement will be
reformed, construed and enforced in such jurisdiction as if such invalid,
illegal or unenforceable provision or portion of any provision had never been
contained herein, so long as the economic and legal substance of the
transactions contemplated

  

  

 

73  

  

  

hereby are not affected in a manner materially adverse to any party hereto.
Upon such determination that any term or other provision is invalid, illegal
or incapable of being enforced, the parties shall negotiate in good faith to
modify this Agreement so as to effect the original intent of the parties as
closely as possible to the fullest extent permitted by applicable Law in an
acceptable manner to the end that the transactions contemplated hereby are
fulfilled to the extent possible.

  


 

  

11.15 _Company Disclosure Schedule_. All capitalized terms not defined in the
Company Disclosure Schedule shall have the meanings ascribed to them in this
Agreement. The representations, warranties, covenants and agreements of the
Company and the Shareholders set forth in this Agreement are made and given
subject to, and are qualified by, the Company Disclosure Schedule. Any
disclosure set forth in one section of the Company Disclosure Schedule shall
be deemed to apply to and qualify the section of this Agreement to which it
corresponds in number and each other section of this Agreement to the extent
that it is reasonably apparent on its face that such information is relevant
to such other section or subsection. The Company Disclosure Schedule may
include brief descriptions or summaries of certain agreements and instruments.
The descriptions or summaries do not purport to be comprehensive and are
qualified in their entirety by reference to the text of the documents
described. No disclosure set forth in the Company Disclosure Schedule relating
to any possible breach or violation of any Contract or Law shall be construed
as an admission or indication that any such breach or violation exists or has
actually occurred. The inclusion of any information in the Company Disclosure
Schedule shall not be deemed to be an admission or acknowledgment that such
information (a) is required by the terms of this Agreement to be disclosed,
(b) is material to the Company, its Subsidiaries or any other party, (c) has
resulted in or would result in a Company Material Adverse Effect or (d) is
outside the ordinary course of business. Matters reflected in the Company
Disclosure Schedule are not necessarily limited to matters required by this
Agreement to be reflected in the Company Disclosure Schedule. Such additional
matters are set forth for informational purposes and do not necessarily
include other matters of a similar nature.

  


 

  

11.16 _Legal Representation_. Each of the parties to this Agreement hereby
agrees, on its own behalf and on behalf of its directors, partners, officers,
employees and affiliates, that Arnold and Porter Kaye Scholer LLP may serve as
counsel to each and any Shareholder and its affiliates (individually and
collectively, and including the Shareholders' Representative, the "
_Shareholder Group_ "), on the one hand, and the Company and its Subsidiaries,
on the other hand, in connection with the negotiation, preparation, execution
and delivery of this Agreement and the consummation of the transactions
contemplated hereby, and that, following consummation of the Closing, Arnold and
Porter Kaye Scholer LLP (or any successor) may serve as counsel to each and
any member of the Shareholder Group or any director, partner, officer,
employee or affiliate of any member of the Shareholder Group, in connection
with any litigation, claim or obligation arising out of or relating to this
Agreement or the transactions contemplated by this Agreement notwithstanding
such representation and each of the parties hereto (including, but not limited
to, the Company) hereby consents thereto and waives any conflict of interest
arising therefrom, and each of such parties shall cause any affiliate thereof
to consent to waive any conflict of interest arising from such representation.
Parent agrees that, as to all communications among Arnold and Porter Kaye
Scholer LLP, the Company and its Subsidiaries, the Shareholders and their
respective affiliates and the Shareholders' Representative that relate in any
way to the

  

  

 

74  

  

  

transactions contemplated by this Agreement, the attorney-client privilege and
the expectation of client confidence belongs to the Shareholders and their
respective affiliates and/or the Shareholders' Representative, as applicable,
and may be controlled by the Shareholders and their respective affiliates
and/or the Shareholders' Representative and shall not pass to or be claimed by
Parent or the Company or its Subsidiaries. Notwithstanding the foregoing, in
the event that a dispute arises between Parent or the Company or its
Subsidiaries and a third party other than a party to this Agreement after the
Closing, the Company may assert the attorney-client privilege to prevent
disclosure of confidential communications by Arnold and Porter Kaye Scholer LLP
to such third party; _provided_ , _however_ , that the Company may not have
access to such confidential communications or waive such privilege without the
prior written consent of the Shareholders' Representative. This _Section
11.16_ is for the benefit of the Shareholder Group and such Persons are
intended third-party beneficiaries of this _Section 11.16_.

  


 

  

11.17 _No Obligation or Liability of Nonparties_. Except with respect to
claims of, or causes of action arising from Fraud, any claim or cause of
action based upon, arising out of, or related to this Agreement may only be
brought against Persons that are expressly named as parties hereto, and then
only with respect to the specific obligations set forth herein. Except with
respect to claims of, or causes of action arising from, Fraud or claims
brought against the Shareholders as parties to this Agreement, no former,
current or future direct or indirect equity holders, controlling persons,
shareholders, directors, officers, employees, members, managers, agents,
trustees, affiliates, general or limited partners or assignees of the Company,
the Shareholders, Parent, the Shareholders' Representative or of any former,
current or future direct or indirect equity holder, controlling person,
shareholder, director, officer, employee, member, manager, trustee, general or
limited partner, affiliate, agent or assignee of any of the foregoing shall
have any liability or obligation for any of the representations, warranties,
covenants, agreements, obligations or liabilities of the Company, the
Shareholders or Parent under this Agreement or of or for any action, suit,
arbitration, claim, litigation, investigation or proceeding based on, in
respect of, or by reason of, the transactions contemplated hereby (including
the breach, termination or failure to consummate such transactions), in each
case whether based on contract, tort or strict liability, by the enforcement
of any assessment, by any legal or equitable proceeding, by virtue of any
statute, regulation or applicable Law or otherwise and whether by or through
attempted piercing of the corporate or partnership veil, by or through a claim
by or on behalf of a party hereto or another Person or otherwise.

  


 

  


 

  


 

  

 

75   

 

  

  

IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be duly
executed and delivered as of the date first above written.

  

  

     | ASHLAND LLC |   
---|---|--- 
     |  |  |   
    

  |  

By:

  | /s/ J. Kevin Willis  |   
     |  | Name: | J. Kevin Willis  |   
     |  | Title: |  

Senior Vice President and

  

Chief Financial Officer

  |   
  

  

  

  

  

  

[SIGNATURE PAGE TO THE STOCK PURCHASE AGREEMENT]

    

  

  

  

  

 

     |  

 _Company_ :

  

  

Pharmachem Laboratories, Inc.

  |   
---|---|--- 
     |  |  |   
    

  |  

By:

  | /s/ Colin Macintyre |   
     |  | Name: | Colin Macintyre |   
     |  | Title: |  

Chief Executive Officer

  |   
  

  

  

  

  

 

[Signature Page to Stock Purchase Agreement]  

* * *

 

 

  

  

 

 

     |  

 _Shareholders_

  

  

  

DAH 2012 Trust No. 3 U/A/D December 27, 2012

  |   
---|---|--- 
     |  |  |   
    

  |  

By:

  | /s/ Howard Tatz |   
     |  | Name: | Howard Tatz |   
     |  | Title: |  

Trustee

  |   
  

  

  

  

  

 

     |  

DAH 2012 Trust No. 2 U/A/D December 27, 2012

  |   
---|---|--- 
     |  |  |   
    

  |  

By:

  | /s/ Howard Tatz |   
     |  | Name: | Howard Tatz |   
     |  | Title: |  

Trustee

  |   
  

  

 

  

  

  

 

     |  

CMH Investment Holdings LLC

  |   
---|---|--- 
     |  |  |   
    

  |  

By:

  | /s/ Catherine M. Holmes |   
     |  | Name: | Catherine M. Holmes |   
     |  | Title: |  

Sole Voting Member and Manager

  |   
  

  

 

  

  

  

 

[Signature Page to Stock Purchase Agreement]  

* * *

 

 

  

 

  

 

 

     |  

Pharmachem Laboratories, Inc. Employee Stock Ownership Trust

  

  

By: Wilmington Trust, N.A., not in its corporate or individual capacity, but
solely in its capacity as Trustee of the Pharmachem Laboratories, Inc.
Employee Stock Ownership Trust

  |   
---|---|--- 
     |  |  |   
    

  |  

By:

  | /s/ Jason L. Johnson |   
     |  | Name: | Jason L. Johnson, Vice President |   
     |  | Title: |  

Wilmington Trust, N.A.

  |   
  

  

 

  

  

 

[Signature Page to Stock Purchase Agreement]  

* * *

 

 

  

  

  

 

     |  

 _Atom Minority Shareholder_

  |   
---|---|--- 
     |  |  |   
    

  |  

By:

  | /s/ Dr. David M. Peele |   
     |  | Dr. David M. Peele |   
  

  

 

 

  

  

  

 

[Signature Page to Stock Purchase Agreement]  

* * *

 

 

  

  

  

 

 

     |  

 _Shareholders ' Representative_:

  

  

Photon SH Representative LLC, solely in its capacity as the Shareholders'
Representative

  |   
---|---|--- 
     |  |  |   
    

  |  

By:

  | /s/ Howard P. Tatz |   
     |  | Name: | Howard P. Tatz |   
     |  | Title: |  

Manager

  |   
  

  

 

  

 

  

  

 

[Signature Page to Stock Purchase Agreement]  

* * *

 

 

  

  

Exhibit A

  

 

 

  

  

    

Company Shareholder

  |  

Shares of Common Stock

   
---|--- 
    

CMH Investment Holdings LLC

  |  

246.22

   
    

DAH 2012 Trust No. 2 U/A/D December 27, 2012

  |  

28.1

   
    

DAH 2012 Trust No. 3 U/A/D December 27, 2012

  |  

28.1

   
    

Pharmachem Laboratories, Inc. Employee Stock Ownership Trust

  |  

156.9646

   
  

  

 

  

 

 

 

 

 

 

      '

